Zum Krankheits- und Symptomverzeichnis
Clinical workspace
Knowledgebase
Search the Metagene knowledgebase for metabolic diseases, symptoms and laboratory findings. Look up disease names, synonyms and ICD codes.
Erkrankungen und Symptome im Verzeichnis
Stoffwechselerkrankungen mit Synonymen und ICD-Codes aus der Metagene-Wissensdatenbank.
Ausgewählte Symptome und zugehörige Erkrankungen
Die Listen zeigen die in Metagene dokumentierten Zuordnungen. Sie ersetzen keine Diagnose.
ataxia (327)
- 2,4-DIENOYL-CoA REDUCTASE DEFICIENCY (DECRD)
- 2-HYDROXYGLUTARIC ACIDURIA (L)
- 2-KETOADIPIC ACIDEMIA (-> MOVED TO 204750)
- 2-KETOGLUTARATE DEHYDROGENASE COMPLEX DEFICIENCY
- 27-HYDROXYLASE DEFICIENCY (CTX)
- 3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY (HMGCLD)
- 3-HYDROXYISOBUTYRYL-CoA HYDROLASE DEFICIENCY (HIBCHD)
- 3-METHYLGLUTACONIC ACIDURIA (TYPE I); MGCA1
- 3-METHYLGLUTACONIC ACIDURIA (TYPE III); MGCA3
- 3-METHYLGLUTACONIC ACIDURIA (TYPE V); MGCA5
- 3-METHYLGLUTACONIC ACIDURIA (TYPE VIIA), MGCA7A
- 3-METHYLGLUTACONIC ACIDURIA (TYPE VIIB), MGCA7B
- 3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY (PHGDH)
- ABETALIPOPROTEINEMIA, BASSEN-KORNZWEIG-SYNDROME, ACANTHOCYTOSIS (ABL)
- ACERULOPLASMINEMIA
- ACETYL-CoA ACETYLTRANSFERASE-2 DEFICIENCY (ACAT2D)
- ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME (AAAS)
- ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE; AEZ
- ACUTE INTERMITTEND PORPHYRIA (AIP)
- ADENYLOSUCCINASE DEFICIENCY (ADSLD)
- ADRENOLEUKODYSTROPHY, X-LINKED (X-ALD)
- ALEXANDER DISEASE
- ALLAN-HERNDON-DUDLEY SYNDROME (AHDS)
- ALPHA-MANNOSIDOSIS
- ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY (AMACRD)
- ALTERNATING HEMIPLEGIA OF CHILDHOOD 2 (AHC2)
- ARGINASE 1 DEFICIENCY
- ARGININOSUCCINIC ACIDURIA (ASL)
- ARTS SYNDROME (ARTS)
- ATAXIA-OCULOMOTOR APRAXIA 1 (AOA1)
- ATAXIA-OCULOMOTOR APRAXIA 2 (AOA2)
- ATAXIA-OCULOMOTOR APRAXIA 3 (AOA3)
- ATAXIA-OCULOMOTOR APRAXIA 4 (AOA4)
- ATAXIA-TELANGIECTASIA (AT)
- BARDET-BIEDL SYNDROME 1 (BBS1)
- BEHR SYNDROME (BEHRS)
- BETA-MANNOSIDOSIS
- BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3 (CBAS3)
- BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6; CBAS6
- BIOTINIDASE DEFICIENCY
- BROWN-VIALETTO-VAN LAERE SYNDROME 1 (BVVLS1)
- CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY (CPS)
- CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS (CAPOS)
- CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY (CASVDD)
- CEREBRAL CREATINE DEFICIENCY SYNDROME 2; CCDS2; GAMT DEFICIENCY
- CEREBRAL FOLATE DEFICIENCY DUE TO FOLR1 AUTOANTIBODIES (CFD)
- CEROID LIPOFUSCINOSIS, NEURONAL, 1 (CLN1; SANTAVUORI-HALTIA-DISEASE)
- CEROID LIPOFUSCINOSIS, NEURONAL, 10 (CLN10)
- CEROID LIPOFUSCINOSIS, NEURONAL, 11 (CLN11)
- CEROID LIPOFUSCINOSIS, NEURONAL, 12 (CLN12)
- CEROID LIPOFUSCINOSIS, NEURONAL, 13 (CLN13)
- CEROID LIPOFUSCINOSIS, NEURONAL, 14 (CLN14)
- CEROID LIPOFUSCINOSIS, NEURONAL, 2 (CLN2)
- CEROID LIPOFUSCINOSIS, NEURONAL, 4B (CLN4B)
- CEROID LIPOFUSCINOSIS, NEURONAL, 5 (CLN5)
- CEROID LIPOFUSCINOSIS, NEURONAL, 6A (CLN6A)
- CEROID LIPOFUSCINOSIS, NEURONAL, 6B (CLN6B)
- CEROID LIPOFUSCINOSIS, NEURONAL, 7 (CLN7)
- CEROID LIPOFUSCINOSIS, NEURONAL, 8 (CLN8)
- CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT
- CEROID LIPOFUSCINOSIS, NEURONAL, 9 (CLN9)
- CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1 (CMTX1)
- CHILDHOOD CNS TUMORS [DD]
- CITRULLINEMIA TYPE I (ASS)
- CITRULLINEMIA TYPE II, NEONATAL ONSET (NICCD)
- COCKAYNE SYNDROME A (CSA)
- COCKAYNE SYNDROME B (CSB)
- COENZYME Q10 DEFICIENCY, PRIMARY, 1 (COQ10D1)
- COENZYME Q10 DEFICIENCY, PRIMARY, 3 (COQ10D3)
- COENZYME Q10 DEFICIENCY, PRIMARY, 4 (COQ10D4)
- COENZYME Q10 DEFICIENCY, PRIMARY, 6 (COQ10D6)
- COENZYME Q10 DEFICIENCY, PRIMARY, 7 (COQ10D7)
- COENZYME Q10 DEFICIENCY, PRIMARY, 9 (COQ10D9)
- COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA (CIAT)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1 (COXPD1)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10 (COXPD10)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15 (COXPD15)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20 (COXPD20)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24 (COXPD24)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3 (COXPD3)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 45 (COXPD45)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 51 (COXPD51)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 58 (COXPD58)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 60 (COXPD60)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7 (COXPD7)
- CONGENITAL DISORDER OF GLYCOSYLATION (ALG1‐CDG)
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ia (PMM2-CDG)
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ic
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ie
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-If
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ih
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIf
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIh
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIj
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-In
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ir
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iaa (CDG1AA)
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq (CDG-Iq)
- CYSTINE-LYSINURIA
- CYTOCHROME b OF COMPLEX III (MTCYB)
- D-BIFUNCTIONAL PROTEIN DEFICIENCY
- DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME (DOORS)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 100 (DEE100)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 103 (DEE103)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 104 (DEE104)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 118 (DEE118)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 120 (DEE120)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 32 (DEE32)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 47 (DEE47)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 5 (DEE5)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 51 (DEE51)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 52 (DEE52)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 71 (DEE71)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 91 (DEE91)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 92 (DEE92)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 95 (DEE95)
- DEVELOPMENTAL DELAY WITH OR WITHOUT EPILEPSY (DEVEP)
- DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY (DLDD)
- DRAVET SYNDROME (DRVT)
- DYSTONIA, DOPA-RESPONSIVE (DRD)
- DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY (SPR)
- EEFSEC DEFICIENCY
- ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1 (PEBEL1)
- ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2 (PEBEL2 )
- EPILEPSY, PROGRESSIVE MYOCLONIC, 6 (EPM6)
- EPILEPSY, PROGRESSIVE MYOCLONIC, 8 (EPM8)
- EPISODIC ATAXIA, TYPE 1 (EA1)
- EPISODIC ATAXIA, TYPE 2 (EA2)
- EPISODIC ATAXIA, TYPE 3 (EA3)
- EPISODIC ATAXIA, TYPE 4 (EA4)
- EPISODIC ATAXIA, TYPE 5 (EA5)
- EPISODIC ATAXIA, TYPE 6 (EA6)
- ETHYLMALONIC ENCEPHALOPATHY, EE (EPEMA)
- FOLATE TRANSPORT DEFICIENCY
- FRIEDREICH ATAXIA (FRDA)
- G(M1)-GANGLIOSIDOSIS, TYPE II. LIPIDOSIS, LATE INFANTILE SYSTEMIC
- G(M1)-GANGLIOSIDOSIS, TYPE III. CHRONIC/ADULT TYPE
- G(M2)-GANGLIOSIDOSIS: VARIANT 0, SANDHOFF DISEASE
- G(M2)-GANGLIOSIDOSIS: VARIANT B, TAY-SACHS DISEASE
- GALACTOSIALIDOSIS
- GALLOWAY-MOWAT SYNDROME 1 (GAMOS1)
- GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO
- GAUCHER DISEASE TYPE III (GD3)
- GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY
- GLUT-1 DEFICIENCY SYNDROME (GLUT1DS1)
- GLUTAMINASE DEFICIENCY WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND PROGRESSIVE ATAXIA
- GLUTARIC ACIDEMIA I (GA1)
- GLUTATHIONE SYNTHETASE DEFICIENCY (GSSD)
- GLYCINE ENCEPHALOPATHY 2 (GCE2)
- HAREL-YOON SYNDROME (HAYOS)
- HARTNUP DISEASE (HND)
- HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY (GPI)
- HEMOLYTIC UREMIC SYNDROME, ATYPICAL, 8, WITH RHIZOMELIC SHORT STATURE (AHUS8)
- HEREDITARY FOLATE MALABSORPTION (HFM)
- HOMOCYSTINURIA DUE TO DEFECT OF N(5,10)-METHYLENE THF DEFICIENCY (MTHFR)
- HOMOCYSTINURIA, CYSTATHIONINE BETA-SYNTHASE DEFICIENCY (CBS)
- HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblE COMPLEMENTATION TYPE (HMAE)
- HYPERGLYCINEMIA, NON-KETOTIC (NKH)
- HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA (HHH-SYNDROME)
- HYPERPHENYLALANINEMIA DUE TO 6-PYRUVOYLTETRAHYDROPTERIN SYNTHASE DEFICIENCY (PTPS)
- HYPOBETALIPOPROTEINEMIA, FAMILIAL, 1 (FHBL1)
- HYPOGLYCEMIA, FAMILIAL NEONATAL
- HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME (HADDTS)
- IMMUNODEFICIENCY 23 (IMD23)
- INFANTILE CEREBELLAR-RETINAL DEGENERATION (ICRD)
- INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 98 (XLID98)
- ISOVALERIC ACIDEMIA (IVA)
- JOUBERT SYNDROME 1 (JBTS1)
- JOUBERT SYNDROME 2 (JBTS2)
- JOUBERT SYNDROME 3 (JBTS3)
- KEARNS-SAYRE SYNDROME (KSS)
- KRABBE DISEASE
- LEBERS HEREDITARY OPTIC NEUROPATHY (LHON)
- LEIGH`S SYNDROME, SUBACUTE NECROTIZING ENCEPHALOPATHY (SNE)
- LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION (LBSL)
- LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE (LKENP)
- MALAN SYNDROME, SOTOS SYNDROME 2 (SOTOS2)
- MAPLE SYRUP URINE DISEASE (MSUD)
- MEGALOBLASTIC ANEMIA 1 (IMERSLUND-GRASBECK SYNDROME, IGS)
- MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY (DHFRD)
- MENKES SYNDROME (MNK)
- MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS; MRFACD (MED13L)
- MENTAL RETARDATION, AUTOSOMAL DOMINANT 56 (MRD56)
- METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION (MECREN)
- METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION (MECRCN)
- METACHROMATIC LEUKODISTROPHY (MLD)
- METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY
- METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY (MAT, MAT1A)
- METHYLMALONIC ACIDURIA (MMA)
- METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE
- METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE
- METHYLMALONYL-CoA EPIMERASE DEFICIENCY (MCEE)
- MEVALONIC ACIDURIA (MKD)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1 (MC1DN1)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10 (MC1DN10)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17 (MC1DN17)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19 (MC1DN19)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21 (MC1DN21)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3 (MC1DN3)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4 (MC1DN4)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5 (MC1DN5)
- MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 1 (MC2DN1)
- MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 3 (MC2DN3)
- MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 4 (MC2DN4)
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2 (MC3DN2)
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4 (MC3DN4)
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8 (MC3DN8)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 1 (MC4DN1)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 17 (MC4DN17)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 21 (MC4DN21)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 3 (MC4DN3)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 5 (MC4DN5)
- MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2 (MC5DN2)
- MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4A (MC5DN4A)
- MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 6 (MC5DN6)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 11 (MTDPS11)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 13, ENCEPHALOMYOPATHIC TYPE (MTDPS13)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (MTDPS3)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 4A, ALPERS TYPE (MTDPS4A)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 4B, MNGIE TYPE (MTDPS4B)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 6, HEPATOCEREBRAL TYPE (MTDPS6)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 7; HEPATOCEREBRAL TYPE (MTDPS7)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 9, ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA (MTDPS9)
- MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME SPECTRUM
- MITOCHONDRIAL MYOPATHY WITH DIABETES
- MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS (MMLA)
- MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B (MOCODB)
- MULTIPLE CARBOXYLASE DEFICIENCY, NEONATAL OR EARLY ONSET FORM (HLCS)
- MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2 (MCAHS2)
- MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3 (MCAHS3)
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA (MMDS2)
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6 (MMDS6)
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 9B (MMDS9B)
- MULTIPLE SULFATASE DEFICIENCY (MSD)
- MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (MDDGA14)
- MYOCLONIC EPILEPSY AND RAGGED RED FIBER DISEASE (MERRF)
- MYOCLONIC EPILEPSY, FAMILIAL INFANTILE (FIME)
- MYOPATHY WITH EXTRAPYRAMIDAL SIGNS (MPXPS)
- MYOPATHY, MITOCHONDRIAL, AND ATAXIA (MMYAT)
- N-ACETYLGLUTAMATE SYNTHETASE DEFICIENCY (NAGSD)
- NARP SYNDROME
- NEPHROTIC SYNDROME, TYPE 14 (NPHS14)
- NEUROBLASTOMA, SUSCEPTIBILITY TO [DD]
- NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET (NADGP)
- NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1 (NBIA1)
- NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4 (NBIA4)
- NEURODEGENERATION, CHILDHOOD-ONSET, WITH ATAXIA, TREMOR, OPTIC ATROPHY, AND COGNITIVE DECLINE (CONATOC)
- NEURODEGENERATION, CHILDHOOD-ONSET, WITH MULTISYSTEM INVOLVEMENT DUE TO MITOCHONDRIAL DYSFUNCTION (CONDMIM)
- NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND BRAIN ATROPHY (NEDEBA)
- NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES (NEDMAS)
- NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, IMPAIRED LANGUAGE, AND GAIT ABNORMALITIES (NEDMILG)
- NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, IMPAIRED LANGUAGE, EPILEPSY, AND GAIT ABNORMALITIES (NEDMILEG)
- NEURODEVELOPMENTAL DISORDER WITH SPASTICITY, HYPOPLASIA OF THE CORPUS CALLOSUM, AND RECURRENT INFECTIONS (NEDSCI)
- NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES
- NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET (IMNEPD1)
- NEUROOCULAR SYNDROME 2, PAROXYSMAL TYPE (NOC2)
- NIEMANN-PICK DISEASE TYPE C1 (NPC1)
- NIEMANN-PICK DISEASE, TYPE C2 (NPC2)
- NUCLEOTIDE DEPLETION SYNDROME
- OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY (OPA1)
- ORNITHINE TRANSCARBAMYLASE DEFICIENCY (OTC)
- PARKINSONISM-DYSTONIA, INFANTILE, 2 (PKDYS2)
- PELIZAEUS MERZBACHER DISEASE
- PELLAGRA-LIKE SYNDROME
- PEROXISOME BIOGENESIS DISORDER 4B (PBD4B)
- PERRAULT SYNDROME 1 (PRLTS1)
- PERRAULT SYNDROME 3 (PRLTS3)
- PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, MITOCHONDRIAL (PEPCK2)
- PHOSPHOGLYCERATE KINASE 1 DEFICIENCY
- PHOSPHOHYDROXYLYSINURIA (PHLU)
- PHOSPHORIBOSYL PYROPHOSPHATE SYNTHETASE I DEFECT (CMTX5)
- PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY (PRPPS)
- POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT (PHARC)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 11 (PCH11)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 13 (PCH13)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 1A (PCH1A)
- PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS (PEO)
- PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2 (PEOB2)
- PROPIONIC ACIDEMIA (PA, PCCA)
- PROPIONIC ACIDEMIA (PA, PCCB)
- PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY (PNP)
- PYRUVATE CARBOXYLASE DEFICIENCY (PC)
- PYRUVATE DEHYDROGENASE DEFICIENCY (E1); PDC
- PYRUVATE DEHYDROGENASE DEFICIENCY (E2)
- PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY
- REFSUM DISEASE, CLASSIC
- RESPIRATORY CHAIN DEFICIENCIES [DD]
- RETT SYNDROME (RTT)
- RIBOFLAVIN TRANSPORTER 2 DEFICIENCY (RTD2)
- RIBOSE-5-PHOSPHATE ISOMERASE DEFICIENCY
- SALLA DISEASE
- SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME (SPDRS)
- SARCOSINEMIA
- SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE (SESAMES)
- SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS (SANDO)
- SERINE DEFIENCY SYNDROME (NEW DISEASE?)
- SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION (SSMED)
- SIALIDOSIS TYPE I
- SIALIDOSIS TYPE II
- SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA (ASAT)
- SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE (SPAX5)
- SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE (SACS)
- SPASTIC PARAPLEGIA 2, X-LINKED (SPG2)
- SPASTIC PARAPLEGIA 91, AUTOSOMAL DOMINANT, WITH OR WITHOUT CEREBELLAR ATAXIA (SPG91)
- SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT (SPG9A)
- SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15 (SCAR15)
- SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20 (SCAR20)
- SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21 (SCAR21)
- SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25 (SCAR25)
- SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 34 (SCAR34)
- SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3 (SCAN3)
- SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE (SEMDG)
- SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY (SSADH)
- SULFITE OXIDASE DEFICIENCY, ISOLATED (ISOD)
- TESSADORI-BICKNELL-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1 (TEBIVANED1)
- THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2
- THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE); THMD5
- THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME (TRMA)
- TRANSCOBALAMIN II DEFICIENCY
- TRYPTOPHANURIA WITH DWARFISM
- TYROSINEMIA III
- UROCANASE DEFICIENCY (UROCD)
- VITAMIN E DEFICIENCY (AVED)
- WILSON DISEASE (WD)
- WOLFRAM SYNDROME 1 (WFS1)
- XIA-GIBBS SYNDROME (XIGIS)
- YME1L1 DEFICIENCY
developmental delay (498)
- 2,4-DIENOYL-CoA REDUCTASE DEFICIENCY (DECRD)
- 2-AMINOADIPIC ACIDURIA (AMOCAD, AMOXAD)
- 2-HYDROXYGLUTARIC ACIDURIA (D) TYPE I
- 2-HYDROXYGLUTARIC ACIDURIA (D) TYPE II
- 2-HYDROXYGLUTARIC ACIDURIA (L)
- 2-KETOGLUTARATE DEHYDROGENASE COMPLEX DEFICIENCY
- 2-METHYL-3-HYDROXYBUTYRYL-CoA DEHYDROGENASE DEFICIENCY (HSD10)
- 27-HYDROXYLASE DEFICIENCY (CTX)
- 3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY (HMGCLD)
- 3-HYDROXYISOBUTYRIC ACIDURIA (HIBADH)
- 3-HYDROXYISOBUTYRYL-CoA HYDROLASE DEFICIENCY (HIBCHD)
- 3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY (MCC2D)
- 3-METHYLGLUTACONIC ACIDURIA (TYPE I); MGCA1
- 3-METHYLGLUTACONIC ACIDURIA (TYPE V); MGCA5
- ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME (AAAS)
- ADENOSINE KINASE DEFICIENCY
- ADENYLOSUCCINASE DEFICIENCY (ADSLD)
- AICARDI-GOUTIERES SYNDROME 1 (AGS1)
- AICARDI-GOUTIERES SYNDROME 5 (AGS5)
- AICARDI-GOUTIERES SYNDROME 6 (AGS6)
- AICARDI-GOUTIERES SYNDROME 8 (AGS8)
- AICARDI-GOUTIERES SYNDROME 9 (AGS9)
- ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME (AAMR)
- ALLAN-HERNDON-DUDLEY SYNDROME (AHDS)
- ALPHA-AMINO-ADIPIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY (AAASAD)
- ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY (AMACRD)
- ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE I: SCHINDLER DISEASE,
- ALSTRÖM SYNDROME (ALMS)
- ARGINASE 1 DEFICIENCY
- ARGININOSUCCINIC ACIDURIA (ASL)
- AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY (AADC)
- ASPARAGINE SYNTHETASE DEFICIENCY (ASNSD)
- ASPARTYLGLUCOSAMINURIA (AGU)
- AUTOINFLAMMATORY SYNDROME WITH CYTOPENIA, HYPERZINCEMIA, AND HYPERCALPROTECTINEMIA (AICZC)
- BARDET-BIEDL SYNDROME 1 (BBS1)
- BARTTER SYNDROME, TYPE 1, ANTENATAL (BARTS1)
- BARTTER SYNDROME, TYPE 2, ANTENATAL (BARTS2)
- BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS (BARTS4A)
- BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS (BARTS4B)
- BEHR SYNDROME (BEHRS)
- BETA-MANNOSIDOSIS
- BHLHE22-RELATED NEURODEVELOPMENTAL DISORDER (NEW)
- BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6; CBAS6
- BIOTINIDASE DEFICIENCY
- BMPR2-RELATED NEURODEVELOPMENTAL DISORDER (NEW)
- BRAIN SMALL VESSEL DISEASE 3 ( BSVD3)
- BRANCHED-CHAIN AMINOTRANSFERASE 2 (BCAT2)
- BRANCHED-CHAIN KETO ACID DEHYDROGENASE KINASE DEFICIENCY (BCKDKD)
- BRUNNER SYNDROME (MONOAMINE OXIDASE-A DEFICIENCY (MAO-A)
- CANAVAN DISEASE (ASPA)
- CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY (CPS)
- CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO (CA5AD)
- CASGID SYNDROME (CASGID)
- CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA (CAGSSS)
- CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY (CASVDD)
- CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1; CREATINE-TRANSPORTER DEFECT (CTD)
- CEREBRAL CREATINE DEFICIENCY SYNDROME 2; CCDS2; GAMT DEFICIENCY
- CEREBRAL CREATINE DEFICIENCY SYNDROME 3 (GATM, AGAT DEFICIENCY)
- CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z (CMT2Z)
- CHONDRODYSPLASIA PUNCTATA1, X-LINKED RECESSIVE (CDPX1)
- CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB
- CITRULLINEMIA TYPE I (ASS)
- CITRULLINEMIA TYPE II, NEONATAL ONSET (NICCD)
- CK SYNDROME
- COBALAMIN F DISEASE (cblF)
- COENZYME Q10 DEFICIENCY, PRIMARY, 4 (COQ10D4)
- COENZYME Q10 DEFICIENCY, PRIMARY, 5 (COQ10D5)
- COENZYME Q10 DEFICIENCY, PRIMARY, 8 (COQ10D8)
- COFFIN-SIRIS SYNDROME 1 (CSS1)
- COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA (CIAT)
- COMBINED MALONIC AND METHYLMALONIC ACIDURIA (CMAMMA)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10 (COXPD10)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11 (COXPD11)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12 (COXPD12)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13 (COXPD13)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14 (COXPD14)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15 (COXPD15)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17 (COXPD17)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20 (COXPD20)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21 (COXPD21)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23 (COXPD23)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24 (COXPD24)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25 (COXPD25)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26 (COXPD26)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28 (COXPD28)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29 (COXPD29)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3 (COXPD3)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31 (COXPD31)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32 (COXPD32)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35 (COXPD35)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36 (COXPD36)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37 (COXPD37)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38 (COXPD38)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39 (COXPD39)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 44 (COXPD44)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 45 (COXPD45)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 46 (COXPD46)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 47 (COXPD47)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 48 (COXPD48)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5 (COXPD5)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 50 (COXPD50)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 51 (COXPD51)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 52 (COXPD52)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 53 (COXPD53)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 54 (COXPD54)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 55 (COXPD55)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 56 (COXPD56)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 57 (COXPD57)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 58 (COXPD58)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 59 (COXPD59)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9 (COXPD9)
- CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION (CHLND)
- CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG (NGLY1-CDDG)
- CONGENITAL DISORDER OF GLYCOSYLATION (GFUS-CDG)
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ic
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ie
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ig
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ii
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIb
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIc
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIf
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIg
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIL
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIm (SLC35A2-CDG)
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIn
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Il
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Im
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ip
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ir
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Is
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ix
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Iy
- CONGENITAL DISORDER OF GLYCOSYLATION TYPE IIv (CDG2V)
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE CDG-Iw (CDG1W)
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Icc (CDG-ICC)
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIbb (CDG2BB)
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIcc (CDG2CC)
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi (CDG-IIi)
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIt (CDG2T)
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu (CDG1U)
- CONGENITAL GLUTAMINE DEFICIENCY; GLUTAMINE SYNTHASE DEFICIENCY
- CONGENITAL HYPERINSULINISM AND HYPOPITUITARISM
- CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB (ARCL2B)
- CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA (ARCL3A)
- D-BIFUNCTIONAL PROTEIN DEFICIENCY
- DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME (DOORS)
- DENT DISEASE 2
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 102 (DEE102)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 103 (DEE103)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 104 (DEE104)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 105 (DEE105)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 106 (DEE106)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 107 (DEE107)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 109 (DEE109)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 11 (DEE11)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 110 (DEE110)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 111 (DEE111)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 112 (DEE112)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 113 (DEE113)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 114 (DEE114)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 116 (DEE116)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 117 (DEE117)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 118 (DEE118)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 119 (DEE119)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 12 (DEE12)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 120 (DEE120)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 121 (DEE121)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 122 (DEE122)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17 (DEE17)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 2 (DEE2)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 26 (DEE26)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 27 (DEE27)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 3 (DEE3)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 35 (DEE35)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 39 WITH LEUKODYSTROPHY (DEE39)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 41 (DEE41)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 44 (DEE44)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 47 (DEE47)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 52 (DEE52)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 55 (DEE55)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 60 (DEE60)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 61 (DEE61)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 67 (DEE67)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 68 (DEE68)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 69 (DEE69)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 7 (DEE7)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 70 (DEE70)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 71 (DEE71)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 72 (DEE72)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 74 (DEE74)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 75 (DEE75)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 78 (DEE78)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 79 (DEE79)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 8 (DEE8)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 80 (DEE80)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 82 (DEE82)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 83 (DEE83)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 84 (DEE84)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 86 (DEE86)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 87 (DEE87)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 88 (DEE88)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 89 (DEE89)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 9 (DEE9)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 91 (DEE91)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 92 (DEE92)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 93 (DEE93)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 94 (DEE94)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 95 (DEE95)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 96 (DEE96)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 97 (DEE97)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 98 (DEE98)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 99 (DEE99)
- DEVELOPMENTAL DELAY WITH HYPOTONIA, MYOPATHY, AND BRAIN ABNORMALITIES (DEDHMB)
- DEVELOPMENTAL DELAY WITH OR WITHOUT EPILEPSY (DEVEP)
- DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL DISABILITY AND DYSMORPHIC FACIES (DIDDF)
- DIABETES MELLITUS, PERMANENT NEONATAL, 3 (PNDM3)
- DIGENIC METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE
- DIGEORGE SYNDROME (DGS)
- DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY (DLDD)
- DIHYDROPYRIMIDINASE DEFICIENCY (DHP)
- DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY (DPD)
- DRAVET SYNDROME (DRVT)
- DYSTONIA, EARLY-ONSET, AND/OR SPASTIC PARAPLEGIA (DYTSPG)
- EEFSEC DEFICIENCY
- EHMT2-RELATED NEURODEVELOPMENTAL DISORDER (NEW)
- EIF1AX-RELATED NEURODEVELOPMENTAL DISORDER (NEW)
- ELAVL2-RELATED NEURODEVELOPMENTAL DISORDER (NEW)
- ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1 (EMPF1)
- ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS
- ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES (NELABA)
- ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM
- ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2 (PEBEL2 )
- EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT MENTAL RETARDATION (FESD)
- EPILEPSY, PROGRESSIVE MYOCLONIC, 6 (EPM6)
- FANCONI-BICKEL SYNDROME (FBS)
- FETAL ALCOHOL SPECTRUM DISORDER (FASD) [DD]
- G(M1)-GANGLIOSIDOSIS, TYPE I. PSEUDO-HURLER-DISEASE
- G(M2)-GANGLIOSIDOSIS: GM2 ACTIVATOR DEFICIENCY
- GALLOWAY-MOWAT SYNDROME 2, X-LINKED (GAMOS2)
- GALLOWAY-MOWAT SYNDROME 3 (GAMOS3)
- GALLOWAY-MOWAT SYNDROME 4 (GAMOS4)
- GAUCHER DISEASE TYPE I (GD1)
- GLUT-1 DEFICIENCY SYNDROME (GLUT1DS1)
- GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY; FORMIMINOGLUTAMIC ACIDURIA (FIGLU)
- GLUTAMINASE DEFICIENCY WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND PROGRESSIVE ATAXIA
- GLUTATHIONURIA (GGT1)
- GLYCINE ENCEPHALOPATHY 2 (GCE2)
- GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE (GLYT1)
- GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 1 (GPIBD1)
- GRISCELLI SYNDROME, TYPE 1 (GS1)
- HAJDU-CHENEY SYNDROME (HJCYS)
- HAREL-YOON SYNDROME (HAYOS)
- HEMOLYTIC UREMIC SYNDROME, ATYPICAL, 8, WITH RHIZOMELIC SHORT STATURE (AHUS8)
- HEREDITARY FOLATE MALABSORPTION (HFM)
- HOMOCYSTINURIA, CYSTATHIONINE BETA-SYNTHASE DEFICIENCY (CBS)
- HYPERALDOSTERONISM, FAMILIAL, TYPE IV (HALD4)
- HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 8 (HHF8)
- HYPERMANGANESEMIA WITH DYSTONIA 2 (HMNDYT2)
- HYPERMETABOLISM DUE TO UNCOUPLED MITOCHONDRIAL OXIDATIVE PHOSPHORYLATION 1 ( HUMOP1)
- HYPERMETABOLISM DUE TO UNCOUPLED MITOCHONDRIAL OXIDATIVE PHOSPHORYLATION 2 (HUMOP2)
- HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA (HHH-SYNDROME)
- HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT (DNAJC12)
- HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2 (HPMRS2, PIGO-CDG))
- HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3 (HPMRS3)
- HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4 (HPMRS4)
- HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6 (HPMRS6)
- HYPERPROLINEMIA, TYPE I
- HYPERTROPHIC CARDIOMYOPATHY AND RENAL TUBULAR DYSFUNCTION
- HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME; HUPRAS
- HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT (HOD)
- HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME (HADDTS)
- HYPOTONIA-CYSTINURIA SYNDROME
- IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA (IMDDHH)
- IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES (ISDNA)
- INFANTILE LIVER FAILURE SYNDROME 1 (ILFS1)
- INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA (IDDCA)
- INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES (IDDNPF)
- INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT PERIPHERAL NEUROPATHY (IDDPN)
- INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 35 (MRD35)
- INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 36 (MRD36)
- INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 61 (MRD61)
- INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 72 (MRD72)
- INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68 (MRT68)
- INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 83 (MRT83)
- INTELLECTUAL DISABILITY, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA (IDEDNIK)
- INTERSTITIAL LUNG AND LIVER DISEASE (ILLD)
- ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY
- ISOVALERIC ACIDEMIA (IVA)
- JOUBERT SYNDROME 1 (JBTS1)
- KABUKI SYNDROME 1 (KABUK1)
- KABUKI SYNDROME 2 (KABUK2)
- KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL RECESSIVE (KIDAR)
- LACTIC ACIDOSIS, HYPOGLYCEMIA AND DEVELOPMENTAL DELAY (NEW DISEASE)
- LANOSTEROL DEMETHYLASE DEFICIENCY
- LATHOSTEROLOSIS
- LEUKOENCEPHALOPATHY, PROGRESSIVE, INFANTILE-ONSET, WITH OR WITHOUT DEAFNESS (LEPID)
- LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE (LKENP)
- MALAN SYNDROME, SOTOS SYNDROME 2 (SOTOS2)
- MALONYL-COA DECARBOXYLASE DEFICIENCY
- MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY (DHFRD)
- MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14 (MRT14)
- MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15 (MAN1B1-CDG)
- MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA (MEDNIK)
- METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION (MECREN)
- METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION (MECRCN)
- METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY
- METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY (MMSDH)
- METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE
- METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA DUE TO ZNF143 DEFICIENCY
- METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE
- METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE
- METHYLMALONIC ACIDURIA, cblB TYPE
- MEVALONIC ACIDURIA (MKD)
- MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 1 (MEDS1)
- MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY (MSCCA)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10 (MC1DN10)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11 (MC1DN11)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12 (MC1DN12)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13 (MC1DN13)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14 (MC1DN14)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17 (MC1DN17)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18 (MC1DN18)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19 (MC1DN19)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2 (MC1DN2)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21 (MC1DN21)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22 (MC1DN22)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23 (MC1DN23)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25 (MC1DN25)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27 (MC1DN27)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28 (MC1DN28)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31 (MC1DN31)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32 (MC1DN32)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33 (MC1DN33)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34 (MC1DN34)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 36 (MC1DN36)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 37 (MC1DN37)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4 (MC1DN4)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5 (MC1DN5)
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1 (MC3DN1)
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2 (MC3DN2)
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3 (MC3DN3)
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4 (MC3DN4)
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5 (MC3DN5)
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7 (MC3DN7)
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8 (MC3DN8)
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9 (MC3DN9)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 1 (MC4DN1)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 12 (MC4DN12)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 14 (MC4DN14)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 15 (MC4DN15)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 2 (MC4DN2)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 20 (MC4DN20)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 21 (MC4DN21)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 23 (MC4DN23)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 24 (MC4DN24)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 25 (MC4DN25)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 3 (MC4DN3)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 5 (MC4DN5)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 6 (MC4DN6)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 7 (MC4DN7)
- MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2 (MC5DN2)
- MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4A (MC5DN4A)
- MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5 (MC5DN5)
- MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 6 (MC5DN6)
- MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 7 (MC5DN7)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 13, ENCEPHALOMYOPATHIC TYPE (MTDPS13)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 17 (MTDPS17)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 4A, ALPERS TYPE (MTDPS4A)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 4B, MNGIE TYPE (MTDPS4B)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (MTDPS5)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 6, HEPATOCEREBRAL TYPE (MTDPS6)
- MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME SPECTRUM
- MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS (MMLA)
- MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY (MPYCD)
- MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY (SCEH)
- MOHR-TRANEBJAERG SYNDROME (MTS)
- MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C (MOCODC)
- MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY
- MORFAN SYNDROME
- MUCOLIPIDOSIS II
- MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME (MPSPS)
- MULTIPLE CARBOXYLASE DEFICIENCY, NEONATAL OR EARLY ONSET FORM (HLCS)
- MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1 (MCAHS1)
- MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2 (MCAHS2)
- MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3 (MCAHS3)
- MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 4 (MCAHS4)
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA (MMDS2)
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5 (MMDS5)
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6 (MMDS6)
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 7 (MMDS7)
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 9B (MMDS9B)
- MULTIPLE SULFATASE DEFICIENCY (MSD)
- MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY (MDCCAID)
- MUSCULAR DYSTROPHY, CONGENITAL, WITH OR WITHOUT SEIZURES (MYOS)
- MYASTHENIC SYNDROME, CONGENITAL, 15 (CMS15)
- N-ACETYLGLUTAMATE SYNTHETASE DEFICIENCY (NAGSD)
- NARP SYNDROME
- NEPHROTIC SYNDROME, TYPE 14 (NPHS14)
- NEURODEGENERATION AND SEIZURES DUE TO COPPER TRANSPORT DEFECT (NSCT)
- NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1 (NBIA1)
- NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6 (NBIA6)
- NEURODEGENERATION, CHILDHOOD-ONSET, WITH MULTISYSTEM INVOLVEMENT DUE TO MITOCHONDRIAL DYSFUNCTION (CONDMIM)
- NEURODEGENERATION, INFANTILE-ONSET, BIOTIN-RESPONSIVE (NERIB)
- NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES (NEDLBA)
- NEURODEVELOPMENTAL DISORDER WITH CARDIOMYOPATHY, SPASTICITY, AND BRAIN ABNORMALITIES (NEDCASB)
- NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND BRAIN ATROPHY (NEDEBA)
- NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND AUTISTIC FEATURES WITH OR WITHOUT HYPERKINETIC MOVEMENTS (NEDHAHM)
- NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ABSENT SPEECH, AND HYPOTONIA (NEDMISH)
- NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION (NEDMEHM)
- NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, IMPAIRED LANGUAGE, AND GAIT ABNORMALITIES (NEDMILG)
- NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, IMPAIRED LANGUAGE, EPILEPSY, AND GAIT ABNORMALITIES (NEDMILEG)
- NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY (NDMSCA)
- NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE (NDHMSR)
- NEURODEVELOPMENTAL DISORDER WITH SPASTICITY, HYPOPLASIA OF THE CORPUS CALLOSUM, AND RECURRENT INFECTIONS (NEDSCI)
- NEURODEVELOPMENTAL DISORDER WITH STRUCTURAL BRAIN ABNORMALITIES AND CRANIOFACIAL ABNORMALITIES (NEDBAC)
- NEUROOCULAR SYNDROME 1 (NOC1)
- NEUROOCULAR SYNDROME 2, PAROXYSMAL TYPE (NOC2)
- NEUTROPENIA, SEVERE CONGENITAL, 9, AUTOSOMAL DOMINANT (SCN9)
- NIEMANN-PICK DISEASE, TYPE C2 (NPC2)
- NOVEL NEURODEVELOPMENTAL SYNDROME (RABGAP1)
- NPTN-RELATED NEURODEVELOPMENTAL DISORDER (NEW)
- NUCLEOTIDE DEPLETION SYNDROME
- OCULOCEREBRORENAL SYNDROME OF LOWE
- ORNITHINE TRANSCARBAMYLASE DEFICIENCY (OTC)
- OROTIC ACIDURIA, HEREDITARY (HOA)
- PAGANINI-MIOZZO SYNDROME (MRXSPM)
- PARKINSONISM-DYSTONIA, INFANTILE, 1 (PKDYS1)
- PARKINSONISM-DYSTONIA, INFANTILE, 2 (PKDYS2)
- PELLAGRA-LIKE SYNDROME
- PEROXISOME BIOGENESIS DISORDER 1B (PBD1B, NALD)
- PEROXISOME BIOGENESIS DISORDER 4B (PBD4B)
- PHOSPHATIDYLINOSITOL 4-KINASE TYPE 2 ALPHA DEFICIENCY (PI4K2A)
- PHOSPHOGLYCERATE KINASE 1 DEFICIENCY
- PHOSPHORIBOSYLFORMYLGLYCINAMIDINE SYNTHASE DEFICIENCY (PFAS)
- PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY (PRPPS)
- PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY
- PONTOCEREBELLAR HYPOPLASIA, TYPE 13 (PCH13)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 14 (PCH14)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 1B (PCH1B)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 2A (PCH2A)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 3 (PCH3)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 6 (PCH6)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 7 (PCH7)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 8 (PCH8)
- PRADER-WILLI SYNDROME (PWS)
- PREP-RELATED NEURODEVELOPMENTAL DISORDER (NEW)
- PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES (PASNA)
- PROLIDASE DEFICIENCY
- PSEUDONEONATAL ADRENOLEUKODYSTROPHY
- PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY (PNP)
- PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY (PNPO)
- PYRUVATE CARBOXYLASE DEFICIENCY (PC)
- PYRUVATE DEHYDROGENASE DEFICIENCY (E1); PDC
- PYRUVATE DEHYDROGENASE DEFICIENCY (E2)
- PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD
- PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY (PDHPD)
- RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 1 (RILDBC1)
- RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 2 (RILDBC2)
- ReNU SYNDROME (RENU)
- RIBOSE-5-PHOSPHATE ISOMERASE DEFICIENCY
- S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY (SAHH)
- SALLA DISEASE
- SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME (SPDRS)
- SARCOSINEMIA
- SC4MOL DEFICIENCY
- SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME (SCBMS)
- SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE (SESAMES)
- SHORT CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY (SCAD)
- SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS (SDDHD, TKT)
- SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION (SSMED)
- SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 9 (DHRS9)
- SIALIDOSIS TYPE I
- SIALIDOSIS TYPE II
- SIALURIA
- SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA (ASAT)
- SMITH-LEMLI-OPITZ SYNDROME (SLOS)
- SNIJDERS BLOK-CAMPEAU SYNDROME (SNIBCPS)
- SOTOS SYNDROME 1 (SOTOS1)
- SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE (SPG5A)
- SPASTIC PARAPLEGIA 82, AUTOSOMAL RECESSIVE (SPG82)
- SPASTIC PARAPLEGIA 91, AUTOSOMAL DOMINANT, WITH OR WITHOUT CEREBELLAR ATAXIA (SPG91)
- SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20 (SCAR20)
- SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE (SEMDG)
- SQUALENE SYNTHASE DEFICIENCY
- STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME (SHDRA)
- SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY (SSADH)
- SULFITE OXIDASE DEFICIENCY, ISOLATED (ISOD)
- TESSADORI-BICKNELL-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1 (TEBIVANED1)
- THIAMINE METABOLISM DYSFUNCTION SYNDROME 3 (MICROCEPHALY TYPE); THMD3
- THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE); THMD5
- THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME (TRMA)
- THYROID HORMONE METABOLISM, ABNORMAL (THMA)
- TIMOTHY SYNDROME (TS)
- TRANSCOBALAMIN II DEFICIENCY
- TYROSINEMIA I
- UREIDOPROPIONASE DEFICIENCY
- XIA-GIBBS SYNDROME (XIGIS)
- ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD; FEEDING: BREAST MILK [DD]
hypoglycemia (195)
- 2-KETOGLUTARATE DEHYDROGENASE COMPLEX DEFICIENCY
- 2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY (2-MBDD, SBCADD)
- 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY (HSD3B2)
- 3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY (HMGCLD)
- 3-HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE DEFICIENCY (HMGCS2D)
- 3-METHYL-CROTONYL-GLYCINURIA (3-MCC, MCC1D)
- 3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY (MCC2D)
- 3-METHYLGLUTACONIC ACIDURIA (TYPE I); MGCA1
- 3-METHYLGLUTACONIC ACIDURIA (TYPE IV); MGCA4
- 3-METHYLGLUTACONIC ACIDURIA (TYPE VI); MGCA6 (MEGDEL)
- [TREATMENT/THERAPY]: GLUCOSE [DD]
- ACETYL-CoA ACETYLTRANSFERASE-2 DEFICIENCY (ACAT2D)
- ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME (AAAS)
- ACTH DEFICIENCY, ISOLATED
- ADENOSINE KINASE DEFICIENCY
- ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY (CAH)
- ADRENAL HYPOPLASIA. ADDISON DISEASE, X-LINKED
- ALPHA-AMINO-ADIPIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY (AAASAD)
- AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY (AADC)
- ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1 (GACI1)
- ASPHYXIA [DD]
- BARTH SYNDROME (BTHS)
- BECKWITH-WIEDEMANN SYNDROME. EXOMPHALOS-MAKROGLOSSIA-GIGANTISM SYNDROME (BWS)
- BETA-KETOTHIOLASE DEFICIENCY; ALPHA-METHYLACETOACETIC ACIDURIA
- BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3 (CBAS3)
- BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6; CBAS6
- BLUE DIAPER SYNDROME
- CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO (CA5AD)
- CARNITINE DEFICIENCY, MYOPATHIC
- CARNITINE PALMITOYL TRANSFERASE DEFICIENCY (II), CPT2, MYOPATHIC, STRESS-INDUCED
- CARNITINE PALMITOYL TRANSFERASE DEFICIENCY 1A (CPT1A)
- CARNITINE PALMITOYLTRANSFERASE DEFICIENCY (II), CPT2, INFANTILE
- CARNITINE TRANSPORTER DEFICIENCY; PRIMARY SYSTEMIC CARNITINE DEFICIENCY
- CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY (CACT)
- CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1; CREATINE-TRANSPORTER DEFECT (CTD)
- CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5 (PFIC5)
- CITRULLINEMIA TYPE II, NEONATAL ONSET (NICCD)
- COMBINED MALONIC AND METHYLMALONIC ACIDURIA (CMAMMA)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10 (COXPD10)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16 (COXPD16)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34 (COXPD34)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36 (COXPD36)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37 (COXPD37)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39 (COXPD39)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 40 (COXPD40)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 41 (COXPD41)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 42 (COXPD42)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 46 (COXPD46)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 52 (COXPD52)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 60 (COXPD60)
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ia (PMM2-CDG)
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ib (MPI)
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Id
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Im
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-It
- CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION (CDGF)
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIaa (CDG2AA)
- CONGENITAL HYPERINSULINISM AND HYPOPITUITARISM
- COPPER CHAPERONE FOR SUPEROXIDE DISMUTASE (CCS)
- COSTELLO SYNDROME (CSTLO)
- CYTOCHROME b OF COMPLEX III (MTCYB)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 105 (DEE105)
- DIABETES, FETAL EFFECTS FROM MATERNAL
- DIARRHEA 13 (DIAR13)
- DICARBOXYLIC AMINOACIDURIA (DCBXA)
- DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY (DLDD)
- DONOHUE SYNDROME
- DOPAMINE BETA-HYDROXYLASE DEFICIENCY (DBH)
- FAMILIAL HYPERINSULINEMIA AND HYPERPROINSULINEAMIA WITH MILD DIABETES
- FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG (FRTS4)
- FANCONI-BICKEL SYNDROME (FBS)
- FEEDING: LITCHI TOXICITY [DD]
- FRUCTOSE INTOLERANCE, HEREDITARY (HFI)
- FRUCTOSE-1,6-BIPHOSPHATASE DEFICIENCY (FBP1D)
- GALACTOSEMIA (GALT-D)
- GLUCAGON DEFICIENCY
- GLUCOCORTICOID DEFICIENCY 1 (GCCD1)
- GLUCOCORTICOID DEFICIENCY 2 (GCCD2)
- GLUCOCORTICOID DEFICIENCY 3 (GCCD3)
- GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY (GCCD4)
- GLUCOCORTICOID RESISTANCE (GCCR)
- GLUTARIC ACIDURIA II (MADD, ETF)
- GLYCEROL INTOLERANCE SYNDROM (GIS)
- GLYCEROL KINASE DEFICIENCY
- GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL
- GLYCOGEN STORAGE DISEASE TYPE 0a (GSD0a)
- GLYCOGEN STORAGE DISEASE TYPE IA (GSD1a)
- GLYCOGEN STORAGE DISEASE TYPE IB (GSD1b)
- GLYCOGEN STORAGE DISEASE TYPE IC (GSD1c)
- GLYCOGEN STORAGE DISEASE TYPE III. FORBES DISEASE, CORI DISEASE (GSD3)
- GLYCOGEN STORAGE DISEASE TYPE IV. ANDERSEN DISEASE (GSD4)
- GLYCOGEN STORAGE DISEASE TYPE IXA1 (GSD9A1)
- GLYCOGEN STORAGE DISEASE TYPE IXB (GSD9B)
- GLYCOGEN STORAGE DISEASE TYPE IXC (GSD9C)
- GLYCOGEN STORAGE DISEASE TYPE VI. HERS DISEASE (GSD6)
- GRACILE SYNDROME
- HEMOCHROMATOSIS, NEONATAL
- HYPERINSULINEMIC HYPOGLYCEMIA DUE TO UNCOUPLING PROTEIN 2 (UCP2)
- HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1 (HHF1)
- HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2 (HHF2)
- HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3 (HHF3)
- HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4 (HHF4)
- HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5 (HHF5)
- HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6 (HHF6)
- HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7 (HHF7)
- HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 8 (HHF8)
- HYPERINSULINEMIC HYPOGLYCEMIA, TRANSIENT OR PERMANENT [DD]
- HYPOADRENOCORTICISM, FAMILIAL
- HYPOGLYCEMIA, FAMILIAL NEONATAL
- HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY (HIHGHH)
- HYPOTONIA-CYSTINURIA SYNDROME
- IMMUNODEFICIENCY 47 (IMD47); ATP6AP1-CDG
- INFANTILE LIVER FAILURE SYNDROME 2 (ILFS2)
- INTRAUTERINE GROWTH RETARDATION (IUGR)
- ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IA (IGHD1A)
- ISOVALERIC ACIDEMIA (IVA)
- KABUKI SYNDROME 1 (KABUK1)
- KABUKI SYNDROME 2 (KABUK2)
- KEARNS-SAYRE SYNDROME (KSS)
- KETOTIC HYPOGLYCEMIA
- LACTIC ACIDOSIS, HYPOGLYCEMIA AND DEVELOPMENTAL DELAY (NEW DISEASE)
- LIVER DISEASE, SEVERE CONGENITAL (SCOLIV)
- LIVER FAILURE, INFANTILE, TRANSIENT (LFIT)
- LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY (LCAD)
- LONG-CHAIN-3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY (LCHAD)
- MAHVASH DISEASE (MVAH )
- MALONYL-COA DECARBOXYLASE DEFICIENCY
- MAPLE SYRUP URINE DISEASE (MSUD)
- MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY (MCAD)
- METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION (MECRCN)
- METHYLMALONIC ACIDURIA (MMA)
- METHYLMALONIC ACIDURIA, cblA TYPE
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1 (MC1DN1)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19 (MC1DN19)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20 (MC1DN20)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33 (MC1DN33)
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1 (MC3DN1)
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3 (MC3DN3)
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5 (MC3DN5)
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7 (MC3DN7)
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9 (MC3DN9)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 12 (MC4DN12)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 22 (MC4DN22)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 3 (MC4DN3)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 4 (MC4DN4)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 5 (MC4DN5)
- MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5 (MC5DN5)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 15, HEPATOCEREBRAL TYPE (MTDPS15)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (MTDPS3)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 6, HEPATOCEREBRAL TYPE (MTDPS6)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 9, ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA (MTDPS9)
- MITOCHONDRIAL DNA DEPLETION SYNDROME, HEPATOCEREBRAL
- MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY (MPYCD)
- MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY (SCEH)
- MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY (MTPD)
- MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY (MTPD, HADHB)
- MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY 2 (MTPD2)
- MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY
- MORFAN SYNDROME
- MULTIPLE CARBOXYLASE DEFICIENCY, NEONATAL OR EARLY ONSET FORM (HLCS)
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 7 (MMDS7)
- NEPHROTIC SYNDROME, TYPE 14 (NPHS14)
- NEURODEGENERATION, CHILDHOOD-ONSET, WITH ATAXIA, TREMOR, OPTIC ATROPHY, AND COGNITIVE DECLINE (CONATOC)
- NEURODEGENERATION, INFANTILE-ONSET, BIOTIN-RESPONSIVE (NERIB)
- NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES
- OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY
- PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY 1, CYTOSOLIC (PEPCK1)
- PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, MITOCHONDRIAL (PEPCK2)
- PHOSPHOPANTOTHENOYLCYSTEINE DECARBOXYLASE DEFCiENCY (PPCDC)
- PITUITARY HORMONE DEFICIENCY, COMBINED, 2 (CPHD2)
- PITUITARY HORMONE DEFICIENCY, COMBINED, 4 (CPHD4)
- PITUITARY STALK INTERRUPTION SYNDROME (PSIS)
- PREMATURE INFANTS [DD]
- PROOPIOMELANOCORTIN DEFICIENCY (POMC)
- PROPIONIC ACIDEMIA (PA, PCCA)
- PROPIONIC ACIDEMIA (PA, PCCB)
- PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY (PNPO)
- PYRUVATE CARBOXYLASE DEFICIENCY (PC)
- RESPIRATORY CHAIN DEFICIENCIES [DD]
- REYE SYNDROME (RS)
- REYE SYNDROME LIKE MANIFESTATIONS
- RIBOFLAVIN TRANSPORTER 1 DEFICIENCY (RTD1)
- S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY (SAHH)
- SEDOHEPTULOKINASE DEFICIENCY (SHPKD)
- SEPSIS, NEONATAL [DD]
- SHORT CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY (HADH)
- SHORT CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY (SCAD)
- SOTOS SYNDROME 1 (SOTOS1)
- SUCCINYL CoA: 3-KETOACID CoA TRANSFERASE DEFICIENCY (SCOT)
- SULFIDE QUINONE OXIDOREDUCTASE DEFICIENCY (SQOR)
- TIMOTHY SYNDROME (TS)
- TRANSALDOLASE DEFICIENCY
- TYROSINEMIA I
- VERY-LONG-CHAIN ACYL CoA DEHYDROGENASE DEFICIENCY (VLCAD)
- WOLFRAM SYNDROME 2 (WFS2)
jaundice (73)
- ACTH DEFICIENCY, ISOLATED
- ADENOSINE KINASE DEFICIENCY
- ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO
- AICARDI-GOUTIERES SYNDROME 1 (AGS1)
- ALAGILLE SYNDROME 1 (ALGS1)
- ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD)
- ARGINASE 1 DEFICIENCY
- BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1 (CBAS1)
- BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2 (CBAS2)
- BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3 (CBAS3)
- BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4 (CBAS4)
- BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5 (CBAS5)
- CARNITINE PALMITOYL TRANSFERASE DEFICIENCY 1A (CPT1A)
- CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 1 (PFIC1)
- CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2 (PFIC2)
- CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3 (PFIC3)
- CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4 (PFIC4)
- CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5 (PFIC5)
- CITRULLINEMIA TYPE II, NEONATAL ONSET (NICCD)
- CONGENITAL CHLORIDE DIARRHEA (DIAR1)
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIo
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIr (CDG2R)
- CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE I (CDAN1)
- CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE II (CDAN2)
- COPROPORPHYRIA, HEREDITARY (HCP)
- CRIGLER-NAJJAR SYNDROME TYPE I
- CRIGLER-NAJJAR SYNDROME TYPE II
- CYSTIC FIBROSIS (CF)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 118 (DEE118)
- DIABETES, FETAL EFFECTS FROM MATERNAL
- DUBIN-JOHNSON SYNDROME (DJS)
- FARBER DISEASE
- FRUCTOSE INTOLERANCE, HEREDITARY (HFI)
- GALACTOSEMIA (GALT-D)
- GALACTOSEMIA III (GALE-D)
- GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO
- GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY (G6PD)
- GLUTATHIONE SYNTHETASE DEFICIENCY (GSSD)
- GLYCOGEN STORAGE DISEASE TYPE IV. ANDERSEN DISEASE (GSD4)
- GLYCOGEN STORAGE DISEASE TYPE VII. TARUI DISEASE
- GLYCOGEN STORAGE DISEASE TYPE XII (GSD12)
- HEMOCHROMATOSIS, NEONATAL
- HEMOLYTIC ANEMIA DUE TO GLUTATHIONE REDUCTASE DEFICIENCY
- HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY (GPI)
- HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY (HK1)
- HYPERBILIRUBINEMIA, ROTOR TYPE (HBLRR)
- HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE (HTGTI)
- HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2 (CHNG2)
- IMMUNODEFICIENCY 47 (IMD47); ATP6AP1-CDG
- INFANTILE LIVER FAILURE SYNDROME 2 (ILFS2)
- INFECTIONS OF THE NEWBORN (TORCH) [DD]
- LIVER DISEASE, LIVER FAILURE, UNSPECIFIC, PRIMARY, SECONDARY [DD]
- LIVER DISEASE, SEVERE CONGENITAL (SCOLIV)
- LIVER FAILURE, INFANTILE, TRANSIENT (LFIT)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 15, HEPATOCEREBRAL TYPE (MTDPS15)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 16, HEPATIC TYPE (MTDPS16)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (MTDPS3)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 6, HEPATOCEREBRAL TYPE (MTDPS6)
- NEONATAL CHOLESTASIS (NC) [DD]
- NEURODEGENERATION, CHILDHOOD-ONSET, WITH ATAXIA, TREMOR, OPTIC ATROPHY, AND COGNITIVE DECLINE (CONATOC)
- NIEMANN-PICK DISEASE TYPE A
- NIEMANN-PICK DISEASE TYPE C1 (NPC1)
- NIEMANN-PICK DISEASE, TYPE C2 (NPC2)
- PATENT DUCTUS VENOSUS [DD]
- PEROXISOME BIOGENESIS DISORDER 2A (PBD2A)
- PITUITARY STALK INTERRUPTION SYNDROME (PSIS)
- PROLIDASE DEFICIENCY
- PYRUVATE KINASE DEFICIENCY
- S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY (SAHH)
- SEPSIS, NEONATAL [DD]
- TRIOSEPHOSPHATE ISOMERASE DEFICIENCY (TPID)
- TYROSINEMIA I
- WILSON DISEASE (WD)
muscle weakness (232)
- 3-METHYL-CROTONYL-GLYCINURIA (3-MCC, MCC1D)
- 3-METHYLGLUTACONIC ACIDURIA (TYPE IX); MGCA9
- 3-METHYLGLUTACONIC ACIDURIA (TYPE V); MGCA5
- ABETALIPOPROTEINEMIA, BASSEN-KORNZWEIG-SYNDROME, ACANTHOCYTOSIS (ABL)
- ACETYL-CoA CARBOXYLASE DEFICIENCY (ACACAD)
- ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME (AAAS)
- ACTH DEFICIENCY, ISOLATED
- ACUTE INTERMITTEND PORPHYRIA (AIP)
- ADENOSINE KINASE DEFICIENCY
- ADENYLOSUCCINATE SYNTHASE-LIKE 1 DEFICIENCY
- ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE II: KANZAKI DISEASE
- AMINOACYLASE I DEFICIENCY (ACY1D)
- ARTS SYNDROME (ARTS)
- ATAXIA-OCULOMOTOR APRAXIA 3 (AOA3)
- ATAXIA-OCULOMOTOR APRAXIA 4 (AOA4)
- BARTH SYNDROME (BTHS)
- BARTTER SYNDROME, TYPE 1, ANTENATAL (BARTS1)
- BARTTER SYNDROME, TYPE 3 (BARTS3)
- BARTTER-LIKE-SYNDROME [DD]
- BENIGN INFANTILE MITOCHONDRIAL MYOPATHY (BIMM)
- BENIGN INFANTILE MITOCHONDRIAL MYOPATHY AND CARDIOMYOPATHY (BIMC)
- BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6; CBAS6
- BIOTINIDASE DEFICIENCY
- BROWN-VIALETTO-VAN LAERE SYNDROME 1 (BVVLS1)
- CARNITINE DEFICIENCY, MYOPATHIC
- CARNITINE PALMITOYL TRANSFERASE DEFICIENCY (II), CPT2, MYOPATHIC, STRESS-INDUCED
- CARNITINE PALMITOYL TRANSFERASE DEFICIENCY 1A (CPT1A)
- CARNITINE TRANSPORTER DEFICIENCY; PRIMARY SYSTEMIC CARNITINE DEFICIENCY
- CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY (CACT)
- CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS (CAPOS)
- CEREBRAL CREATINE DEFICIENCY SYNDROME 3 (GATM, AGAT DEFICIENCY)
- CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2MM (CMT2MM)
- CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y (CMT2Y)
- CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z (CMT2Z)
- CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C (CMTDIC)
- COBALAMIN MALABSORPTION
- COENZYME Q10 DEFICIENCY, PRIMARY, 1 (COQ10D1)
- COENZYME Q10 DEFICIENCY, PRIMARY, 4 (COQ10D4)
- COENZYME Q10 DEFICIENCY, PRIMARY, 8 (COQ10D8)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13 (COXPD13)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16 (COXPD16)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19 (COXPD19)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24 (COXPD24)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26 (COXPD26)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28 (COXPD28)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3 (COXPD3)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33 (COXPD33)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 48 (COXPD48)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 49 (COXPD49)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 50 (COXPD50)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 54 (COXPD54)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 55 (COXPD55)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 58 (COXPD58)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6 (COXPD6)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8 (COXPD8)
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ic
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIk
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ij
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Io
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-It
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq (CDG-Iq)
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu (CDG1U)
- CONGENITAL MYOPATHY 3 WITH RIGID SPINE (CMYO3)
- CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID (ARCL2D)
- CYCLIC VOMITING SYNDROME (CSV)
- CYTOCHROME b OF COMPLEX III (MTCYB)
- DELTA-AMINOLEVULINIC ACID DEHYDRATASE-DEFICIENT PORPHYRIA (ALAD)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 117 (DEE117)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 122 (DEE122)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 51 (DEE51)
- DEVELOPMENTAL DELAY WITH HYPOTONIA, MYOPATHY, AND BRAIN ABNORMALITIES (DEDHMB)
- DIABETES MELLITUS, PERMANENT NEONATAL, 3 (PNDM3)
- DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY (DLDD)
- DIMETHYLGLYCINURIA (DMGDHD)
- DUCHENNE MUSCULAR DYSTROPHY (DMD)
- DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY (SPR)
- ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM
- ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2 (PEBEL2 )
- ERYTHROCYTE LACTATE TRANSPORTER DEFECT
- FANCONI RENOTUBULAR SYNDROME 1 (FRTS1)
- FANCONI RENOTUBULAR SYNDROME 2 (FRTS2)
- FAZIO-LONDE SYNDROME
- FRIEDREICH ATAXIA (FRDA)
- GITELMAN SYNDROME (GTLMNS)
- GLUTARIC ACIDURIA II (MADD, ETF)
- GLYCEROL KINASE DEFICIENCY
- GLYCOGEN STORAGE DISEASE TYPE 0b (GSD0b)
- GLYCOGEN STORAGE DISEASE TYPE II. INFANTILE ONSET. POMPE DISEASE (GSD2)
- GLYCOGEN STORAGE DISEASE TYPE IIB. DANON DISEASE
- GLYCOGEN STORAGE DISEASE TYPE III. FORBES DISEASE, CORI DISEASE (GSD3)
- GLYCOGEN STORAGE DISEASE TYPE IV. ANDERSEN DISEASE (GSD4)
- GLYCOGEN STORAGE DISEASE TYPE IXB (GSD9B)
- GLYCOGEN STORAGE DISEASE TYPE IXd (GSD9D)
- GLYCOGEN STORAGE DISEASE TYPE VII. TARUI DISEASE
- GLYCOGEN STORAGE DISEASE TYPE VIII (GSD8) -> TYPE IX
- GLYCOGEN STORAGE DISEASE TYPE X (GSD10)
- GLYCOGEN STORAGE DISEASE TYPE XI (GSD11)
- GLYCOGEN STORAGE DISEASE TYPE XII (GSD12)
- GLYCOGEN STORAGE DISEASE TYPE XIII (GSD13)
- GLYCOGEN STORAGE DISEASE TYPE XV (GSD15)
- GLYCOGEN STORAGE DISEASE, TYPE V. McARDLE DISEASE (GSD5)
- HEMOCHROMATOSIS, TYPE 2A
- HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY (GPI)
- HOMOCYSTINURIA DUE TO DEFECT OF N(5,10)-METHYLENE THF DEFICIENCY (MTHFR)
- HYPERALDOSTERONISM, FAMILIAL, TYPE III (HALD3)
- HYPERMETABOLISM DUE TO UNCOUPLED MITOCHONDRIAL OXIDATIVE PHOSPHORYLATION 1 ( HUMOP1)
- HYPERORNITHINEMIA WITH GYRATE ATROPHY (HOGA, OAT)
- HYPERPHOSPHATASIA (JPD)
- HYPERVALINEMIA
- HYPOMAGNESEMIA 2, RENAL (HOMG2)
- HYPOMAGNESEMIA 3, RENAL (HOMG3)
- HYPOMAGNESEMIA 6, RENAL (HOMG6)
- HYPOPARATHYROIDISM, FAMILIAL ISOLATED (FIH)
- HYPOPHOSPHATASIA, INFANTILE
- HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT (XLHR)
- HYPOTONIA-CYSTINURIA SYNDROME
- INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA (IDDCA)
- INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT PERIPHERAL NEUROPATHY (IDDPN)
- INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68 (MRT68)
- KEARNS-SAYRE SYNDROME (KSS)
- LEIGH`S SYNDROME, SUBACUTE NECROTIZING ENCEPHALOPATHY (SNE)
- LETHAL INFANTILE MITOCHONDRIAL DISEASE (LIMM)
- LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION (LBSL)
- LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY (LSMFLAD)
- LYSINURIC PROTEIN INTOLERANCE (LPI)
- MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY (MCAD)
- METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION (MECREN)
- METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION (MECRCN)
- METACHROMATIC LEUKODISTROPHY (MLD)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20 (MC1DN20)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23 (MC1DN23)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29 (MC1DN29)
- MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 1 (MC2DN1)
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1 (MC3DN1)
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10 (MC3DN10)
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2 (MC3DN2)
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8 (MC3DN8)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 1 (MC4DN1)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 15 (MC4DN15)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 18 (MC4DN18)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 3 (MC4DN3)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 6 (MC4DN6)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 7 (MC4DN7)
- MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5 (MC5DN5)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 1, MNGIE (MTDPS1)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 11 (MTDPS11)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 12A, CARDIOMYOPATHIC TYPE, AUTOSOMAL DOMINANT (MTDPS12A)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 12B, CARDIOMYOPATHIC TYPE, AUTOSOMAL RECESSIVE (MTDPS12B)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 14, CARDIOENCEPHALOMYOPATHIC TYPE (MTDPS14)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 18 (MTDPS18)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MTDPS2)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 20 (MTDPS20)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 21 (MTDPS21)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (MTDPS3)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 4B, MNGIE TYPE (MTDPS4B)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (MTDPS5)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 6, HEPATOCEREBRAL TYPE (MTDPS6)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 7; HEPATOCEREBRAL TYPE (MTDPS7)
- MITOCHONDRIAL DNA DEPLETION SYNDROME, NEW TYPE (GUK1)
- MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME SPECTRUM
- MITOCHONDRIAL MYOPATHY WITH DIABETES
- MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS (MMLA)
- MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY (MEOAL)
- MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY
- MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY (MTPD)
- MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY (MTPD, HADHB)
- MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY 2 (MTPD2)
- MITOCHONDRIAL tRNA(Phe) DEFICIENCY (MT-TF)
- MITOCHONDRIAL-ENCEPHALOPATHY-LACTIC ACIDOSIS-STROKE (MELAS)
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1 (MMDS1)
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 10 (MMDS10)
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3 (MMDS3)
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 9B (MMDS9B)
- MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY (MDCCAID)
- MUSCULAR DYSTROPHY, CONGENITAL, WITH OR WITHOUT SEIZURES (MYOS)
- MUSCULAR DYSTROPHY, LIMB-GIRDLE (LGMDR28)
- MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (MDDGA14)
- MYASTHENIC SYNDROME, CONGENITAL, 15 (CMS15)
- MYOADENYLATE DEAMINASE DEFICIENCY (AMPDA)
- MYOCLONIC EPILEPSY AND RAGGED RED FIBER DISEASE (MERRF)
- MYOGLOBINURIA, ACUTE RECURRENT, AUTOSOMAL RECESSIVE (LPIN1)
- MYOPATHY OR CARDIOMYOPATHY DUE TO DESMIN DEFECT
- MYOPATHY WITH EXTRAPYRAMIDAL SIGNS (MPXPS)
- MYOPATHY WITH LACTIC ACIDOSIS, HEREDITARY (HML, ISCU)
- MYOPATHY WITH RIMMED UBIQUITIN-POSITIVE AUTOPHAGIC VACUOLATION, AUTOSOMAL DOMINANT (MRUPAV)
- MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1 (MLASA1)
- MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2 (MLASA2)
- MYOPATHY, MITOCHONDRIAL, AND ATAXIA (MMYAT)
- NARP SYNDROME
- NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4 (NBIA4)
- NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES (NEDMAS)
- NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, IMPAIRED LANGUAGE, AND GAIT ABNORMALITIES (NEDMILG)
- NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, IMPAIRED LANGUAGE, EPILEPSY, AND GAIT ABNORMALITIES (NEDMILEG)
- NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES
- NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE (HMSNR)
- NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY (NLSDM)
- NIEMANN-PICK DISEASE TYPE A
- PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, MITOCHONDRIAL (PEPCK2)
- PHOSPHOGLYCERATE KINASE 1 DEFICIENCY
- POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY (PGBM1)
- POLYGLUCOSAN BODY MYOPATHY 2 (PGBM2)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 1A (PCH1A)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 1B (PCH1B)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 1C (PCH1C)
- PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS (PEO)
- PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 6 (PEOA6)
- PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2 (PEOB2)
- PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 6 (PEOB6)
- PYRUVATE DEHYDROGENASE DEFICIENCY (E1); PDC
- REFSUM DISEASE, CLASSIC
- RENAL TUBULAR ACIDOSIS, DISTAL, 1 (DRTA1)
- RIBOFLAVIN TRANSPORTER 2 DEFICIENCY (RTD2)
- S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY (SAHH)
- SENGERS SYNDROME
- SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS (SANDO)
- SHORT CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY (HADH)
- SHORT CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY (SCAD)
- SIALIDOSIS TYPE II
- SINGLETON-MERTEN SYNDROME 1 (SGMRT1)
- SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE (SACS)
- SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT (SPG73)
- SPASTIC PARAPLEGIA 91, AUTOSOMAL DOMINANT, WITH OR WITHOUT CEREBELLAR ATAXIA (SPG91)
- SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT (SPG9A)
- SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION (SPEMR)
- SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21 (SCAR21)
- SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3 (SCAN3)
- THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY TYPE); THMD4
- TRANSCOBALAMIN II DEFICIENCY
- TRIOSEPHOSPHATE ISOMERASE DEFICIENCY (TPID)
- VERY-LONG-CHAIN ACYL CoA DEHYDROGENASE DEFICIENCY (VLCAD)
- VITAMIN B12 DEFICIENCY [DD]
- VITAMIN D-DEPENDENT RICKETS, TYPE 2A (VDDR2A)
seizures (722)
- 2,4-DIENOYL-CoA REDUCTASE DEFICIENCY (DECRD)
- 2-AMINOADIPIC ACIDURIA (AMOCAD, AMOXAD)
- 2-HYDROXYGLUTARIC ACIDURIA (D) TYPE I
- 2-HYDROXYGLUTARIC ACIDURIA (D) TYPE II
- 2-HYDROXYGLUTARIC ACIDURIA (L)
- 2-KETOADIPIC ACIDEMIA (-> MOVED TO 204750)
- 2-KETOGLUTARATE DEHYDROGENASE COMPLEX DEFICIENCY
- 2-METHYL-3-HYDROXYBUTYRYL-CoA DEHYDROGENASE DEFICIENCY (HSD10)
- 2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY (2-MBDD, SBCADD)
- 27-HYDROXYLASE DEFICIENCY (CTX)
- 3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY (HMGCLD)
- 3-HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE DEFICIENCY (HMGCS2D)
- 3-HYDROXYISOBUTYRYL-CoA HYDROLASE DEFICIENCY (HIBCHD)
- 3-METHYL-CROTONYL-GLYCINURIA (3-MCC, MCC1D)
- 3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY (MCC2D)
- 3-METHYLGLUTACONIC ACIDURIA (TYPE I); MGCA1
- 3-METHYLGLUTACONIC ACIDURIA (TYPE IV); MGCA4
- 3-METHYLGLUTACONIC ACIDURIA (TYPE IX); MGCA9
- 3-METHYLGLUTACONIC ACIDURIA (TYPE V); MGCA5
- 3-METHYLGLUTACONIC ACIDURIA (TYPE VI); MGCA6 (MEGDEL)
- 3-METHYLGLUTACONIC ACIDURIA (TYPE VIIA), MGCA7A
- 3-METHYLGLUTACONIC ACIDURIA (TYPE VIIB), MGCA7B
- 3-METHYLGLUTACONIC ACIDURIA (TYPE VIII); MGCA8
- 3-METHYLGLUTACONIC ACIDURIA, NOVEL SUBTYPE
- 3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY (PHGDH)
- 5-OXOPROLINASE DEFICIENCY (OPLAHD)
- ACETYL-CoA ACETYLTRANSFERASE-2 DEFICIENCY (ACAT2D)
- ACETYL-CoA CARBOXYLASE DEFICIENCY (ACACAD)
- ACTH DEFICIENCY, ISOLATED
- ACUTE INTERMITTEND PORPHYRIA (AIP)
- ADENOSINE KINASE DEFICIENCY
- ADENYLOSUCCINASE DEFICIENCY (ADSLD)
- ADRENAL HYPOPLASIA. ADDISON DISEASE, X-LINKED
- ADRENOLEUKODYSTROPHY, X-LINKED (X-ALD)
- AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY (ATIC)
- AICARDI-GOUTIERES SYNDROME 1 (AGS1)
- AICARDI-GOUTIERES SYNDROME 7 (AGS7)
- AICARDI-GOUTIERES SYNDROME 8 (AGS8)
- AICARDI-GOUTIERES SYNDROME 9 (AGS9)
- ALEXANDER DISEASE
- ALLAN-HERNDON-DUDLEY SYNDROME (AHDS)
- ALPHA-AMINO-ADIPIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY (AAASAD)
- ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY (AMACRD)
- ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE I: SCHINDLER DISEASE,
- ALTERNATING HEMIPLEGIA OF CHILDHOOD 2 (AHC2)
- AMINOACYLASE I DEFICIENCY (ACY1D)
- ANTI-NMDA RECEPTOR ENCEPHALITIS (NMDAR) [DD]
- ARGINASE 1 DEFICIENCY
- ARGININOSUCCINIC ACIDURIA (ASL)
- AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY (AADC)
- ARTS SYNDROME (ARTS)
- ASPARAGINE SYNTHETASE DEFICIENCY (ASNSD)
- ASPARTYLGLUCOSAMINURIA (AGU)
- ASPHYXIA [DD]
- ATAXIA-TELANGIECTASIA (AT)
- AUTISM
- AUTISM, SUSCEPTIBILITY TO, X-LINKED 1 (AUTSX1)
- AUTISM, SUSCEPTIBILITY TO, X-LINKED 3 (AUTSX3)
- BARTTER SYNDROME, TYPE 1, ANTENATAL (BARTS1)
- BARTTER SYNDROME, TYPE 2, ANTENATAL (BARTS2)
- BARTTER SYNDROME, TYPE 3 (BARTS3)
- BETA-KETOTHIOLASE DEFICIENCY; ALPHA-METHYLACETOACETIC ACIDURIA
- BETA-MANNOSIDOSIS
- BETA-MERCAPTOLACTATE-CYSTEINE DISULFIDURIA
- BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4 (CBAS4)
- BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6; CBAS6
- BIOTINIDASE DEFICIENCY
- BRAIN SMALL VESSEL DISEASE 3 ( BSVD3)
- BRANCHED-CHAIN KETO ACID DEHYDROGENASE KINASE DEFICIENCY (BCKDKD)
- CANAVAN DISEASE (ASPA)
- CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY (CPS)
- CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO (CA5AD)
- CARNITINE PALMITOYL TRANSFERASE DEFICIENCY (II), CPT2, LETHAL NEONATAL
- CARNITINE PALMITOYL TRANSFERASE DEFICIENCY (II), CPT2, MYOPATHIC, STRESS-INDUCED
- CARNITINE PALMITOYL TRANSFERASE DEFICIENCY 1A (CPT1A)
- CARNITINE PALMITOYLTRANSFERASE DEFICIENCY (II), CPT2, INFANTILE
- CARNITINE TRANSPORTER DEFICIENCY; PRIMARY SYSTEMIC CARNITINE DEFICIENCY
- CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY (CACT)
- CARNOSINURIA, CARNOSINEMIA AND HOMOCARNOSINOSIS
- CASGID SYNDROME (CASGID)
- CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA (CAGSSS)
- CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY (CASVDD)
- CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1; CREATINE-TRANSPORTER DEFECT (CTD)
- CEREBRAL CREATINE DEFICIENCY SYNDROME 2; CCDS2; GAMT DEFICIENCY
- CEREBRAL CREATINE DEFICIENCY SYNDROME 3 (GATM, AGAT DEFICIENCY)
- CEREBRAL FOLATE DEFICIENCY DUE TO FOLR1 AUTOANTIBODIES (CFD)
- CEROID LIPOFUSCINOSIS, NEURONAL, 1 (CLN1; SANTAVUORI-HALTIA-DISEASE)
- CEROID LIPOFUSCINOSIS, NEURONAL, 10 (CLN10)
- CEROID LIPOFUSCINOSIS, NEURONAL, 11 (CLN11)
- CEROID LIPOFUSCINOSIS, NEURONAL, 13 (CLN13)
- CEROID LIPOFUSCINOSIS, NEURONAL, 14 (CLN14)
- CEROID LIPOFUSCINOSIS, NEURONAL, 2 (CLN2)
- CEROID LIPOFUSCINOSIS, NEURONAL, 3 (CLN3)
- CEROID LIPOFUSCINOSIS, NEURONAL, 4B (CLN4B)
- CEROID LIPOFUSCINOSIS, NEURONAL, 5 (CLN5)
- CEROID LIPOFUSCINOSIS, NEURONAL, 6A (CLN6A)
- CEROID LIPOFUSCINOSIS, NEURONAL, 6B (CLN6B)
- CEROID LIPOFUSCINOSIS, NEURONAL, 7 (CLN7)
- CEROID LIPOFUSCINOSIS, NEURONAL, 8 (CLN8)
- CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT
- CEROID LIPOFUSCINOSIS, NEURONAL, 9 (CLN9)
- CHILDHOOD CNS TUMORS [DD]
- CHONDRODYSTROPHIA CALCIFICANS CONGENITA
- CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB
- CITRULLINEMIA TYPE I (ASS)
- CITRULLINEMIA TYPE II, ADULT-ONSET
- CK SYNDROME
- COBALAMIN F DISEASE (cblF)
- COCKAYNE SYNDROME A (CSA)
- COCKAYNE SYNDROME B (CSB)
- COENZYME Q10 DEFICIENCY, PRIMARY, 1 (COQ10D1)
- COENZYME Q10 DEFICIENCY, PRIMARY, 3 (COQ10D3)
- COENZYME Q10 DEFICIENCY, PRIMARY, 4 (COQ10D4)
- COENZYME Q10 DEFICIENCY, PRIMARY, 5 (COQ10D5)
- COENZYME Q10 DEFICIENCY, PRIMARY, 6 (COQ10D6)
- COENZYME Q10 DEFICIENCY, PRIMARY, 7 (COQ10D7)
- COENZYME Q10 DEFICIENCY, PRIMARY, 9 (COQ10D9)
- COFFIN-SIRIS SYNDROME 1 (CSS1)
- COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA (CIMAH)
- COMBINED MALONIC AND METHYLMALONIC ACIDURIA (CMAMMA)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1 (COXPD1)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10 (COXPD10)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12 (COXPD12)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14 (COXPD14)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15 (COXPD15)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17 (COXPD17)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20 (COXPD20)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23 (COXPD23)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24 (COXPD24)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26 (COXPD26)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27 (COXPD27)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29 (COXPD29)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3 (COXPD3)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30 (COXPD30)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31 (COXPD31)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35 (COXPD35)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37 (COXPD37)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39 (COXPD39)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 44 (COXPD44)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 45 (COXPD45)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 48 (COXPD48)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5 (COXPD5)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 52 (COXPD52)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 53 (COXPD53)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 54 (COXPD54)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 55 (COXPD55)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 57 (COXPD57)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 58 (COXPD58)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6 (COXPD6)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 60 (COXPD60)
- COMBINED SAPOSIN DEFICIENCY
- CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION (CHLND)
- CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG (NGLY1-CDDG)
- CONGENITAL DISORDER OF GLYCOSYLATION (ALG1‐CDG)
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ia (PMM2-CDG)
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ic
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Id
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ie
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-If
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ig
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ih
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ii
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIa
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIb
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIc
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIe
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIf
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIg
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIh
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIj
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIL
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIm (SLC35A2-CDG)
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIn
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIo
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ij
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Il
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Im
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-In
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ip
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Is
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ix
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Iy
- CONGENITAL DISORDER OF GLYCOSYLATION TYPE IIv (CDG2V)
- CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION (CDGF)
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE CDG-Iw (CDG1W)
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iaa (CDG1AA)
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIbb (CDG2BB)
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIcc (CDG2CC)
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi (CDG-IIi)
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq (CDG2Q)
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIt (CDG2T)
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq (CDG-Iq)
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu (CDG1U)
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw, AUTOSOMAL DOMINANT (CDG1WAD)
- CONGENITAL GLUTAMINE DEFICIENCY; GLUTAMINE SYNTHASE DEFICIENCY
- COPPER CHAPERONE FOR SUPEROXIDE DISMUTASE (CCS)
- COPROPORPHYRIA, HEREDITARY (HCP)
- CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA, WITH CONGENITAL DISORDER OF GLYCOSYLATION (ARCL2A, CDG)
- CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC (ARCL2C)
- CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID (ARCL2D)
- CYCLIC VOMITING SYNDROME (CSV)
- CYSTATHIONINURIA
- CYSTINE-LYSINURIA
- CYTOCHROME b OF COMPLEX III (MTCYB)
- D,L-2-HYDROXYGLUTARIC ACIDURIA
- D-BIFUNCTIONAL PROTEIN DEFICIENCY
- D-GLYCERIC ACIDURA
- DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME (DOORS)
- DESMOSTEROLOSIS
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY (DEE)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1 (DEE1)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 100 (DEE100)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 101 (DEE101)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 102 (DEE102)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 103 (DEE103)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 104 (DEE104)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 105 (DEE105)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 106 (DEE106)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 107 (DEE107)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 108 (DEE108)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 109 (DEE109)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 11 (DEE11)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 110 (DEE110)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 111 (DEE111)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 112 (DEE112)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 113 (DEE113)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 114 (DEE114)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 115 (DEE115)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 116 (DEE116)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 117 (DEE117)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 118 (DEE118)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 119 (DEE119)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 12 (DEE12)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 120 (DEE120)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 121 (DEE121)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 13 (DEE13)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 14 (DEE14)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 15 (DEE15)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 16 (DEE16)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17 (DEE17)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 18 (DEE18)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 19 (DEE19)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 2 (DEE2)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 21 (DEE21)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 23 (DEE23)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 26 (DEE26)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 27 (DEE27)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 3 (DEE3)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 32 (DEE32)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 35 (DEE35)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 39 WITH LEUKODYSTROPHY (DEE39)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 4 (DEE4)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 40 (DEE40)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 41 (DEE41)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 44 (DEE44)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 46 (DEE46)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 47 (DEE47)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 5 (DEE5)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 50 (DEE50)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 51 (DEE51)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 52 (DEE52)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 55 (DEE55)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 60 (DEE60)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 61 (DEE61)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 62 (DEE62)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 63 (DEE63)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 64 (DEE64)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 67 (DEE67)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 68 (DEE68)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 69 (DEE69)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 7 (DEE7)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 70 (DEE70)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 71 (DEE71)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 72 (DEE72)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 73 (DEE73)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 74 (DEE74)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 76 (DEE76)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 78 (DEE78)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 79 (DEE79)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 8 (DEE8)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 80 (DEE80)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 81 (DEE81)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 82 (DEE82)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 83 (DEE83)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 85 WITH OR WITHOUT MIDLINE BRAIN DEFECTS (DEE85)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 86 (DEE86)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 87 (DEE87)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 88 (DEE88)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 89 (DEE89)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 9 (DEE9)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 90 (DEE90)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 91 (DEE91)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 93 (DEE93)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 94 (DEE94)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 95 (DEE95)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 96 (DEE96)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 98 (DEE98)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 99 (DEE99)
- DEVELOPMENTAL DELAY WITH HYPOTONIA, MYOPATHY, AND BRAIN ABNORMALITIES (DEDHMB)
- DEVELOPMENTAL DELAY WITH OR WITHOUT EPILEPSY (DEVEP)
- DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL DISABILITY AND DYSMORPHIC FACIES (DIDDF)
- DIABETES AND DEAFNESS, MATERNALLY INHERITED (MIDD)
- DIABETES MELLITUS, PERMANENT NEONATAL
- DIABETES MELLITUS, PERMANENT NEONATAL, 3 (PNDM3)
- DIGENIC METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE
- DIGEORGE SYNDROME (DGS)
- DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY (DLDD)
- DIHYDROPYRIMIDINASE DEFICIENCY (DHP)
- DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY (DPD)
- DOPA-RESPONSIVE DYSTONIA
- DOPAMINE BETA-HYDROXYLASE DEFICIENCY (DBH)
- DRAVET SYNDROME (DRVT)
- DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY (SPR)
- EARLY-ONSET EPILEPTIC ENCEPHALOPATHIES [DD]
- EEFSEC DEFICIENCY
- ELAVL2-RELATED NEURODEVELOPMENTAL DISORDER (NEW)
- ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS
- ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES (NELABA)
- ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM
- ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1 (PEBEL1)
- ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2 (PEBEL2 )
- ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS (PEERB)
- EPILEPSY, BENIGN NEONATAL [DD]
- EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT
- EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT MENTAL RETARDATION (FESD)
- EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10 (EIG10)
- EPILEPSY, NOCTURNAL FRONTAL LOBE, 1 (ENFL1)
- EPILEPSY, NOCTURNAL FRONTAL LOBE, 2 (ENFL2)
- EPILEPSY, PROGRESSIVE MYOCLONIC, 6 (EPM6)
- EPILEPSY, PROGRESSIVE MYOCLONIC, 8 (EPM8)
- EPISODIC ATAXIA, TYPE 6 (EA6)
- ETHYLMALONIC ENCEPHALOPATHY, EE (EPEMA)
- EXOSTOSES, MULTIPLE, TYPE II (EXT2)
- FARBER DISEASE
- FOLATE TRANSPORT DEFICIENCY
- FRUCTOSE INTOLERANCE, HEREDITARY (HFI)
- FRUCTOSE-1,6-BIPHOSPHATASE DEFICIENCY (FBP1D)
- FUCOSIDOSIS
- FUMARASE DEFICIENCY
- G(M1)-GANGLIOSIDOSIS, TYPE I. PSEUDO-HURLER-DISEASE
- G(M1)-GANGLIOSIDOSIS, TYPE II. LIPIDOSIS, LATE INFANTILE SYSTEMIC
- G(M2)-GANGLIOSIDOSIS: GM2 ACTIVATOR DEFICIENCY
- G(M2)-GANGLIOSIDOSIS: VARIANT 0, SANDHOFF DISEASE
- G(M2)-GANGLIOSIDOSIS: VARIANT B, TAY-SACHS DISEASE
- GABA TRANSAMINASE DEFICIENCY
- GALACTOSEMIA (GALT-D)
- GALACTOSIALIDOSIS
- GALLOWAY-MOWAT SYNDROME 1 (GAMOS1)
- GALLOWAY-MOWAT SYNDROME 2, X-LINKED (GAMOS2)
- GALLOWAY-MOWAT SYNDROME 3 (GAMOS3)
- GALLOWAY-MOWAT SYNDROME 4 (GAMOS4)
- GAUCHER DISEASE TYPE I (GD1)
- GAUCHER DISEASE TYPE II (GD2)
- GAUCHER DISEASE TYPE III (GD3)
- GAUCHER DISEASE TYPE IIIC (GD3C)
- GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY
- GAUCHER DISEASE, PERINATAL LETHAL
- GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1 (GEFSP1)
- GITELMAN SYNDROME (GTLMNS)
- GLUCOCORTICOID DEFICIENCY 1 (GCCD1)
- GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY (GCCD4)
- GLUCOCORTICOID RESISTANCE (GCCR)
- GLUT-1 DEFICIENCY SYNDROME (GLUT1DS1)
- GLUTAMYL RIBOSE-5-PHOSPHATE STORAGE DISEASE
- GLUTARIC ACIDEMIA I (GA1)
- GLUTARIC ACIDURIA II (MADD, ETF)
- GLUTATHIONE SYNTHETASE DEFICIENCY (GSSD)
- GLYCEROL INTOLERANCE SYNDROM (GIS)
- GLYCEROL KINASE DEFICIENCY
- GLYCINE ENCEPHALOPATHY 2 (GCE2)
- GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL
- GLYCOGEN STORAGE DISEASE TYPE 0a (GSD0a)
- GLYCOGEN STORAGE DISEASE TYPE 0b (GSD0b)
- GLYCOGEN STORAGE DISEASE TYPE IA (GSD1a)
- GLYCOGEN STORAGE DISEASE TYPE IB (GSD1b)
- GLYCOGEN STORAGE DISEASE TYPE IC (GSD1c)
- GLYCOGEN STORAGE DISEASE TYPE III. FORBES DISEASE, CORI DISEASE (GSD3)
- GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 1 (GPIBD1)
- GRACILE SYNDROME
- GRISCELLI SYNDROME, TYPE 1 (GS1)
- GRISCELLI SYNDROME, TYPE 2 (GS2)
- GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY (GRIDHH)
- HAREL-YOON SYNDROME (HAYOS)
- HEMOLYTIC UREMIC SYNDROME, ATYPICAL, 8, WITH RHIZOMELIC SHORT STATURE (AHUS8)
- HEREDITARY FOLATE MALABSORPTION (HFM)
- HISTIDINURIA
- HOMOCYSTINURIA DUE TO DEFECT OF N(5,10)-METHYLENE THF DEFICIENCY (MTHFR)
- HOMOCYSTINURIA, CYSTATHIONINE BETA-SYNTHASE DEFICIENCY (CBS)
- HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA DUE TO DEFECT IN COBALAMIN METABOLISM, cblG COMPLEMENTATION TYPE
- HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblE COMPLEMENTATION TYPE (HMAE)
- HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA (HLASA)
- HYDROXYLYSINURIA
- HYPER BETA-ALANINEMIA
- HYPEREKPLEXIA
- HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES (HGCLAS)
- HYPERGLYCINEMIA, NON-KETOTIC (NKH)
- HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1 (HHF1)
- HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2 (HHF2)
- HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3 (HHF3)
- HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4 (HHF4)
- HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5 (HHF5)
- HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6 (HHF6)
- HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7 (HHF7)
- HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 8 (HHF8)
- HYPERLEUCINE-ISOLEUCINEMIA (BCAA)
- HYPERLYSINEMIA I, FAMILIAL
- HYPERORNITHINEMIA WITH GYRATE ATROPHY (HOGA, OAT)
- HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA (HHH-SYNDROME)
- HYPERPHENYLALANIEMIA DUE TO GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE DEFICIENCY (GTP)
- HYPERPHENYLALANINEMIA DUE TO 6-PYRUVOYLTETRAHYDROPTERIN SYNTHASE DEFICIENCY (PTPS)
- HYPERPHENYLALANINEMIA DUE TO DHPR-DEFICIENCY (DHPR)
- HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT (DNAJC12)
- HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 1 (HPMRS1)
- HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2 (HPMRS2, PIGO-CDG))
- HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3 (HPMRS3)
- HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 5 (HPMRS5)
- HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6 (HPMRS6)
- HYPERPIPECOLATEMIA
- HYPERPROLINEMIA, TYPE I
- HYPERPROLINEMIA, TYPE II
- HYPERTROPHIC CARDIOMYOPATHY AND RENAL TUBULAR DYSFUNCTION
- HYPOADRENOCORTICISM, FAMILIAL
- HYPOGLYCEMIA, FAMILIAL NEONATAL
- HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY (HIHGHH)
- HYPOMAGNESEMIA 1, INTESTINAL (HOMG1)
- HYPOMAGNESEMIA 2, RENAL (HOMG2)
- HYPOMAGNESEMIA 3, RENAL (HOMG3)
- HYPOMAGNESEMIA 4, RENAL (HOMG4)
- HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 1 (HOMGSMR1)
- HYPOPARATHYROIDISM, FAMILIAL ISOLATED (FIH)
- HYPOPARATHYROIDISM, X-LINKED (HYPX)
- HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME (HRDS)
- HYPOPHOSPHATASIA, CHILDHOOD
- HYPOPHOSPHATASIA, INFANTILE
- HYPOTONIA-CYSTINURIA SYNDROME
- IMMUNODEFICIENCY 47 (IMD47); ATP6AP1-CDG
- IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES (ISDNA)
- INFANTILE CEREBELLAR-RETINAL DEGENERATION (ICRD)
- INFANTILE LIVER FAILURE SYNDROME 1 (ILFS1)
- INFANTILE METABOLIC DISORDER AFFECTING MITOCHONDRIAL FUNCTION
- INFANTILE-ONSET MITOCHONDRIAL ENCEPHALOPATHY
- INFECTIONS OF THE NEWBORN (TORCH) [DD]
- INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA (IDDCA)
- INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES (IDDNPF)
- INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 35 (MRD35)
- INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 36 (MRD36)
- INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 61 (MRD61)
- INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68 (MRT68)
- INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 83 (MRT83)
- INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 98 (XLID98)
- INTELLECTUAL DISABILITY, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA (IDEDNIK)
- ISOVALERIC ACIDEMIA (IVA)
- JOUBERT SYNDROME 1 (JBTS1)
- KABUKI SYNDROME 1 (KABUK1)
- KABUKI SYNDROME 2 (KABUK2)
- KRABBE DISEASE
- LACTIC ACIDOSIS, HYPOGLYCEMIA AND DEVELOPMENTAL DELAY (NEW DISEASE)
- LEIGH`S SYNDROME, SUBACUTE NECROTIZING ENCEPHALOPATHY (SNE)
- LEUKOENCEPHALOPATHY, PROGRESSIVE, INFANTILE-ONSET, WITH OR WITHOUT DEAFNESS (LEPID)
- LIPOYLTRANSFERASE 1 DEFICIENCY (LIPT1D)
- LIVER DISEASE, LIVER FAILURE, UNSPECIFIC, PRIMARY, SECONDARY [DD]
- LIVER FAILURE, INFANTILE, TRANSIENT (LFIT)
- LONG-CHAIN-3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY (LCHAD)
- LYSINURIC PROTEIN INTOLERANCE (LPI)
- MALONYL-COA DECARBOXYLASE DEFICIENCY
- MAPLE SYRUP URINE DISEASE (MSUD)
- MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 12 (MODY12)
- MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY (MCAD)
- MEGALOBLASTIC ANEMIA 1 (IMERSLUND-GRASBECK SYNDROME, IGS)
- MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY (DHFRD)
- MENKES SYNDROME (MNK)
- MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS; MRFACD (MED13L)
- MENTAL RETARDATION, AUTOSOMAL DOMINANT 56 (MRD56)
- MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES (MRD6)
- MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15 (MAN1B1-CDG)
- MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE (MRXSSR)
- METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION (MECREN)
- METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION (MECRCN)
- METACHROMATIC LEUKODISTROPHY (MLD)
- METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY
- METHIONINE MALABSORPTION
- METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE
- METHYLMALONIC ACIDURIA (MMA)
- METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA DUE TO ZNF143 DEFICIENCY
- METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE
- METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE
- METHYLMALONIC ACIDURIA, cblA TYPE
- METHYLMALONYL-CoA EPIMERASE DEFICIENCY (MCEE)
- MEVALONIC ACIDURIA (MKD)
- MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 1 (MEDS1)
- MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY (MSCCA)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1 (MC1DN1)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10 (MC1DN10)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12 (MC1DN12)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13 (MC1DN13)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14 (MC1DN14)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15 (MC1DN15)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16 (MC1DN16)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17 (MC1DN17)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18 (MC1DN18)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19 (MC1DN19)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2 (MC1DN2)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23 (MC1DN23)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27 (MC1DN27)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3 (MC1DN3)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31 (MC1DN31)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32 (MC1DN32)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34 (MC1DN34)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 36 (MC1DN36)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 37 (MC1DN37)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4 (MC1DN4)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5 (MC1DN5)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7 (MC1DN7)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9 (MC1DN9)
- MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 1 (MC2DN1)
- MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 3 (MC2DN3)
- MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 4 (MC2DN4)
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5 (MC3DN5)
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7 (MC3DN7)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 12 (MC4DN12)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 15 (MC4DN15)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 16 (MC4DN16)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 17 (MC4DN17)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 2 (MC4DN2)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 21 (MC4DN21)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 23 (MC4DN23)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 3 (MC4DN3)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 4 (MC4DN4)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 5 (MC4DN5)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 6 (MC4DN6)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 7 (MC4DN7)
- MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY (MC5DN1)
- MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2 (MC5DN2)
- MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4 (MC5DN4)
- MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5 (MC5DN5)
- MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 7 (MC5DN7)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 12A, CARDIOMYOPATHIC TYPE, AUTOSOMAL DOMINANT (MTDPS12A)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 13, ENCEPHALOMYOPATHIC TYPE (MTDPS13)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 17 (MTDPS17)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 19 (MTDPS19)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 20 (MTDPS20)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (MTDPS3)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 4A, ALPERS TYPE (MTDPS4A)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 4B, MNGIE TYPE (MTDPS4B)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (MTDPS5)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 6, HEPATOCEREBRAL TYPE (MTDPS6)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 7; HEPATOCEREBRAL TYPE (MTDPS7)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY) (MTDPS8A)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 9, ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA (MTDPS9)
- MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS (MMLA)
- MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY (MPYCD)
- MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY (SCEH)
- MITOCHONDRIAL tRNA(Phe) DEFICIENCY (MT-TF)
- MITOCHONDRIAL-ENCEPHALOPATHY-LACTIC ACIDOSIS-STROKE (MELAS)
- MOHR-TRANEBJAERG SYNDROME (MTS)
- MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A (MOCODA)
- MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B (MOCODB)
- MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C (MOCODC)
- MUCOPOLYSACCHARIDOSIS I-H; HURLER SYNDROME (MPS1-H)
- MUCOPOLYSACCHARIDOSIS II; HUNTER SYNDROME
- MUCOPOLYSACCHARIDOSIS III; SAN FILIPPO A SYNDROME
- MUCOPOLYSACCHARIDOSIS III; SAN FILIPPO B SYNDROME
- MUCOPOLYSACCHARIDOSIS III; SAN FILIPPO C SYNDROME
- MULTIPLE CARBOXYLASE DEFICIENCY, NEONATAL OR EARLY ONSET FORM (HLCS)
- MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1 (MCAHS1)
- MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2 (MCAHS2)
- MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3 (MCAHS3)
- MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 4 (MCAHS4)
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA (MMDS2)
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3 (MMDS3)
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5 (MMDS5)
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 7 (MMDS7)
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 9B (MMDS9B)
- MULTIPLE SULFATASE DEFICIENCY (MSD)
- MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY (MDCCAID)
- MUSCULAR DYSTROPHY, CONGENITAL, WITH OR WITHOUT SEIZURES (MYOS)
- MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (MDDGA14)
- MYOCLONIC EPILEPSY AND RAGGED RED FIBER DISEASE (MERRF)
- MYOCLONIC EPILEPSY, FAMILIAL INFANTILE (FIME)
- MYOPATHY WITH EXTRAPYRAMIDAL SIGNS (MPXPS)
- N-ACETYLGLUTAMATE SYNTHETASE DEFICIENCY (NAGSD)
- NARP SYNDROME
- NEPHROTIC SYNDROME, TYPE 14 (NPHS14)
- NEU-LAXOVA SYNDROME 1; NLS1 (PHGDH)
- NEU-LAXOVA SYNDROME 2; NLS2 (PSAT)
- NEURODEGENERATION AND SEIZURES DUE TO COPPER TRANSPORT DEFECT (NSCT)
- NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5 (NBIA5)
- NEURODEGENERATION, CHILDHOOD-ONSET, WITH MULTISYSTEM INVOLVEMENT DUE TO MITOCHONDRIAL DYSFUNCTION (CONDMIM)
- NEURODEGENERATION, INFANTILE-ONSET, BIOTIN-RESPONSIVE (NERIB)
- NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES (NEDLBA)
- NEURODEVELOPMENTAL DISORDER WITH BRAIN ABNORMALITIES, POOR GROWTH, AND DYSMORPHIC FACIES (NEDBGF)
- NEURODEVELOPMENTAL DISORDER WITH DEVELOPMENTAL DELAY AND INFANTILE SPASM
- NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND BRAIN ATROPHY (NEDEBA)
- NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND AUTISTIC FEATURES WITH OR WITHOUT HYPERKINETIC MOVEMENTS (NEDHAHM)
- NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ABSENT SPEECH, AND HYPOTONIA (NEDMISH)
- NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES (NEDMAS)
- NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION (NEDMEHM)
- NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, IMPAIRED LANGUAGE, AND GAIT ABNORMALITIES (NEDMILG)
- NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, IMPAIRED LANGUAGE, EPILEPSY, AND GAIT ABNORMALITIES (NEDMILEG)
- NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY (NDMSCA)
- NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT (NDHMSD)
- NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT, ABSENT LANGUAGE, CEREBRAL HYPOMYELINATION, AND BRAIN ATROPHY;
- NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES
- NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET (IMNEPD1)
- NEUTROPENIA, SEVERE CONGENITAL, 9, AUTOSOMAL DOMINANT (SCN9)
- NIEMANN-PICK DISEASE TYPE C1 (NPC1)
- NIEMANN-PICK DISEASE, TYPE C2 (NPC2)
- NOVEL NEURODEVELOPMENTAL SYNDROME (RABGAP1)
- NUCLEOTIDE DEPLETION SYNDROME
- OCULOCEREBRORENAL SYNDROME OF LOWE
- ORNITHINE TRANSCARBAMYLASE DEFICIENCY (OTC)
- PAGANINI-MIOZZO SYNDROME (MRXSPM)
- PELIZAEUS MERZBACHER DISEASE
- PEROXISOME BIOGENESIS DISORDER 1A (PBD1A)
- PEROXISOME BIOGENESIS DISORDER 1B (PBD1B, NALD)
- PEROXISOME BIOGENESIS DISORDER 2A (PBD2A)
- PEROXISOME BIOGENESIS DISORDER 2B (PBD2B)
- PEROXISOME BIOGENESIS DISORDER 3A (PBD3A)
- PEROXISOME BIOGENESIS DISORDER 4A (PBD4A)
- PEROXISOME BIOGENESIS DISORDER 4B (PBD4B)
- PERRAULT SYNDROME 3 (PRLTS3)
- PERRAULT SYNDROME 4 (PRLTS4)
- PHENYLKETONURIA (PKU)
- PHOSPHATIDYLINOSITOL 4-KINASE TYPE 2 ALPHA DEFICIENCY (PI4K2A)
- PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY 1, CYTOSOLIC (PEPCK1)
- PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, MITOCHONDRIAL (PEPCK2)
- PHOSPHOGLYCERATE KINASE 1 DEFICIENCY
- PHOSPHOHYDROXYLYSINURIA (PHLU)
- PHOSPHORIBOSYLFORMYLGLYCINAMIDINE SYNTHASE DEFICIENCY (PFAS)
- PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY
- PHOSPHOSERINE PHOSPHATASE DEFICIENCY (PSPH)
- PITUITARY HORMONE DEFICIENCY, COMBINED, 2 (CPHD2)
- PITUITARY STALK INTERRUPTION SYNDROME (PSIS)
- PONTOCEREBELLAR HYPOPLASIA
- PONTOCEREBELLAR HYPOPLASIA, TYPE 10 (PCH10)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 11 (PCH11)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 13 (PCH13)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 14 (PCH14)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 1B (PCH1B)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 1D (PCH1D)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 1E (PCH1E)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 2A (PCH2A)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 2B (PCH2B)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 2D (PCH2D)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 2F (PCH2F)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 3 (PCH3)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 4 (PCH4)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 5 (PCH5) -> (PCH4)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 6 (PCH6)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 7 (PCH7)
- PONTOCEREBELLAR HYPOPLASIA, TYPE 9 (PCH9)
- PORPHYRIA VARIEGATA (VP)
- PREP-RELATED NEURODEVELOPMENTAL DISORDER (NEW)
- PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES (PASNA)
- PROOPIOMELANOCORTIN DEFICIENCY (POMC)
- PROPIONIC ACIDEMIA (PA, PCCA)
- PROPIONIC ACIDEMIA (PA, PCCB)
- PSEUDOHYPOPARATHYROIDISM, TYPE IA (PHP1A)
- PSEUDONEONATAL ADRENOLEUKODYSTROPHY
- PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY (PNPO)
- PYRUVATE CARBOXYLASE DEFICIENCY (PC)
- PYRUVATE DEHYDROGENASE DEFICIENCY (E1); PDC
- PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY
- PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY (PDHPD)
- RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 1 (RILDBC1)
- ReNU SYNDROME (RENU)
- RETINITIS PIGMENTOSA 59 (CDG)
- RETT SYNDROME (RTT)
- REYE SYNDROME (RS)
- RIBOFLAVIN TRANSPORTER 1 DEFICIENCY (RTD1)
- RIBONUCLEOTIDE REDUCTASE, M2B (RRM2B)
- RIBOSE-5-PHOSPHATE ISOMERASE DEFICIENCY
- S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY (SAHH)
- SALLA DISEASE
- SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME (SPDRS)
- SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME (SCBMS)
- SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE (SESAMES)
- SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS (SANDO)
- SEPSIS, NEONATAL [DD]
- SHORT CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY (HADH)
- SHORT CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY (SCAD)
- SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 9 (DHRS9)
- SIALIDOSIS TYPE I
- SIALIDOSIS TYPE II
- SIALURIA
- SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA (ASAT)
- SMITH-LEMLI-OPITZ SYNDROME (SLOS)
- SNIJDERS BLOK-CAMPEAU SYNDROME (SNIBCPS)
- SOTOS SYNDROME 1 (SOTOS1)
- SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT (SPG6)
- SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT (SPG73)
- SPASTIC PARAPLEGIA 82, AUTOSOMAL RECESSIVE (SPG82)
- SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION (SPEMR)
- SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20 (SCAR20)
- SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 34 (SCAR34)
- SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE (SEMDG)
- SQUALENE SYNTHASE DEFICIENCY
- SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY (SSADH)
- SUCCINYL CoA: 3-KETOACID CoA TRANSFERASE DEFICIENCY (SCOT)
- SUDDEN CARDIAC FAILURE, INFANTILE (SCFI)
- SULFIDE QUINONE OXIDOREDUCTASE DEFICIENCY (SQOR)
- SULFITE OXIDASE DEFICIENCY, ISOLATED (ISOD)
- SYNTAXIN-BINDING PROTEIN 6 (STXBP6)
- TELANGIECTASIA, IMPAIRED INTELLECTUAL DEVELOPMENT, MICROCEPHALY, METAPHYSEAL DYSPLASIA, EYE ABNORMALITIES, SHORT STATURE
- TESSADORI-BICKNELL-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1 (TEBIVANED1)
- THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2
- THIAMINE METABOLISM DYSFUNCTION SYNDROME 3 (MICROCEPHALY TYPE); THMD3
- THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE); THMD5
- THYMIDYLATE KINASE DEFICIENCY
- THYROID HORMONE METABOLISM, ABNORMAL (THMA)
- TIMOTHY SYNDROME (TS)
- TRANSCOBALAMIN II DEFICIENCY
- TRIOSEPHOSPHATE ISOMERASE DEFICIENCY (TPID)
- TYROSINE HYDROXYLASE DEFICIENCY
- TYROSINEMIA II
- TYROSINEMIA III
- UREIDOPROPIONASE DEFICIENCY
- URIDINE-CYTIDINEURIA (URCTU)
- VICI SYNDROME (VICIS)
- VITAMIN D-DEPENDENT RICKETS, TYPE 2A (VDDR2A)
- WOLFRAM SYNDROME 1 (WFS1)
- XIA-GIBBS SYNDROME (XIGIS)
seizures, absence (4)
vomiting (178)
- 2,4-DIENOYL-CoA REDUCTASE DEFICIENCY (DECRD)
- 2-HYDROXYGLUTARIC ACIDURIA (D) TYPE I
- 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY (HSD3B2)
- 3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY (HMGCLD)
- 3-HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE DEFICIENCY (HMGCS2D)
- 3-HYDROXYISOBUTYRIC ACIDURIA (HIBADH)
- 3-HYDROXYISOBUTYRYL-CoA HYDROLASE DEFICIENCY (HIBCHD)
- 3-METHYL-CROTONYL-GLYCINURIA (3-MCC, MCC1D)
- 3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY (MCC2D)
- 5-OXOPROLINASE DEFICIENCY (OPLAHD)
- ABETALIPOPROTEINEMIA, BASSEN-KORNZWEIG-SYNDROME, ACANTHOCYTOSIS (ABL)
- ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME (AAAS)
- ACTH DEFICIENCY, ISOLATED
- ACUTE INTERMITTEND PORPHYRIA (AIP)
- ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY (CAH)
- ADRENAL HYPOPLASIA. ADDISON DISEASE, X-LINKED
- ALEXANDER DISEASE
- ALPHA-AMINO-ADIPIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY (AAASAD)
- ANTICONVULSANT HYPERSENSITIVITY SYNDROME : VALPROATE ASSOCIATED HEPATOTOXICITY [DD]
- ARGINASE 1 DEFICIENCY
- ARGININOSUCCINIC ACIDURIA (ASL)
- BARTH SYNDROME (BTHS)
- BARTTER SYNDROME, TYPE 1, ANTENATAL (BARTS1)
- BARTTER SYNDROME, TYPE 2, ANTENATAL (BARTS2)
- BARTTER SYNDROME, TYPE 3 (BARTS3)
- BETA-KETOTHIOLASE DEFICIENCY; ALPHA-METHYLACETOACETIC ACIDURIA
- BIOTINIDASE DEFICIENCY
- BRANCHED-CHAIN AMINOTRANSFERASE 2 (BCAT2)
- CANAVAN DISEASE (ASPA)
- CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY (CPS)
- CARNITINE PALMITOYL TRANSFERASE DEFICIENCY (II), CPT2, MYOPATHIC, STRESS-INDUCED
- CARNITINE PALMITOYL TRANSFERASE DEFICIENCY 1A (CPT1A)
- CARNITINE PALMITOYLTRANSFERASE DEFICIENCY (II), CPT2, INFANTILE
- CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY (CACT)
- CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1; CREATINE-TRANSPORTER DEFECT (CTD)
- CHILDHOOD CNS TUMORS [DD]
- CHRONIC DIARRHEA [DD]
- CITRULLINEMIA TYPE I (ASS)
- CITRULLINEMIA TYPE II, ADULT-ONSET
- COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA (CIMAH)
- COMBINED MALONIC AND METHYLMALONIC ACIDURIA (CMAMMA)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3 (COXPD3)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34 (COXPD34)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36 (COXPD36)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 46 (COXPD46)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 52 (COXPD52)
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 59 (COXPD59)
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ia (PMM2-CDG)
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ib (MPI)
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-If
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ip
- COPROPORPHYRIA, HEREDITARY (HCP)
- CORTICOSTERONE METHYL OXIDASE I DEFICIENCY- CMO I
- CORTICOSTERONE METHYL OXIDASE II DEFICIENCY - CMO II
- CYCLIC VOMITING SYNDROME (CSV)
- DEHYDRATION, SEVERE, UNSPECIFIC [DD]
- DELTA-AMINOLEVULINIC ACID DEHYDRATASE-DEFICIENT PORPHYRIA (ALAD)
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 90 (DEE90)
- DIARRHEA 13 (DIAR13)
- DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY (DLDD)
- DIHYDROPYRIMIDINASE DEFICIENCY (DHP)
- DISTAL RENAL TUBULAR ACIDOSIS (RTA) WITH HYPERAMMONEMIA [DD]
- DOPAMINE BETA-HYDROXYLASE DEFICIENCY (DBH)
- ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2 (PEBEL2 )
- EPISODIC ATAXIA, TYPE 3 (EA3)
- EPISODIC ATAXIA, TYPE 6 (EA6)
- FABRY DISEASE
- FAMILIAL LIPOPROTEIN LIPASE DEFICIENCY (LPL-FCS)
- FANCONI-BICKEL SYNDROME (FBS)
- FEEDING: SHORT BOWEL SYNDROME [DD]
- FEEDING: THIAMINE DEFICIENY [DD]
- FRUCTOSE INTOLERANCE, HEREDITARY (HFI)
- FRUCTOSE-1,6-BIPHOSPHATASE DEFICIENCY (FBP1D)
- FUMARASE DEFICIENCY
- GALACTOSEMIA (GALT-D)
- GALACTOSEMIA III (GALE-D)
- GITELMAN SYNDROME (GTLMNS)
- GLUTARIC ACIDEMIA I (GA1)
- GLUTARIC ACIDURIA II (MADD, ETF)
- GLUTARIC ACIDURIA TYPE III
- GLUTATHIONE SYNTHETASE DEFICIENCY (GSSD)
- GLYCEROL INTOLERANCE SYNDROM (GIS)
- GLYCEROL KINASE DEFICIENCY
- HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblE COMPLEMENTATION TYPE (HMAE)
- HYPER-IgD SYNDROME (HIDS), MEVALONIC ACIDURIA
- HYPERAMMONEMIA, TRANSIENT, OF THE NEWBORN (THAN) [DD]
- HYPERLEUCINE-ISOLEUCINEMIA (BCAA)
- HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA (HHH-SYNDROME)
- HYPERVALINEMIA
- HYPOADRENOCORTICISM, FAMILIAL
- HYPOPHOSPHATASIA, INFANTILE
- INFANTILE LIVER FAILURE SYNDROME 1 (ILFS1)
- INFANTILE LIVER FAILURE SYNDROME 2 (ILFS2)
- INTOXICATION ACETAMINOPHEN [DD]
- INTOXICATION: SULCOTRIONE [DD]
- ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY
- ISOVALERIC ACIDEMIA (IVA)
- KEARNS-SAYRE SYNDROME (KSS)
- KETOSIS, UNSPECIFIC [DD]
- KETOTIC HYPOGLYCEMIA
- KRABBE DISEASE
- LACTOSE INTOLERANCE
- LEIGH`S SYNDROME, SUBACUTE NECROTIZING ENCEPHALOPATHY (SNE)
- LESCH-NYHAN SYNDROME (HGPRT, HPRT)
- LIPOID ADRENAL HYPERPLASIA (StAR DEFICIENCY)
- LIPOYLTRANSFERASE 1 DEFICIENCY (LIPT1D)
- LIVER DISEASE, SEVERE CONGENITAL (SCOLIV)
- LIVER FAILURE, INFANTILE, TRANSIENT (LFIT)
- LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY (LCAD)
- LONG-CHAIN-3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY (LCHAD)
- LYSINURIC PROTEIN INTOLERANCE (LPI)
- LYSOSOMAL ACID LIPASE DEFICIENCY (LAL-D)
- MAHVASH DISEASE (MVAH )
- MALAN SYNDROME, SOTOS SYNDROME 2 (SOTOS2)
- MALONYL-COA DECARBOXYLASE DEFICIENCY
- MAPLE SYRUP URINE DISEASE (MSUD)
- MEDIUM CHAIN 3-KETOACYL-CoA THIOLASE DEFICIENCY
- MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY (MCAD)
- MEGALOBLASTIC ANEMIA 1 (IMERSLUND-GRASBECK SYNDROME, IGS)
- METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY (MMSDH)
- METHYLMALONIC ACIDURIA (MMA)
- METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE
- METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE
- METHYLMALONIC ACIDURIA, cblA TYPE
- METHYLMALONIC ACIDURIA, cblB TYPE
- METHYLMALONYL-CoA EPIMERASE DEFICIENCY (MCEE)
- MEVALONIC ACIDURIA (MKD)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1 (MC1DN1)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16 (MC1DN16)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4 (MC1DN4)
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5 (MC1DN5)
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 11 (MC3DN11)
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 20 (MC4DN20)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 1, MNGIE (MTDPS1)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 12B, CARDIOMYOPATHIC TYPE, AUTOSOMAL RECESSIVE (MTDPS12B)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 20 (MTDPS20)
- MITOCHONDRIAL DNA DEPLETION SYNDROME 6, HEPATOCEREBRAL TYPE (MTDPS6)
- MITOCHONDRIAL-ENCEPHALOPATHY-LACTIC ACIDOSIS-STROKE (MELAS)
- MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A (MOCODA)
- MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY
- MULTIPLE CARBOXYLASE DEFICIENCY, NEONATAL OR EARLY ONSET FORM (HLCS)
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA (MMDS2)
- N-ACETYLGLUTAMATE SYNTHETASE DEFICIENCY (NAGSD)
- NEURODEGENERATION, INFANTILE-ONSET, BIOTIN-RESPONSIVE (NERIB)
- NIEMANN-PICK DISEASE TYPE A
- ORNITHINE TRANSCARBAMYLASE DEFICIENCY (OTC)
- PHENYLKETONURIA (PKU)
- POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY (PGBM1)
- PORPHYRIA VARIEGATA (VP)
- PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 6 (PEOB6)
- PROPIONIC ACIDEMIA (PA, PCCA)
- PROPIONIC ACIDEMIA (PA, PCCB)
- PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT (PHA1A)
- PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE (PHA1B)
- PSEUDOHYPOALDOSTERONISM, TYPE IIA (PHA2A)
- PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY (PNPO)
- PYRUVATE CARBOXYLASE DEFICIENCY (PC)
- RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 1 (RILDBC1)
- RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 2 (RILDBC2)
- RENAL TUBULAR ACIDOSIS, DISTAL, 1 (DRTA1)
- RESPIRATORY CHAIN DEFICIENCIES [DD]
- REYE SYNDROME (RS)
- REYE SYNDROME LIKE MANIFESTATIONS
- RHABDOMYOLYSIS AND MYOGLOBINURIA [DD]
- SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME (SPDRS)
- SARCOSINEMIA
- SEPSIS, NEONATAL [DD]
- SEVERE COMBINED IMMUNODEFICIENCY DUE TO ADENOSINE DEAMINASE DEFICIENY (ADA-SCID)
- SHORT CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY (HADH)
- SHORT CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY (SCAD)
- SMITH-LEMLI-OPITZ SYNDROME (SLOS)
- SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT (SPG9A)
- SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION (SPEMR)
- TRANSCOBALAMIN II DEFICIENCY
- TYROSINEMIA I
- WILSON DISEASE (WD)
- WOLFRAM SYNDROME 2 (WFS2)
- X-LINKED ALPORT SYNDROME-DIFFUSE LEIOMYOMATOSIS
Alphabetisches Krankheitsverzeichnis
- 11-BETA-HYDROXYLASE DEFICIENCY (CYP11B1) · ADRENAL HYPERPLASIA VI; STEROID 11 BETA-HYDROXYLASE DEFICIENCY · ICD-10 E25.08 · ICD-11 9C82.0
- 17-BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY (17-ß-HSD3) · PSEUDOHERMAPHRODITISM, MALE, WITH GYNECOMASTIA · ICD-10 E29.1 · ICD-11 FA26.2
- 2,4-DIENOYL-CoA REDUCTASE DEFICIENCY (DECRD) · 2,4-DIENOYL-CoA REDUCTASE; DECRD · ICD-10 G31.8 · ICD-11 5C54.2
- 2-AMINOADIPIC ACIDURIA (AMOCAD, AMOXAD) · AMINOADIPIC ACIDURIA; AMOXAD · ICD-10 E72.3 · ICD-11 4A01.1Y
- 2-HYDROXYGLUTARIC ACIDURIA (D) TYPE I · D-2-HYDROXYGLUTARIC ACIDURIA 1; D2HGA1 · ICD-10 E72.8 · ICD-11 5C59.01
- 2-HYDROXYGLUTARIC ACIDURIA (D) TYPE II · D-2-HYDROXYGLUTARIC ACIDURIA 2; D2HGA2 · ICD-10 E72.8 · ICD-11 5C5Y
- 2-HYDROXYGLUTARIC ACIDURIA (L) · 2-HYDROXYGLUTARIC ACIDEMIA (L); L-2-HYDROXYGLUTARIC ACIDURIA; L2HGA · ICD-10 E72.8 · ICD-11 5C52.01
- 2-KETOADIPIC ACIDEMIA (-> MOVED TO 204750) · KETOADIPICACIDURIA; · ICD-10 E72.3 · ICD-11 5C50.4
- 2-KETOGLUTARATE DEHYDROGENASE COMPLEX DEFICIENCY · ALPHA-KETOGLUTARATE DEHYDROGENASE COMPLEX DEFICIENCY ; 2-OXOGLUTARIC ACIDURIA; OGDH · ICD-10 E88.8 · ICD-11 5C50.E0
- 2-METHYL-3-HYDROXYBUTYRYL-CoA DEHYDROGENASE DEFICIENCY (HSD10) · 17-BETA-HYDROXYSTEROID DEHYDROGENASE X DEFICIENCY; HSD10 MITOCHONDRIAL DISEASE; HSD10MD · ICD-10 E72.8 · ICD-11 XM6J29
- 2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY (2-MBDD, SBCADD) · SHORT/BRANCHED-CHAIN ACYL-CoA DEHYDROGENASE DEFICIENCY · ICD-10 E71.3 · ICD-11 KB60.20
- 27-HYDROXYLASE DEFICIENCY (CTX) · CEREBROTENDINOUS XANTHOMATOSIS; CTX · ICD-10 E75.5 · ICD-11 3A00.Y
- 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY (HSD3B2) · ADRENAL HYPERPLASIA II; STEROID 3 BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY · ICD-10 E25.0 · ICD-11 5A71.01
- 3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY (HMGCLD) · 3-HYDROXY-3-METHYLGLUTARIC ACIDEMIA; LEUCINE METABOLISM, DEFECT IN, HMG-CoA LYASE DEFICIENCY; HMGCL · ICD-10 E71.1 · ICD-11 5C50.E0
- 3-HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE DEFICIENCY (HMGCS2D) · HMCS2; MITOCHONDRIAL HMG-CoA SYNTHASE DEFICIENCY · ICD-10 E71.3 · ICD-11 5B5B
- 3-HYDROXYDICARBOXYLIC ACIDURIA · ICD-10 E88.8 · ICD-11 5C50.D0
- 3-HYDROXYISOBUTYRIC ACIDURIA (HIBADH) · 3-HYDROXYISOBUTYRIC ACIDURIA; · ICD-10 E71.1 · ICD-11 FB85.0
- 3-HYDROXYISOBUTYRYL-CoA HYDROLASE DEFICIENCY (HIBCHD) · BETA-HYDROXYISOBUTYRYL CoA DEACYLASE DEFICIENCY; METHACRYLIC ACIDURIA · ICD-10 E71.1 · ICD-11 5A61.0
- 3-METHYL-CROTONYL-GLYCINURIA (3-MCC, MCC1D) · BETA-METHYLCROTONYLGLYCINURIA I · ICD-10 E71.1 · ICD-11 5C50.E0
- 3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY (MCC2D) · MCC2 DEFICIENCY · ICD-10 E71.1 · ICD-11 8C20.1
- 3-METHYLGLUTACONIC ACIDURIA (TYPE I); MGCA1 · MGA-1; 3-METHYLGLUTACONIC TYPE I (AUH), 3-@METHYLGLUTACONIC ACIDURIA, TYPE I · ICD-10 E71.1 · ICD-11 5C50.E0
- 3-METHYLGLUTACONIC ACIDURIA (TYPE III); MGCA3 · COSTEFF SYNDROME; OPTIC ATROPHY PLUS SYNDROME;MGA3 · ICD-10 E71.1 · ICD-11 4A60.Y
- 3-METHYLGLUTACONIC ACIDURIA (TYPE IV); MGCA4 · MGCA4, 3-@METHYLGLUTACONIC ACIDURIA, TYPE IV · ICD-10 E71.1 · ICD-11 5C56.21
- 3-METHYLGLUTACONIC ACIDURIA (TYPE IX); MGCA9 · MITOCHONDRIAL EPILEPTIC ENCEPHALOPATHY, TIMM50 · ICD-10 E71.1 · ICD-11 5C50.E0
- 3-METHYLGLUTACONIC ACIDURIA (TYPE V); MGCA5 · DILATED CARDIOMYOPATHY WITH ATAXIA SYNDROME (DCMA) · ICD-10 E71.1 · ICD-11 5C56.2Z
- 3-METHYLGLUTACONIC ACIDURIA (TYPE VI); MGCA6 (MEGDEL) · ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL · ICD-10 E71.1 · ICD-11 5C61.62
- 3-METHYLGLUTACONIC ACIDURIA (TYPE VIIA), MGCA7A · ICD-10 E71.1 · ICD-11 5C50.E0
- 3-METHYLGLUTACONIC ACIDURIA (TYPE VIIB), MGCA7B · MEGCANN · ICD-10 E71.1 · ICD-11 5A71.Y
- 3-METHYLGLUTACONIC ACIDURIA (TYPE VIII); MGCA8 · HTRA2 · ICD-10 E71.1 · ICD-11 GB90.42
- 3-METHYLGLUTACONIC ACIDURIA, NOVEL SUBTYPE · ICD-10 E71.1 · ICD-11 5C54.0
- 3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY (PHGDH) · PHGDH DEFICIENCY · ICD-10 E72.8 · ICD-11 5C54.0
- 5-OXOPROLINASE DEFICIENCY (OPLAHD) · 5-OXOPROLINURIA · ICD-10 E72.8 · ICD-11 5C50.B
- [ARTEFACTS AND PIFALLS]: DIATARY PULSES [DD] · ICD-11 5C53.2Y
- [ARTEFACTS AND PIFALLS]: MEDICAL PRODUCTS - CATHEDER USAGE [DD] · ICD-11 GB90.43
- [ARTEFACTS AND PITFALLS ]: PHARMACEUTICAL PRODUCTS, INTERFERENCE IN AMINOACID AND ORGANIC ACID ANALYSIS: ACETAMINOPHEN · PITFALLS IN AMINOACID AND ORGANIC ACID ANALYSIS · ICD-11 5A13.6
- [ARTEFACTS AND PITFALLS ]: PHARMACEUTICAL PRODUCTS, INTERFERENCE IN AMINOACID AND ORGANIC ACID ANALYSIS: PIVMECILLINAM · FALSE POSITIVE NEWBORN SCREENING · ICD-10 R79.8 · ICD-11 LD2F.1Y
- [ARTEFACTS AND PITFALLS ]: PSEUDOHYPERTRIGLYCERIDEMIA · pseudohypertriglyceridemia secondary to glycerol kinase deficiency (GKD) · ICD-11 5C64.41
- [ARTEFACTS AND PITFALLS]: BACTERIAL CONTAMINATION, EXCRETION OF ORGANIC ACIDS [DD] · ICD-11 5C54.0
- [ARTEFACTS AND PITFALLS]: DRUG ABUSE - GAMMA-AMINONOBUTYRIC ACID [DD] · ICD-11 LD90.Y
- [ARTEFACTS AND PITFALLS]: PHARMACEUTICAL PRODUCTS, INTERFERENCE IN AMINOACID AND ORGANIC ACID ANALYSIS [DD] · ICD-11 5C64.3
- [ARTEFACTS AND PITFALLS]: TRADITIONAL CHINESE MEDICINE; ORANGE JUICE [DD] · ICD-11 3A10.Y
- [CHECK CONDITIONS AND REPEAT MEASUREMENT] · CHECK CREATININE · ICD-11 5C60.Z
- [MITOCHONDRIAL DISEASE] · ICD-10 G31.9 · ICD-11 5C81.1
- [TREATMENT/THERAPY]: ACETAMINMOPHEN [DD] · ICD-11 LD2H.Y
- [TREATMENT/THERAPY]: ALLOPURINOL [DD] · ICD-11 5C63.1
- [TREATMENT/THERAPY]: BETAINE [DD] · ICD-11 8A03.Z
- [TREATMENT/THERAPY]: gamma-AMINOBUTYRIC ACID [DD] · SOMSANIT (R) · ICD-11 5C53.2Y
- [TREATMENT/THERAPY]: GLUCOSE [DD] · ICD-11 GB90.4Y
- [TREATMENT/THERAPY]: GLYCEROL [DD] · ICD-11 5C53.2Y
- [TREATMENT/THERAPY]: SAPROPTERIN (BH4) [DD] · KUVAN (R) · ICD-11 8C73.Z
- [TREATMENT/THERAPY]: SODIUM BENZOATE [DD] · ICD-11 LD27.Y
- [TREATMENT/THERAPY]: VALPROIC ACID [DD] · ICD-11 5A13.6
- ABETALIPOPROTEINEMIA, BASSEN-KORNZWEIG-SYNDROME, ACANTHOCYTOSIS (ABL) · ABETALIPOPROTEINEMIA; ABETALIPOPROTEINEMIA · ICD-10 E78.6 · ICD-11 5C51.0
- ACATALASEMIA · CATALASE DEFICIENCY; TAKAHARAS DISEASE; CAT · ICD-10 E80.3 · ICD-11 5C50.E0
- ACERULOPLASMINEMIA · HYPOCERULOPLASMINEMIA; CERULOPLASMIN DEFICIENCY; HEMOSIDEROSIS, SYSTEMIC; CP · ICD-10 G23.0 · ICD-11 LA12.1
- ACETYL-CoA ACETYLTRANSFERASE-2 DEFICIENCY (ACAT2D) · ICD-10 E88.9 · ICD-11 5C51.3
- ACETYL-CoA CARBOXYLASE DEFICIENCY (ACACAD) · ACACA DEFICIENCY · ICD-10 E88.9 · ICD-11 5C51.3
- ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME (AAAS) · TRIPLE-A SYNDROME; ALLGROVE SYNDROME · ICD-10 E27.4 · ICD-11 5A74.Y
- ACHONDROGENESIS, TYPE IA (ACG1A) · GMAP210-CDG; Golgi-microtubule-associated protein, 210 kD, deficiency · ICD-10 Q77.0 · ICD-11 LD24.50
- ACHONDROPLASIA (ACH) · ICD-10 Q77.4
- ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE; AEZ · ICD-10 E83.2 · ICD-11 5C64.41
- ACTH DEFICIENCY, ISOLATED · ADRENOCORTICOTROPIC HORMONE DEFICIENCY, ISOLATED · ICD-10 E23.6 · ICD-11 5A74.Y
- ACUTE INTERMITTEND PORPHYRIA (AIP) · PORPHYRIA, ACUTE INTERMITTEND; PORPHYRIA, ACUTE INTERMITTEND · ICD-10 E80.2 · ICD-11 5C58.1Y
- ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY (APRT) · ADENINE PHOSPHORIBOSYLTRANSFERASE; ADENINE PHOSPHO-RIBOSYL-TRANSFERASE (APRT) DEFICIENCY · ICD-10 E79.8 · ICD-11 5C53.24
- ADENOSINE KINASE DEFICIENCY · Hypermethionia due to adenosine kinase deficiency · ICD-10 E72.1 · ICD-11 5C56.1
- ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO · ICD-10 D55.3 · ICD-11 8D20.11
- ADENYLOSUCCINASE DEFICIENCY (ADSLD) · ADENYLOSUCCINASE ; ADENYLOSUCCINATE LYASE DEFICIENCY · ICD-10 E79.8 · ICD-11 LA8B.4
- ADENYLOSUCCINATE SYNTHASE-LIKE 1 DEFICIENCY · MYOPATHY, DISTAL, 5 (MPD5); ADSSL1 · ICD-10 E79.8 · ICD-11 LD20.01
- ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY · 17-ALPHA-HYDROXYLASE DEFICIENCY (CYP17); 17,20-LYASE DEFICIENCY, ISOLATED, INCLUDED · ICD-10 E25.08 · ICD-11 5C64.2Y
- ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY (CAH) · ADRENAL HYPERPLASIA III; STEROID 21-HYDROXYLASE DEFICIENCY · ICD-10 E25.00 · ICD-11 5A71.01
- ADRENAL HYPOPLASIA. ADDISON DISEASE, X-LINKED · ADRENAL HYPOPLASIA; ADRENAL HYPOPLASIA, CONGENITAL · ICD-10 E27.1 · ICD-11 LC80
- ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE · P450scc DEFICIENCY · ICD-10 Q56.1 · ICD-11 3A72.0Y
- ADRENOLEUKODYSTROPHY, X-LINKED (X-ALD) · ADDISON DISEASE AND CEREBRAL SCLEROSIS; ADRENOLEUKODYSTROPHY, X-LINKED; ADDISON DISEASE AND CEREBRAL SCLEROSIS · ICD-10 E71.3 · ICD-11 5C57.1
- AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY (ATIC) · ATIC DEFICIENCY; AICA-RIBOSURIA DUE TO ATIC DEFICIENCY · ICD-10 E79.8 · ICD-11 6A00.Z
- AICARDI-GOUTIERES SYNDROME 1 (AGS1) · ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATION AND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS · ICD-10 G31.8 · ICD-11 5C55.2
- AICARDI-GOUTIERES SYNDROME 2 (AGS2) · ICD-10 G31.8 · ICD-11 5C55.2
- AICARDI-GOUTIERES SYNDROME 3 (AGS3) · ICD-10 G31.8 · ICD-11 5C55.2
- AICARDI-GOUTIERES SYNDROME 4 (AGS4) · ICD-10 G31.8 · ICD-11 5C55.2
- AICARDI-GOUTIERES SYNDROME 5 (AGS5) · ICD-10 G31.8 · ICD-11 5C55.2
- AICARDI-GOUTIERES SYNDROME 6 (AGS6) · ICD-10 G31.8 · ICD-11 5C55.Y
- AICARDI-GOUTIERES SYNDROME 7 (AGS7) · ICD-10 G31.8 · ICD-11 5C55.Y
- AICARDI-GOUTIERES SYNDROME 8 (AGS8) · ICD-10 G31.8 · ICD-11 5C55.Y
- AICARDI-GOUTIERES SYNDROME 9 (AGS9) · ICD-10 G31.8 · ICD-11 5C55.Y
- ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME (AAMR) · GMPPA-CDG · ICD-10 E27.4 · ICD-11 5C53.23
- ALAGILLE SYNDROME 1 (ALGS1) · ICD-10 Q44.7 · ICD-11 LB20.0Y
- ALAGILLE SYNDROME 2 (ALGS2) · ICD-10 Q44.7 · ICD-11 LB20.0Y
- ALEXANDER DISEASE · ALXDRD · ICD-10 E75.2 · ICD-11 4A01.10
- ALKAPTONURIA (AKU) · HOMOGENTISIC ACID OXIDASE DEFICIENCY · ICD-10 E70.2 · ICD-11 5C50.10
- ALLAN-HERNDON-DUDLEY SYNDROME (AHDS) · MONOCARBOXYLATE TRANSPORTER 8 DEFICIENCY (MCT8) · ICD-10 G31.8 · ICD-11 9C82.4
- ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD) · ANTITRYPSIN; ALPHA(1)-ANTITRYPSIN DEFICIENCY; PROTEASE INHIBITOR 1; SERPINA1 · ICD-10 E88.00 · ICD-11 5A45
- ALPHA-AMINO-ADIPIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY (AAASAD) · PYRIDOXINE DEPENDENCY WITH SEIZURES (PDE); ALDH7A1 · ICD-10 G40.8 · ICD-11 5A71.01
- ALPHA-MANNOSIDOSIS · MANNOSIDOSIS, ALPHA-; MANNOSIDOSIS · ICD-10 E77.1 · ICD-11 5C56.21
- ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY (AMACRD) · AMACR DEFICIENCY · ICD-10 K76.8 · ICD-11 5D2Z
- ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE I: SCHINDLER DISEASE, · ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE I; SCHINDLER DISEASE, TYPE III, INCLUDED · ICD-10 E77.1 · ICD-11 5C54.0
- ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE II: KANZAKI DISEASE · ALPHA-GALACTOSIDASE B; ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY · ICD-10 E77.1 · ICD-11 5C54.2
- ALPORT SYNDROME · ALPORT SYNDROME; NEPHROPATHY AND DEAFNESS, X-LINKED · ICD-10 Q87.8 · ICD-11 8A02.11
- ALSTRÖM SYNDROME (ALMS) · ALSTROM SYNDROME · ICD-10 E43.8 · ICD-11 LD2H.Y
- ALTERNATING HEMIPLEGIA OF CHILDHOOD 2 (AHC2) · ICD-10 G98 · ICD-11 LD20.Y
- AMINOACYLASE I DEFICIENCY (ACY1D) · ICD-10 E72.8 · ICD-11 5C51.3
- ANTI-NMDA RECEPTOR ENCEPHALITIS (NMDAR) [DD] · ICD-10 G13.1 · ICD-11 5C53.2Y
- ANTICONVULSANT HYPERSENSITIVITY SYNDROME : CARBAMAZEPINE [DD] · ICD-10 T42.7 · ICD-11 5A13.6
- ANTICONVULSANT HYPERSENSITIVITY SYNDROME : VALPROATE ASSOCIATED HEPATOTOXICITY [DD] · ACUTE HYPERSENSITIVITY SYNDROME: VALPROATE · ICD-10 T42.7 · ICD-11 5C53.02
- ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS (ABS1) · PORD; P450 OXIREDUCTASE DEFICIENCY · ICD-10 Q87.8 · ICD-11 5C56.2Z
- APOLIPOPROTEIN C-II DEFICIENCY (APOC2) · APOC2-DEFICIENCY; HYPERLIPOPROTEINEMIA TYPE IB · ICD-10 E78.3 · ICD-11 5C58.10
- APPARENT MINERALOCORTICOID EXCESS (AME) · 11-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY, TYPE II; HSD11B2 · ICD-10 E26.1 · ICD-11 5C54
- ARGINASE 1 DEFICIENCY · ARGININEMIA; HYPERARGININEMIA; ARG1 · ICD-10 E72.2 · ICD-11 5C50.A2
- ARGININOSUCCINIC ACIDURIA (ASL) · ARGININOSUCCINASE DEFICIENCY; ARGININOSUCCINATE LYASE DEFICIENCY; ASL DEFICIENCY · ICD-10 E72.2 · ICD-11 5C50.A0
- AROMATASE DEFICIENCY · AROMATASE; GYNECOMASTIA DUE TO INCREASED AROMATASE ACTIVITY · ICD-10 E25.8 · ICD-11 EC20.01
- AROMATASE EXCESS SYNDROME (AEXS) · AROMATASE ACTIVITY, INCREASED · ICD-10 E30.1 · ICD-11 LD20.01
- AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY (AADC) · AROMATIC L-AMINO ACID DECARBOXYLASE; DOPA DECARBOXYLASE; ADDC · ICD-10 G24.8 · ICD-11 5C50.A3
- ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1 (GACI1) · ENPP1 · ICD-10 Q28.8 · ICD-11 5D2Z
- ARTERIAL TORTUOSITY SYNDROME (ATORS) · ARTERIAL TORTUOSITY (ATS) · ICD-10 I77.1 · ICD-11 5D2Z
- ARTS SYNDROME (ARTS) · PRPS1; MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS · ICD-10 E79.8 · ICD-11 8B44.01
- ASPARAGINE SYNTHETASE DEFICIENCY (ASNSD) · ICD-10 E72.8 · ICD-11 5C5Y
- ASPARTYLGLUCOSAMINURIA (AGU) · ASPARTYLGLUCOSAMINIDASE DEFICIENCY; AGA DEFICIENCY · ICD-10 E77.1 · ICD-11 5C56.21
- ASPHYXIA [DD] · NEONATAL HYPOXIC ISCHEMIC ENCEPHALOPATHY (HIE) · ICD-10 P21.9 · ICD-11 5C50.7Z
- ATAXIA-OCULOMOTOR APRAXIA 1 (AOA1) · ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH · ICD-10 G11.3 · ICD-11 8A62.Y
- ATAXIA-OCULOMOTOR APRAXIA 2 (AOA2) · SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 2; SCAN2; SETX · ICD-10 G60.2 · ICD-11 LD90.Y
- ATAXIA-OCULOMOTOR APRAXIA 3 (AOA3) · PIK3R5 · ICD-10 G60.2 · ICD-11 BC65.Y
- ATAXIA-OCULOMOTOR APRAXIA 4 (AOA4) · PNKP · ICD-10 G60.2 · ICD-11 8A62.Y
- ATAXIA-TELANGIECTASIA (AT) · LOUIS-BAR SYNDROME · ICD-10 G11.3 · ICD-11 4A01.31
- ATRANSFERRINEMIA · HYPOTRANSFERRINEMIA, FAMILIAL · ICD-10 E88.08 · ICD-11 5C53.2Y
- AUTISM · AUTISTIC DISORDER; AUTISM, SUSCEPTIBILITY TO, 1, INCLUDED; AUTS1 · ICD-10 F84.5 · ICD-11 5C56.3Y
- AUTISM SPECTRUM DISORDERS (ASD) [DD] · ICD-10 F84.9 · ICD-11 GB41
- AUTISM, SUSCEPTIBILITY TO, X-LINKED 1 (AUTSX1) · ASPERGER SYNDROME, SUSCEPTIBILITY TO, X-LINKED 1 · ICD-10 F84.9 · ICD-11 LD20.01
- AUTISM, SUSCEPTIBILITY TO, X-LINKED 2 (AUTSX2) · ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2 · ICD-10 F84.9 · ICD-11 LD20.01
- AUTISM, SUSCEPTIBILITY TO, X-LINKED 3 (AUTSX3) · ICD-10 F84.9 · ICD-11 LD20.01
- AUTISM, SUSCEPTIBILITY TO, X-LINKED 6 (AUTSX6) · EPSILON-TRIMETHYLLYSINE HYDROXYLASE DEFICIENCY · ICD-10 F84.9 · ICD-11 LD20.01
- AUTOINFLAMMATORY SYNDROME WITH CYTOPENIA, HYPERZINCEMIA, AND HYPERCALPROTECTINEMIA (AICZC) · PSTPIP1 · ICD-10 E83.2 · ICD-11 5A13.6
- AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE (ADTKD-MUC1) · MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1 · ICD-10 Q61.5 · ICD-11 5A74.Y
- AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE (ADTKD-UMOD) · HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1 (HNFJ1) · ICD-10 Q61.5 · ICD-11 2B33.3
- BARDET-BIEDL SYNDROME 1 (BBS1) · ICD-10 Q87.8 · ICD-11 5A61.0
- BARTH SYNDROME (BTHS) · 3-METHYLGLUTACONIC ACIDURIA (TYPE II) · ICD-10 E71.1 · ICD-11 5C50.E0
- BARTTER SYNDROME, TYPE 1, ANTENATAL (BARTS1) · HYPOKALEMIC ALKALOSIS WITH HYPERCALCIURIA 1, ANTENATAL · ICD-10 E26.8 · ICD-11 5C53.20
- BARTTER SYNDROME, TYPE 2, ANTENATAL (BARTS2) · HYPOKALEMIC ALKALOSIS WITH HYPERCALCIURIA 2, ANTENATAL · ICD-10 E26.8 · ICD-11 ---
- BARTTER SYNDROME, TYPE 3 (BARTS3) · BARTTER SYNDROME, CLASSIC; CLCNKB · ICD-10 E26.8 · ICD-11 5C53.Y
- BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS (BARTS4A) · BARTTER SYNDROME, NEONATAL, WITH SENSORINEURAL DEAFNESS · ICD-10 E26.8 · ICD-11 ---
- BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS (BARTS4B) · ICD-10 E26.8 · ICD-11 8A62.Y
- BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT (BARTS5) · ICD-10 E26.8 · ICD-11 5C56.2Z
- BARTTER-LIKE-SYNDROME [DD] · AQUIRED BARTTER-LIKE-SYNDROME · ICD-10 E26.9 · ICD-11 5A42
- BECKWITH-WIEDEMANN SYNDROME. EXOMPHALOS-MAKROGLOSSIA-GIGANTISM SYNDROME (BWS) · EMG SYNDROME; BECKWITH-WIEDEMANN SYNDROME · ICD-10 Q87.3 · ICD-11 LD2C
- BEHR SYNDROME (BEHRS) · OPTIC ATROPHY, INFANTILE HEREDITARY, WITH NEUROLOGIC ABNORMALITIES · ICD-10 H47.2 · ICD-11 5C5Y
- BENIGN INFANTILE MITOCHONDRIAL MYOPATHY (BIMM) · MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT · ICD-10 G71.3 · ICD-11 5C50.6
- BENIGN INFANTILE MITOCHONDRIAL MYOPATHY AND CARDIOMYOPATHY (BIMC) · ICD-10 G71.3 · ICD-11 5C81.1
- BETA-AMINOISOBUTYRIC ACIDURIA (BAIBA) · BETA-AMINOISOBUTYRIC ACID, URINARY EXCRETION OF BAIB URINARY EXCRETION · ICD-10 E71.3 · ICD-11 5C5Y
- BETA-KETOTHIOLASE DEFICIENCY; ALPHA-METHYLACETOACETIC ACIDURIA · ACIDEMIA, 3-KETOTHIOLASE DEFICIENCY, 3-OXOTHIOLASE DEFICIENCY, T2 DEFICIENCY, MITOCHONDRIA; ACAT1 · ICD-10 E71.1 · ICD-11 5C50.DY
- BETA-MANNOSIDOSIS · MANNOSIDOSIS, BETA-; MANNOSIDOSIS; MANBA · ICD-10 E77.1 · ICD-11 5C56.21
- BETA-MERCAPTOLACTATE-CYSTEINE DISULFIDURIA · MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; AMPOLA SYNDROME · ICD-10 E72.1 · ICD-11 5C50.B
- BHLHE22-RELATED NEURODEVELOPMENTAL DISORDER (NEW) · ICD-10 E88.8
- BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1 (CBAS1) · 3-BETA-HYDROXY-DELTA-5-C27-STEROID OXIDOREDUCTASE DEFICIENCY · ICD-10 K76.8 · ICD-11 5C53.23
- BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2 (CBAS2) · CHOLESTASIS WITH DELTA(4)-3-OXOSTEROID 5-BETA-REDUCTASE DEFICIENCY · ICD-10 K76.8 · ICD-11 5C53.23
- BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3 (CBAS3) · ICD-10 K76.8 · ICD-11 5C53.23
- BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4 (CBAS4) · TRIHYDROXYCOPROSTANIC ACIDEMIA; COPROSTANIC ACIDEMIA; AMACR · ICD-10 K76.8 · ICD-11 5C52.11
- BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5 (CBAS5) · ICD-10 K76.8 · ICD-11 5C56.2Z
- BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6; CBAS6 · ICD-10 K76.8 · ICD-11 8A61.2Y
- BIOTINIDASE DEFICIENCY · MULTIPLE CARBOXYLASE DEFICIENCY, LATE ONSET; BIOTINIDASE DEFICIENCY · ICD-10 E53.8 · ICD-11 5C50.E0
- BLUE DIAPER SYNDROME · HYPERCALCEMIA, FAMILIAL, WITH NEPHROCALCINOSIS AND INDICANURIA · ICD-10 E70.8 · ICD-11 8A44.0
- BMPR2-RELATED NEURODEVELOPMENTAL DISORDER (NEW) · ICD-10 E88.8
- BRAIN SMALL VESSEL DISEASE 3 ( BSVD3) · COLGALT1 · ICD-10 Q04.6 · ICD-11 8A62.Y
- BRANCHED-CHAIN AMINOTRANSFERASE 2 (BCAT2) · BCAT2 · ICD-10 E71.2 · ICD-11 5A13.6
- BRANCHED-CHAIN KETO ACID DEHYDROGENASE KINASE DEFICIENCY (BCKDKD) · BCKDK DEFICIENCY · ICD-10 E71.1 · ICD-11 5C56.2Z
- BROWN-VIALETTO-VAN LAERE SYNDROME 1 (BVVLS1) · BULBAR PALSY, PROGRESSIVE, WITH SENSORINEURAL DEAFNESS · ICD-10 G12.1 · ICD-11 5A61.0
- BRUNNER SYNDROME (MONOAMINE OXIDASE-A DEFICIENCY (MAO-A) · MONOAMINE OXIDASE-A DEFICIENCY (MAO-A) · ICD-10 E70.8 · ICD-11 5C50.E1
- BUTYROBETAINE-GAMMA,2-OXOGLUTARATE DIOXYGENASE 1 (BBOX1) · COQ5 DEFICIENCY · ICD-10 E88.8 · ICD-11 EC23.Y
- CANAVAN DISEASE (ASPA) · AMINOACYLASE 2 DEFICIENCY; CANAVAN-VAN BOGAERT-BERTRAND DISEASE · ICD-10 E75.2 · ICD-11 5C50.E1
- CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY (CPS) · CPS I DEFICIENCY · ICD-10 E72.2 · ICD-11 5C50.A1
- CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO (CA5AD) · ICD-10 E74.8 · ICD-11 DD7Z
- CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 3 (CEMCOX3) · ICD-10 G71.3 · ICD-11 5C53.24
- CARDIOMYOPATHY, DILATED, 1G (CMD1G) · ICD-10 I42.0
- CARDIOMYOPATHY, DILATED, 2C (CMD2C) · PHOSPHOPANTOTHENOYLCYSTEINE SYNTHETASE DEFICIENY; PPCS · ICD-10 I42.0 · ICD-11 LD20.4
- CARDIOMYOPATHY, FAMILIAL DILATED · CARDIOMYOPATHY, FAMILIAL IDIOPATHIC; CARDIOMYOPATHY, FAMILIAL DILATED; CMD1A · ICD-10 I42.0 · ICD-11 BC43.00
- CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6 (CMH6) · GLYCOGEN STORAGE DISEASE OF HEART; PRKAG2 · ICD-10 E74.0+ G73.6* · ICD-11 5C58.03
- CARNITINE DEFICIENCY, MYOPATHIC · CARNITINE DEFICIENCY, MYOPATHIC; MYOPATHY-METABOLIC, CARNITINE DEFICIENCY, PRIMARY AND SECOND · ICD-10 E71.3 · ICD-11 5C55.0Y
- CARNITINE PALMITOYL TRANSFERASE DEFICIENCY (II), CPT2, LETHAL NEONATAL · CPT2 DEFICIENCY, LETHAL NEONATAL · ICD-10 E71.3 · ICD-11 LD20.01
- CARNITINE PALMITOYL TRANSFERASE DEFICIENCY (II), CPT2, MYOPATHIC, STRESS-INDUCED · CPT2 DEFICIENCY, LATE-ONSET, CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ADULT-ONSET · ICD-10 E71.3 · ICD-11 5C52.00
- CARNITINE PALMITOYL TRANSFERASE DEFICIENCY 1A (CPT1A) · CARNITINE PALMITOYLTRANSFERASE IA DEFICIENCY · ICD-10 E71.3 · ICD-11 5B6Z
- CARNITINE PALMITOYLTRANSFERASE DEFICIENCY (II), CPT2, INFANTILE · CPT2 DEFICIENCY, INFANTILE · ICD-10 E71.3 · ICD-11 LD20.01
- CARNITINE TRANSPORTER DEFICIENCY; PRIMARY SYSTEMIC CARNITINE DEFICIENCY · CARNITINE DEFICIENCY, SYSTEMIC, DUE TO DEFECT IN RENAL ABS.; MYOPATHY-METABOLIC, CARNITINE DEFICIENCY, PRIMARY AND SECON · ICD-10 E71.3 · ICD-11 5C52.00
- CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY (CACT) · CARNITINE-ACYLCARNITINE TRANSLOCASE; CACTD · ICD-10 E71.3 · ICD-11 5C61.5
- CARNOSINURIA, CARNOSINEMIA AND HOMOCARNOSINOSIS · CARNOSINASE DEFICIENCY; CNDP1 · ICD-10 E70.8 · ICD-11 5C50.F1
- CASGID SYNDROME (CASGID) · INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT (CASGID) · ICD-10 G40.4 · ICD-11 LD24.H
- CATARACT 47 (CTRCT47) · SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 12; SLC16A12 · ICD-10 E88.8 · ICD-11 8A62.Y
- CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA (CAGSSS) · IARS2 · ICD-10 E88.8 · ICD-11 9C82.4
- CATIONIC AMINO ACID TRANSPORTER 2 (CAT-2) DEFECT · ICD-10 E88.8 · ICD-11 EC23.2Y
- CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS (CAPOS) · CAPOS -SYNDROME · ICD-10 G11.1 · ICD-11 LD90.Y
- CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY (CASVDD) · ICD-10 G23.8
- CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1; CREATINE-TRANSPORTER DEFECT (CTD) · CREATINE DEFICIENCY SYNDROME, X-LINKED; SLC6A8 · ICD-10 E72.8 · ICD-11 5C53.2Y
- CEREBRAL CREATINE DEFICIENCY SYNDROME 2; CCDS2; GAMT DEFICIENCY · GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY (GAMT) · ICD-10 E72.8 · ICD-11 5C54.0
- CEREBRAL CREATINE DEFICIENCY SYNDROME 3 (GATM, AGAT DEFICIENCY) · CREATINE-DEFICIENCY-SYNDROME · ICD-10 E72.8 · ICD-11 5C53.24
- CEREBRAL FOLATE DEFICIENCY DUE TO FOLR1 AUTOANTIBODIES (CFD) · NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY; NCFTD · ICD-10 G31.8 · ICD-11 9B10.2Y
- CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 1 (CPSQ1) -> MOVED TO 619026 AND 612900 · ICD-10 G82.4 · ICD-11 5C53.24
- CEROID LIPOFUSCINOSIS, NEURONAL, 1 (CLN1; SANTAVUORI-HALTIA-DISEASE) · CLN1; CEROID LIPOFUSCINOSIS, NEURONAL, 1, VARIABLE AGE AT ONSET · ICD-10 E75.4 · ICD-11 5C55.00
- CEROID LIPOFUSCINOSIS, NEURONAL, 10 (CLN10) · CLN10; CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT · ICD-10 E75.4 · ICD-11 8A62.Y
- CEROID LIPOFUSCINOSIS, NEURONAL, 11 (CLN11) · CLN11 · ICD-10 E75.4 · ICD-11 8A62.Y
- CEROID LIPOFUSCINOSIS, NEURONAL, 12 (CLN12) · CLN12; KUFOR-RAKEB SYNDROME · ICD-10 E75.4 · ICD-11 5C50.E0
- CEROID LIPOFUSCINOSIS, NEURONAL, 13 (CLN13) · CLN13; CEROID LIPOFUSCINOSIS, NEURONAL, 13, KUFS TYPE · ICD-10 E75.4 · ICD-11 5C50.E0
- CEROID LIPOFUSCINOSIS, NEURONAL, 14 (CLN14) · CLN14; EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS; EPM3 · ICD-10 G40.3 · ICD-11 LD90.Y
- CEROID LIPOFUSCINOSIS, NEURONAL, 2 (CLN2) · BATTEN DISEASE; JANSKY-BIELSCHOWSKY DISEASE · ICD-10 E75.4 · ICD-11 GB90.44
- CEROID LIPOFUSCINOSIS, NEURONAL, 3 (CLN3) · BATTEN DISEASE; JUVENILE NEURONAL CEROID LIPOFUSCINOSIS; VOGT-SPIELMEYER DISEASE · ICD-10 E75.4 · ICD-11 LD28.Y
- CEROID LIPOFUSCINOSIS, NEURONAL, 4B (CLN4B) · CLN4B; KUFS DISEASE, AUTOSOMAL DOMINANT · ICD-10 E75.4 · ICD-11 BA04.Y
- CEROID LIPOFUSCINOSIS, NEURONAL, 5 (CLN5) · CLN5; NEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED · ICD-10 E75.4 · ICD-11 5C64.41
- CEROID LIPOFUSCINOSIS, NEURONAL, 6A (CLN6A) · CLN6; NEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, VARIANT, INCLUDED · ICD-10 E75.4 · ICD-11 5C50.EY
- CEROID LIPOFUSCINOSIS, NEURONAL, 6B (CLN6B) · KUFS DISEASE · ICD-10 E75.4 · ICD-11 GB90.41
- CEROID LIPOFUSCINOSIS, NEURONAL, 7 (CLN7) · CLN7 · ICD-10 E75.4 · ICD-11 5C63.0
- CEROID LIPOFUSCINOSIS, NEURONAL, 8 (CLN8) · CLN8 · ICD-10 E75.4 · ICD-11 8A62.Y
- CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT · NORTHERN EPILEPSY · ICD-10 E75.4 · ICD-11 5C50.EY
- CEROID LIPOFUSCINOSIS, NEURONAL, 9 (CLN9) · CLN9 · ICD-10 E75.4 · ICD-11 8A62.Y
- CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2MM (CMT2MM) · ICD-10 G60.0 · ICD-11 8C20.1
- CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Y (CMT2Y) · ICD-10 G60.0
- CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z (CMT2Z) · ICD-10 G60.0
- CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C (CMTDIC) · CHARCOT-MARIE-TOOTH NEUROPATHY, DOMINANT INTERMEDIATE C; DI-CMTC ; YARS1 · ICD-10 G60.0 · ICD-11 LD20.01
- CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1 (CMTX1) · GJB1 · ICD-10 G50.0
- CHEMICAL PHENYLKETONURIA (PKU)
- CHILD SYNDROME · CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS · ICD-10 Q87.8 · ICD-11 5C64.10
- CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL) [DD] · ICD-10 C95.90 · ICD-11 LD90.Y
- CHILDHOOD CNS TUMORS [DD] · ICD-10 D43.9 · ICD-11 5D2Z
- CHILDHOOD VASCULITIS [DD] · KAWASAKI DISEASE · ICD-10 M30.3 · ICD-11 5C64.10
- CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 1 (PFIC1) · BYLER DISEASE; ATP8B1 · ICD-10 K76.8 · ICD-11 5C52.0Z
- CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2 (PFIC2) · ABCB11 · ICD-10 K76.8 · ICD-11 6A02.Z
- CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3 (PFIC3) · ABCB4 · ICD-10 K76.8 · ICD-11 8A62
- CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4 (PFIC4) · TJP2 · ICD-10 K76.8 · ICD-11 8A62.Y
- CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5 (PFIC5) · NR1H4 · ICD-10 K76.8 · ICD-11 8A62.Y
- CHOLESTATIC LIVER DISEASE [DD] · ICD-10 Q44.7 · ICD-11 5C63.1
- CHOLESTERYL ESTER STORAGE DISEASE · LYSOSOMAL ACID LIPASE DEFICIENCY; LIPA · ICD-10 E75.5 · ICD-11 5C56.0Y
- CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANT · CHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY · ICD-10 Q77.3 · ICD-11 LD24.04
- CHONDRODYSPLASIA PUNCTATA1, X-LINKED RECESSIVE (CDPX1) · CHONDRODYSPLASIA PUNCTATA, X-LINKED DOMINANT; CHONDRODYSPLASIA PUNCTATA, X-LINKED DOMINANT TYPE · ICD-10 Q77.3 · ICD-11 8A02.11
- CHONDRODYSPLASIA PUNCTATA2, X-LINKED DOMINANT (CDPX2) · CHONDRODYSPLASIA PUNCTATA, X-LINKED DOMINANT; CHONDRODYSPLASIA PUNCTATA, X-LINKED DOMINANT TYPE · ICD-10 Q77.3 · ICD-11 LD24.04
- CHONDRODYSTROPHIA CALCIFICANS CONGENITA · CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC TYPE · ICD-10 Q77.3 · ICD-11 LD24.04
- CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB · AUTISM, SUSCEPTIBILITY TO, 14A, INCLUDED; AUTS14A, INCLUDED · ICD-10 Q93.5 · ICD-11 LD44.G1
- CHRONIC DIARRHEA [DD] · ICD-10 K52.9 · ICD-11 GB90.43
- CITRULLINEMIA TYPE I (ASS) · ARGININOSUCCINATE SYNTHETASE DEFICIENCY; ASS DEFICIENCY · ICD-10 E72.2 · ICD-11 5C50.A3
- CITRULLINEMIA TYPE II, ADULT-ONSET · CITRULLINEMIA, ADULT-ONSET TYPE II; CTLN2 · ICD-10 E72.2 · ICD-11 5C53.2Y
- CITRULLINEMIA TYPE II, NEONATAL ONSET (NICCD) · NEONATAL INTRAHEPATIC CHOLESTASIS CAUSED BY CITRIN DEFICIENCY, NICCD · ICD-10 E72.2 · ICD-11 5C50.3
- CK SYNDROME · MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICAL MALFORMATION · ICD-10 Q87.0 · ICD-11 5C53.21
- COBALAMIN F DISEASE (cblF) · METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE · ICD-10 E72.1 · ICD-11 4A00.Y
- COBALAMIN MALABSORPTION · ICD-10 E53.8 · ICD-11 5C58.13
- COCKAYNE SYNDROME A (CSA) · ICD-10 Q87.8 · ICD-11 8A61.22
- COCKAYNE SYNDROME B (CSB) · ICD-10 Q87.8 · ICD-11 8A62.Y
- COENZYME Q10 DEFICIENCY, PRIMARY, 1 (COQ10D1) · COENZYME Q 10 DEFICIENCY; UBIQUINONE DEFICIENCY; COQ2 · ICD-10 G31.8 · ICD-11 5B81.Y
- COENZYME Q10 DEFICIENCY, PRIMARY, 2 (COQ10D2) · ICD-10 E88.8 · ICD-11 5A4Y
- COENZYME Q10 DEFICIENCY, PRIMARY, 3 (COQ10D3) · ICD-10 G31.8 · ICD-11 5C55.1
- COENZYME Q10 DEFICIENCY, PRIMARY, 4 (COQ10D4) · SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 9; SCAR9 · ICD-10 G11.1 · ICD-11 5C55.1
- COENZYME Q10 DEFICIENCY, PRIMARY, 5 (COQ10D5) · ICD-10 E88.8 · ICD-11 8A62
- COENZYME Q10 DEFICIENCY, PRIMARY, 6 (COQ10D6) · ICD-10 N04.8 · ICD-11 5B5F
- COENZYME Q10 DEFICIENCY, PRIMARY, 7 (COQ10D7) · ICD-10 E88.8 · ICD-11 GB6Z
- COENZYME Q10 DEFICIENCY, PRIMARY, 8 (COQ10D8) · ICD-10 E88.8 · ICD-11 4A01.10
- COENZYME Q10 DEFICIENCY, PRIMARY, 9 (COQ10D9) · C-METHYLTRANSFERASE DEFICIENCY (COQ5) · ICD-10 G11.1 · ICD-11 8A62.Y
- COFFIN-SIRIS SYNDROME 1 (CSS1) · ICD-10 Q87.1 · ICD-11 8A62.Y
- COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA (CIAT) · ICD-10 F06.9
- COMBINED IMMUNODEFICIENCY 135 (IMD135) · ICD-10 D81.9 · ICD-11 4A01.1Y
- COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA (CIMAH) · METHYLENETETRAHYDROFOLATE DEHYDROGENASE 1 DEFICIENCY · ICD-10 E88.8 · ICD-11 5C54.2
- COMBINED MALONIC AND METHYLMALONIC ACIDURIA (CMAMMA) · ICD-10 E71.1 · ICD-11 5C56.1
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1 (COXPD1) · HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE · ICD-10 E88.8 · ICD-11 LD28.1Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10 (COXPD10) · CARDIOMYOPATHY, INFANTILE HYPERTROPHIC MITOCHONDRIAL, AND LACTIC ACIDOSIS (MTO1) · ICD-10 I42.2 · ICD-11 5A4Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11 (COXPD11) · ENCEPHALONEUROMYOPATHY, INFANTILE, DUE TO MITOCHONDRIAL TRANSLATION DEFECT · ICD-10 E88.8 · ICD-11 5C5Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12 (COXPD12) · EARS2 · ICD-10 E88.8 · ICD-11 8A61.0Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13 (COXPD13) · PNPT1 · ICD-10 G71.3 · ICD-11 LD2E,5C5Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14 (COXPD14) · FARS2 DEFICIENCY · ICD-10 E88.8 · ICD-11 5C53.2Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15 (COXPD15) · MTFMT · ICD-10 G31.8 · ICD-11 5C53.20
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16 (COXPD16) · MRPL44 · ICD-10 I42.2 · ICD-11 5C50.B
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17 (COXPD17) · ELAC2 · ICD-10 E88.8 · ICD-11 5C60.2
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18 (COXPD18) · SFXN4 · ICD-10 E88.8 · ICD-11 8A62.Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19 (COXPD19) · ICD-10 E88.8 · ICD-11 5C50.E0
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2 (COXPD2) · CORPUS CALLOSUM, AGENESIS OF, WITH DYSMORPHISM AND FATAL LACTIC ACIDOSIS · ICD-10 E88.8 · ICD-11 5C52.0Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20 (COXPD20) · VARS2 · ICD-10 G31.88 · ICD-11 5C53.2Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21 (COXPD21) · TARS2 · ICD-10 E88.8 · ICD-11 5C63.Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22 (COXPD22) · ATP5A1 · ICD-10 E88.8 · ICD-11 5C5Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23 (COXPD23) · GTPBP3 · ICD-10 I42.2 · ICD-11 LD2H.Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24 (COXPD24) · NARS2 · ICD-10 E88.8 · ICD-11 8A62.Z
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25 (COXPD25) · MARS2 · ICD-10 E88.8 · ICD-11 8A62
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26 (COXPD26) · TRMT5 · ICD-10 E88.8 · ICD-11 3A10.0Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27 (COXPD27) · CARS2 · ICD-10 E88.8 · ICD-11 5C53.23
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28 (COXPD28) · SLC25A26 · ICD-10 E88.8 · ICD-11 5C53.2Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29 (COXPD29) · MITOCHONDRIAL THIOREDOXIN 2 DEFICIENCY · ICD-10 E88.8 · ICD-11 9C40.8
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3 (COXPD3) · ENCEPHALOMYOPATHY, RESPIRATORY FAILURE, AND LACTIC ACIDOSIS CONCENTRIC CARDIOMYOPATHY, HYPOTONIA, AND LACTIC ACIDOSIS; · ICD-10 E88.8 · ICD-11 5C52.2
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30 (COXPD30) · TRMT10C · ICD-10 E88.8 · ICD-11 5C53.24
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31 (COXPD31) · MIPEP · ICD-10 E88.8 · ICD-11 5C53.2Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32 (COXPD32) · MRPS34 · ICD-10 E88.8 · ICD-11 5C53.2Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33 (COXPD33) · C1QBP · ICD-10 E88.8 · ICD-11 5C53.2Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34 (COXPD34) · MRPS7 · ICD-10 E88.8 · ICD-11 5C53.2Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35 (COXPD35) · TRIT1 · ICD-10 E88.8 · ICD-11 LD24.20
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36 (COXPD36) · MRPS2 · ICD-10 E88.8 · ICD-11 LD20.01
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37 (COXPD37) · QIL1/MICOS13 · ICD-10 E71.1 · ICD-11 LD20.01
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38 (COXPD38) · MRPS14 · ICD-10 E88.8 · ICD-11 LD20.01
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39 (COXPD39) · GFM2 · ICD-10 E88.8 · ICD-11 LB9Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4 (COXPD4) · TUFM · ICD-10 E88.8 · ICD-11 8C70.6
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 40 (COXPD40) · QRSL1 · ICD-10 E88.8 · ICD-11 5C81.Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 41 (COXPD41) · ICD-10 E88.8 · ICD-11 CB04.31
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 42 (COXPD42) · ICD-10 E88.8 · ICD-11 5C53.24
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 43 (COXPD43) · ICD-10 E88.8 · ICD-11 BC43.0Z
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 44 (COXPD44) · ICD-10 G71.3 · ICD-11 LD25.2
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 45 (COXPD45) · MRPL12 · ICD-10 E88.8 · ICD-11 5C53.2Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 46 (COXPD46) · Small ribosomal subunit protein mS23 · ICD-10 E88.8 · ICD-11 5C53.2Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 47 (COXPD47) · MRPS28 · ICD-10 E88.8 · ICD-11 5C53.2Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 48 (COXPD48) · NSUN3 · ICD-10 E88.8 · ICD-11 8A62.Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 49 (COXPD49) · MIEF2 · ICD-10 E88.8 · ICD-11 LA9Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5 (COXPD5) · MRPS22 · ICD-10 E88.8 · ICD-11 5C51.0
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 50 (COXPD50) · MRPS25 · ICD-10 E88.8 · ICD-11 5C53.2Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 51 (COXPD51) · PTCD3 · ICD-10 E88.8 · ICD-11 5A72.0
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 52 (COXPD52) · NFS1 · ICD-10 E88.8 · ICD-11 8A62.Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 53 (COXPD53) · ELBRACHT-ISIKAY SYNDROME · ICD-10 E88.8 · ICD-11 LD2Z
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 54 (COXPD54) · PRORP · ICD-10 E88.8 · ICD-11 5C55.2
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 55 (COXPD55) · POLRMT · ICD-10 E88.8 · ICD-11 5C55.2
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 56 (COXPD56) · TAMM41 · ICD-10 E88.8 · ICD-11 8A62.Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 57 (COXPD57) · CRLS1 · ICD-10 E88.8 · ICD-11 8A62.Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 58 (COXPD58) · TEFM · ICD-10 E88.8 · ICD-11 8A62.Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 59 (COXPD59) · MRPL39 · ICD-10 E88.8 · ICD-11 8A62.Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6 (COXPD6) · ENCEPHALOMYOPATHY, MITOCHONDRIAL, X-LINKED; AIFM1 · ICD-10 G31.81 · ICD-11 DB99.Y
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 60 (COXPD60) · ICD-10 E88.8
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7 (COXPD7) · C12ORF65 · ICD-10 G31.8 · ICD-11 5D2Z
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8 (COXPD8) · AARS2 · ICD-10 E88.8 · ICD-11 KB29.0
- COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9 (COXPD9) · MRPL3 · ICD-10 E88.8 · ICD-11 LD90.Y
- COMBINED SAPOSIN DEFICIENCY · PROSAPOSIN DEFICIENCY; PSAPD · ICD-10 E75.2 · ICD-11 5C51.3
- CONGENITAL CATARACT [DD] · ICD-10 Q12.0 · ICD-11 5A61.0
- CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION (CHLND) · HUPPKE-BRENDEL SYNDROME (HPBDS); SLC33A1 · ICD-10 E88.8 · ICD-11 PL0Z
- CONGENITAL CHLORIDE DIARRHEA (DIAR1) · DIARRHEA, CONGENITAL CHLORIDE, CLD, DARROW-GAMBLE DISEASE · ICD-10 P78.3 · ICD-11 DA90.1
- CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG (NGLY1-CDDG) · CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iv, FORMERLY (CDG1V) · ICD-10 E77.8 · ICD-11 5C56.3Z
- CONGENITAL DISORDER OF GLYCOSYLATION (ALG1‐CDG) · ALG1-CDG; formerly CDG1K · ICD-10 E77.8 · ICD-11 3A02.Y
- CONGENITAL DISORDER OF GLYCOSYLATION (CSGALNACT1) · CSGALNACT1-CDG · ICD-10 E77.8 · ICD-11 LD2H.Y
- CONGENITAL DISORDER OF GLYCOSYLATION (GFUS-CDG) · GFUS-CDG · ICD-10 E77.8 · ICD-11 5C58.03
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ia (PMM2-CDG) · CDG1A; PMM2-CDG; JAEKEN SYNDROME · ICD-10 E77.8 · ICD-11 LD20.00
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ib (MPI) · CDG1B; MPI-CDG; SLSJ SYNDROME · ICD-10 E77.8 · ICD-11 5C54.2
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ic · CDG1C; ALG6-CDG · ICD-10 E77.8 · ICD-11 5C54.2
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Id · CDG1D; ALG3-CDG · ICD-10 E77.8 · ICD-11 5C54.2
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ie · CDG1E; DPM1-CDG; DMP1 · ICD-10 E77.8 · ICD-11 DB92.Z
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-If · CDG1F; MPDU1-CDG · ICD-10 E77.8 · ICD-11 DB91.1
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ig · CDG1G; ALG12-CDG · ICD-10 E77.8 · ICD-11 5C53.20
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ih · CDG1H; ALG8-CDG · ICD-10 E77.8 · ICD-11 5C53.20
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ii · CDG1I; ALG2-CDG · ICD-10 E77.8 · ICD-11 5C54.0
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIa · CDG2A; MGAT2-CDG; ALKURAYA SYNDROME · ICD-10 E77.8 · ICD-11 5C54.0
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIb · CDG2B; GCS1-CDG; MOGS-CDG · ICD-10 E77.8 · ICD-11 5C54.2
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIc · CDG2C; SLC35C1-CDG; LEUKOCYTE ADHESION DEFICIENCY, TYPE II; RAMBAM-HASHARON SYNDROME; CDG-IIc · ICD-10 D84.8 · ICD-11 5C54.2
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IId · CDG2D; B4GALT1-CDG · ICD-10 E77.8 · ICD-11 5C50.EY
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIe · CDG2E; COG7-CDG · ICD-10 E77.8 · ICD-11 KB60.2Y
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIf · CDG2F; SLC35A1 · ICD-10 E77.8 · ICD-11 5A13.6
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIg · CDG2G; COG1-CDG · ICD-10 E77.8 · ICD-11 LD24.3
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIh · CDG2H; COG8-CDG · ICD-10 E77.8 · ICD-11 5A13.6
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIj · CDG2J; COG4-CDG · ICD-10 E77.8 · ICD-11 5A13.6
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIk · CDG2K; TMEM165-CDG · ICD-10 E77.8 · ICD-11 LD27.60
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIL · CGD2L; COG6-CDG · ICD-10 E77.8 · ICD-11 LA05.0
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIm (SLC35A2-CDG) · CDG2M; SLC35A2-CDG · ICD-10 E77.8 · ICD-11 5C50.E0
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIn · CDG2N; SLC39A8-CDG · ICD-10 E77.8 · ICD-11 5C50.EY
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIo · CDG2O; CCDC115-CDG · ICD-10 E88.8 · ICD-11 4B0Y
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-IIp · CDG2P; TMEM199-CDG · ICD-10 E88.8 · ICD-11 LD27.60
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ij · CDG1J; DPAGT1-CDG · ICD-10 E77.8 · ICD-11 5C54.0
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Il · CDG IL; ALG9-CDG · ICD-10 E77.8 · ICD-11 5C54.0
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Im · CDG1M; DOLK-CDG · ICD-10 E77.8 · ICD-11 5C52.11
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-In · CDG1N; RTF1-CDG · ICD-10 E77.8 · ICD-11 FB32.Y
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Io · CDG1O; DPM3-CDG · ICD-10 E77.8 · ICD-11 5C52.11
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ip · CDG1P; ALG11-CDG · ICD-10 E77.8 · ICD-11 5A45
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ir · CDG1R; DDOST-CDG · ICD-10 E77.8 · ICD-11 5A61.0
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Is · CDG1S; ALG13-CDG; EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36 · ICD-10 E77.8 · ICD-11 5C63.Y
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-It · PGM1-CDG; GLYCOGEN STORAGE DISEASE XIV (GSD14); PGM1 · ICD-10 E77.8 · ICD-11 5D2Z
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ix · CDG1X; STT3B-CDG · ICD-10 E77.8 · ICD-11 5D2Z
- CONGENITAL DISORDER OF GLYCOSYLATION CDG-Iy · CDG1Y; SSR4-CDG · ICD-10 E77.8 · ICD-11 5C53.20
- CONGENITAL DISORDER OF GLYCOSYLATION TYPE IIv (CDG2V) · EDEM3-CDG · ICD-10 E77.8 · ICD-11 8A62.Y
- CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION (CDGF) · FUT8 · ICD-10 E77.8 · ICD-11 5C50.Y
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE CDG-Iw (CDG1W) · CDG1W; STT3A-CDG · ICD-10 E77.8 · ICD-11 5D2Z
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iaa (CDG1AA) · CDG1AA; NUS1-CDG · ICD-10 G40.4 · ICD-11 LD20.01
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Icc (CDG-ICC) · CDG1cc · ICD-10 D81.8 · ICD-11 LD20.01
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIaa (CDG2AA) · CDG2AA · ICD-10 E77.8 · ICD-11 5C54.Y
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIbb (CDG2BB) · CDG2BB; COG3 · ICD-10 E77.8 · ICD-11 5C54.Y
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIcc (CDG2CC) · CDGIICC · ICD-10 E77.8 · ICD-11 5C54.Y
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi (CDG-IIi) · CDG2I; COG5-CDG · ICD-10 E77.8 · ICD-11 LD20.0Y
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq (CDG2Q) · CDG IIq; COG2-CDG · ICD-10 E77.8 · ICD-11 5A74.0
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIr (CDG2R) · ATP6AP2-CDG · ICD-10 E77.8 · ICD-11 5C53.2Y
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIt (CDG2T) · GALNT2-CDG · ICD-10 E77.8 · ICD-11 5C53.2Y
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq (CDG-Iq) · CDG1Q; SRD5A3-CDG · ICD-10 E77.8 · ICD-11 5A00.01
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu (CDG1U) · CDG1U; DPM2-CDG · ICD-10 E77.8 · ICD-11 8E7Z
- CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw, AUTOSOMAL DOMINANT (CDG1WAD) · CDG1WAD · ICD-10 E77.8 · ICD-11 5D2Z
- CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE I (CDAN1) · CDA, TYPE I · ICD-10 D64.4 · ICD-11 8C61
- CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE II (CDAN2) · DYSERYTHROPOIETIC ANEMIA, HEMPAS TYPE · ICD-10 D64.4 · ICD-11 5C53.23
- CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE IIIa (CDAN3a) · CDA, TYPE IIIA · ICD-10 D64.4 · ICD-11 8C61
- CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE IIIb (CDAN3b) · RACGAP1 · ICD-10 D64.4 · ICD-11 8A62.Y
- CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE IV (CDAN4) · KLF1 · ICD-10 D64.4 · ICD-11 5C53.2Y
- CONGENITAL ENTEROVIRUS INFECTION [DD] · ICD-10 P35.8 · ICD-11 KA62.5
- CONGENITAL ERYTHTOPOIETIC PORPHYRIA (CEP, GUNTHER DISEASE) · PORPHYRIA, CONGENITAL ERYTHTOPOIETIC; PORPHYRIA, ERYTHTOPOIETIC · ICD-10 E80.0 · ICD-11 5C50.EY
- CONGENITAL GLUTAMINE DEFICIENCY; GLUTAMINE SYNTHASE DEFICIENCY · GLUTAMINE SYNTHASE DEFICIENCY, CONGENITAL SYSTEMIC; GLUL · ICD-10 E72.8 · ICD-11 5C53.2Y
- CONGENITAL HYPERINSULINISM AND HYPOPITUITARISM · ICD-10 E16.1 · ICD-11 6A02.Y
- CONGENITAL MYOPATHY 3 WITH RIGID SPINE (CMYO3) · ICD-10 G71.2 · ICD-11 8C72.0Y
- CONGENITAL SECRETORY DIARRHEA · SPINT2 · ICD-10 P78.3 · ICD-11 DA90.1
- CONGENITAL SUCRASE-ISOMALTASE DEFICIENCY (CSID) · DISACCARIDE INTOLERANCE I; SI · ICD-10 E74.3 · ICD-11 5C61.2
- COPPER CHAPERONE FOR SUPEROXIDE DISMUTASE (CCS) · ICD-10 G23.8 · ICD-11 6C40.3
- COPROPORPHYRIA, HEREDITARY (HCP) · COPROPORPHYRINOGEN OXIDASE DEFICIENCY · ICD-10 E80.2 · ICD-11 5C50.6
- CORTICOSTERONE METHYL OXIDASE I DEFICIENCY- CMO I · ALDOSTERONE DEFICIENCY DUE TO DEFECT IN 18-HYDROXYLASE, ALDOSTERONE DEFICIENCY I · ICD-10 E27.4 · ICD-11 5B5K.7
- CORTICOSTERONE METHYL OXIDASE II DEFICIENCY - CMO II · CYTOCHROME P450, SUBFAMILY XIB, POLYPEPTIDE 2, CYP11B2, ALDOSTERONE DEFICIENCY II · ICD-10 E27.4 · ICD-11 3B61.0Y
- CORTISONE REDUCTASE DEFICIENCY 1 (CORTRD1) · ICD-10 E25.8
- CORTISONE REDUCTASE DEFICIENCY 2 (CORTRD2) · 11-BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE I; HSD11B1 · ICD-10 E25.8 · ICD-11 BA04.Y
- COSMETICS, VITAMINES, DRUGS AND DRUG METABOLITES [DD] · THERAPEUTIC AGENTS · ICD-11 9C40.8
- COSTELLO SYNDROME (CSTLO) · HRAS · ICD-10 Q87.8 · ICD-11 8A62.Y
- CRIGLER-NAJJAR SYNDROME TYPE I · CRIGLER-NAJJAR SYNDROME; UDP-GLUCURONOSYLTRANSFERASE, SEVERE DEFICIENCY TYPE I; CN1 · ICD-10 E80.5 · ICD-11 PL12
- CRIGLER-NAJJAR SYNDROME TYPE II · HYPERBILIRUBINEMIA I; HYPERBILIRUBINEMIA, UNCONJUGATED; CN2 · ICD-10 E80.5 · ICD-11 2D11.2
- CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA, WITH CONGENITAL DISORDER OF GLYCOSYLATION (ARCL2A, CDG) · ATP6V0A2-CDG; CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA · ICD-10 Q82.8 · ICD-11 5A61.0
- CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB (ARCL2B) · PYRROLINE-5-CARBOXYLATE REDUCTASE DEFICIENCY · ICD-10 Q82.8 · ICD-11 5D0Y
- CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC (ARCL2C) · ATP6V1E1 · ICD-10 Q82.8 · ICD-11 5C53.2Y
- CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID (ARCL2D) · ATP6V1A · ICD-10 Q82.8 · ICD-11 5C53.2Y
- CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA (ARCL3A) · PYRROLINE-5-CARBOXYLATE SYNTHASE DEFICIENCY; DE BARSY SYNDROME · ICD-10 Q87.8 · ICD-11 5C50.21
- CYCLIC VOMITING SYNDROME (CSV) · CYCLIC VOMITING SYNDROME WITH NEUROMUSCULAR DISEASE; CVS · ICD-10 R11 · ICD-11 AB56
- CYSTATHIONINURIA · GAMMA-CYSTATHIONASE DEFICIENCY (CTH) · ICD-10 E72.1 · ICD-11 5C50.B
- CYSTIC FIBROSIS (CF) · CYSTIC FIBROSIS; CYSTIC FIBROSIS · ICD-10 E84.9 · ICD-11 CA25
- CYSTINE-LYSINURIA · DIAMINOPENTANURIA · ICD-10 E72.0 · ICD-11 5C53.2Y
- CYSTINOSIS, ADULT NONNEPHROPATHIC · CYSTINOSIS, OCULAR NONNEPHROPATHIC · ICD-10 E72.0 · ICD-11 LD20.1
- CYSTINOSIS, INFANTILE NEPHROPATHIC (CTNS) · INFANTILE NEPHROPATHIC CYSTINOSIS (CN) · ICD-10 E72.0 · ICD-11 5C60.1
- CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE · CYSTINOSIS, INTERMEDIATE · ICD-10 E72.0+ N16.3* · ICD-11 3A10.Y
- CYSTINURIA · CYSTINURIA, TYPE A; CYSTINURIA, TYPE B · ICD-10 E72.0 · ICD-11 5C60.2
- CYSTINYLGLYCINURIA · MEMBRANE-BOUND DIPEPTIDASE (CYTEINYL-DIPEPTIDASE) DEFICIENCY · ICD-10 E88.8 · ICD-11 5C64.10
- CYTOCHROME b OF COMPLEX III (MTCYB) · ICD-10 G71.3 · ICD-11 8C73.Y
- D,L-2-HYDROXYGLUTARIC ACIDURIA · COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD; DL2HGA; SLC25A1 · ICD-10 E72.8 · ICD-11 5A45
- D-BIFUNCTIONAL PROTEIN DEFICIENCY · PSEUDO ZELLWEGER; DBP DEFICIENCY; HSD17B4 · ICD-10 E71.3 · ICD-11 5C57.1
- D-GLYCERIC ACIDURA · D-GLYCERICACIDEMIA; D-GLYCERATE KINASE DEFICIENCY · ICD-10 E74.8 · ICD-11 5C50.7Y
- D-LACTIC ACIDOSIS - AND SHORT BOWEL SYNDROME [DD] · ICD-10 K91.2, E87.2 · ICD-11 9B70
- D-LACTIC ACIDURIA (DLACD) · LACTIC ACIDURIA DUE TO D-LACTIC ACID, LDHD · ICD-10 E87.2 · ICD-11 LD90.Y
- DEAFNESS, AMINOGLYCOSIDE-INDUCED · DEAFNESS, STREPTOMYCIN-INDUCED; STREPTOMYCIN OTOTOXICITY · ICD-10 H90.3, H91.0 · ICD-11 5C50.DY
- DEAFNESS, AUTOSOMAL DOMINANT 1, WITH OR WITHOUT THROMBOCYTOPENIA (DFNA1) · KONIGSMARK SYNDROME · ICD-10 H90.3
- DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME (DOORS) · DOOR SYNDROME · ICD-10 Q87.8 · ICD-11 5C53.23
- DEHYDRATION, SEVERE, UNSPECIFIC [DD] · ICD-11 5C50.3
- DELTA-AMINOLEVULINIC ACID DEHYDRATASE-DEFICIENT PORPHYRIA (ALAD) · PORPHYRIA, ACUTE HEPATIC · ICD-10 E80.2 · ICD-11 5C50.Y
- DENT DISEASE 1 · NEPHROLITHIASIS, HYPERCALCIURIC, X-LINKED (CLCN5) · ICD-10 N25.8 · ICD-11 5C53.21
- DENT DISEASE 2 · OCRL1 · ICD-10 N25.8 · ICD-11 5C53.21
- DESMOSTEROLOSIS · DESMOSTEROL-TO-CHOLESTEROL ENZYME, DCE · ICD-10 Q87.8 · ICD-11 5C64.10
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY (DEE) · ICD-10 G40.3 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1 (DEE1) · WEST SYNDROME, X-LINKED; OHTAHARA SYNDROME, X-LINKED; EIEE1 · ICD-10 G25.3 · ICD-11 5C53.25
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 100 (DEE100) · ICD-10 G40.2
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 101 (DEE101) · ICD-10 G40.2
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 102 (DEE102) · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 103 (DEE103) · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 104 (DEE104) · ICD-10 G40.2
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 105 (DEE105) · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 106 (DEE106) · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 107 (DEE107) · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 108 (DEE108) · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 109 (DEE109) · ICD-10 G0.4
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 11 (DEE11) · EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11 (EIEE11) · ICD-10 G40.3 · ICD-11 LD20.01
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 110 (DEE110) · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 111 (DEE111) · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 112 (DEE112) · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 113 (DEE113) · ICD-10 G40.3 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 114 (DEE114) · ICD-10 G40.3 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 115 (DEE115) · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 116 (DEE116) · ICD-10 G40.3 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 117 (DEE117) · ICD-10 G70.2
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 118 (DEE118) · ICD-10 G40.3 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 119 (DEE119) · ICD-10 G40.3 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 12 (DEE12) · EIEE12 · ICD-10 G40.0 · ICD-11 8A61.12
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 120 (DEE120) · ICD-10 G40.3 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 121 (DEE121) · ICD-10 G40.3 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 122 (DEE122) · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 13 (DEE13) · EIEE13 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 14 (DEE14) · EIEE14 · ICD-10 G40.0 · ICD-11 8A61.12
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 15 (DEE15) · ST3GAL3 · ICD-10 G40.4 · ICD-11 5C64.10
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 16 (DEE16) · EIEE16 · ICD-10 G40.0 · ICD-11 8A61.12
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17 (DEE17) · EIEE17 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 18 (DEE18) · EIEE18 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 19 (DEE19) · EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19 ; GABRA1 · ICD-10 G40.4 · ICD-11 LD2F.1Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 2 (DEE2) · INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2 · ICD-10 F40.4
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 21 (DEE21) · EIEE21 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 23 (DEE23) · EIEE23 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 26 (DEE26) · EIEE26 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 27 (DEE27) · EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27; GRIN2B · ICD-10 G40.4 · ICD-11 5A71.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 3 (DEE3) · EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3 · ICD-10 G40.3 · ICD-11 LD24.2Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 32 (DEE32) · EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32 · ICD-10 G40.4 · ICD-11 5C54.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 35 (DEE35) · EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35 (EIEE35) · ICD-10 G40.4 · ICD-11 5C53.2Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 39 WITH LEUKODYSTROPHY (DEE39) · ASPARTATE-GLUTAMATE CARRIER 1 DEFICIENCY; AGC1 DEFICIENCY; EIEE39 · ICD-10 G31.8 · ICD-11 LD28.1Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 4 (DEE4) · STXBP1 · ICD-10 G93.8 · ICD-11 LD20.01
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 40 (DEE40) · PILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40; EIEE40; GUF1 · ICD-10 G40.4 · ICD-11 5C50.E0
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 41 (DEE41) · ICD-10 G40.3 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 44 (DEE44) · EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44 (EIEE44) · ICD-10 G40.4 · ICD-11 LD2H.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 46 (DEE46) · EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46 · ICD-10 G40.4 · ICD-11 3A10.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 47 (DEE47) · EIEE47 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 5 (DEE5) · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 50 (DEE50) · EIEE50 (CAD); CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iz, FORMERLY · ICD-10 E77.8 · ICD-11 5C56.0Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 51 (DEE51) · EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51 (EIEE51) · ICD-10 G40.3 · ICD-11 5C53.2Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 52 (DEE52) · EIEE52 · ICD-10 G40.3 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 55 (DEE55) · GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 14; GPIBD14; PIGP-CDG; EIEE55 · ICD-10 G40.3 · ICD-11 5C53.24
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 60 (DEE60) · EIEE60 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 61 (DEE61) · EIEE61 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 62 (DEE62) · EIEE62 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 63 (DEE63) · EIEE63 · ICD-10 G40.3 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 64 (DEE64) · EIEE64 · ICD-10 G40.3 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 67 (DEE67) · EIEE67 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 68 (DEE68) · EIEE68 · ICD-10 G40.4 · ICD-11 5C53.2Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 69 (DEE69) · EIEE69 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 7 (DEE7) · EIEE7 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 70 (DEE70) · EIEE70 · ICD-10 G404
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 71 (DEE71) · GLUTAMINASE DEFICIENCY WITH NEONATAL EPILEPTIC ENCEPHALOPATHY (GLS) · ICD-10 G40.4 · ICD-11 4B4Z
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 72 (DEE72) · EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72; NEUROD2 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 73 (DEE73) · EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73; RNF13 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 74 (DEE74) · EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74; GABRG2 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 75 (DEE75) · EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75 (EIEE75); PARS2 · ICD-10 G40.4 · ICD-11 3A73
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 76 (DEE76) · EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 76; EIEE76; ACTL6B; · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 78 (DEE78) · EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 78; EIEE78; GABRA2 · ICD-10 G40.4 · ICD-11 5C53.24
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 79 (DEE79) · EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 79; EIEE79; GABRA5 · ICD-10 G40.4 · ICD-11 4B00.00
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 8 (DEE8) · EIEE8 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 80 (DEE80) · PHOSPHATIDYLINOSITOL GLYCAN ANCHOR BIOSYNTHESIS CLASS B PROTEIN (PIGB); EIEE80 · ICD-10 G40.4 · ICD-11 5C53.2Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 81 (DEE81) · EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 81; EIEE81 · ICD-10 G40.4 · ICD-11 LD2H.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 82 (DEE82) · MITOCHONDRIAL ASPARTATE AMINOTRANSFERASE DEFICIENCY; GOT2 · ICD-10 G40.4 · ICD-11 5C53.2Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 83 (DEE83) · EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 83; EIEE83 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 84 (DEE84) · EPILEPTIC ENCEPHALOPATHY, EARLY IFANTILE, 84; EIEE84 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 85 WITH OR WITHOUT MIDLINE BRAIN DEFECTS (DEE85) · EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 85, WITH OR WITHOUT MIDLINE BRAIN DEFECTS; EIEE85 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 86 (DEE86) · EIEE86 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 87 (DEE87) · EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 87; EIEE87 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 88 (DEE88) · EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 88; EIEE88 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 89 (DEE89) · EIEE89 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 9 (DEE9) · EIEE9; JUBERG-HELLMAN SYNDROME · ICD-10 G40.8
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 90 (DEE90) · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 91 (DEE91) · ICD-10 G04.4
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 92 (DEE92) · EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 93 (DEE93) · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 94 (DEE94) · EEOC · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 95 (DEE95) · GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18 · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 96 (DEE96) · EIEE96 · ICD-10 G40.3 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 97 (DEE97) · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 98 (DEE98) · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 99 (DEE99) · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL DELAY WITH HYPOTONIA, MYOPATHY, AND BRAIN ABNORMALITIES (DEDHMB) · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL DELAY WITH OR WITHOUT EPILEPSY (DEVEP) · ICD-10 G40.4 · ICD-11 8A62.Y
- DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL DISABILITY AND DYSMORPHIC FACIES (DIDDF) · ICD-10 F84.8 · ICD-11 8C20.1
- DIABETES AND DEAFNESS, MATERNALLY INHERITED (MIDD) · BALLINGER-WALLACE SYNDROME · ICD-10 E13.8 · ICD-11 5C53.23
- DIABETES MELLITUS, INSULIN-DEPENDENT · INSULIN-DEPENDENT DIABETES MELLITUS (IDDM); DIABETES MELLITUS, INSULIN DEPENDENT TYPE · ICD-10 E10.90 · ICD-11 8A03.10
- DIABETES MELLITUS, KETOSIS-PRONE (KPD) · ICD-10 E11.9- · ICD-11 5C52.11
- DIABETES MELLITUS, NONINSULIN-DEPENDENT (NIDDM) · ICD-10 E14.90 · ICD-11 LD2H.Y
- DIABETES MELLITUS, PERMANENT NEONATAL · DIABETES MELLITUS, PERMANENT, OF INFANCY; PDMI · ICD-10 P70.2 · ICD-11 5C53.23
- DIABETES MELLITUS, PERMANENT NEONATAL, 3 (PNDM3) · DEVELOPMENTAL DELAY, EPILEPSY, AND NEONATAL DIABETES 2, INCLUDED; DEND2, INCLUDED; · ICD-10 P70.2 · ICD-11 8A62.Y
- DIABETES, FETAL EFFECTS FROM MATERNAL · FETAL EFFECTS FROM MATERNAL DIABETES · ICD-10 P70.0 · ICD-11 KB60.0
- DIARRHEA 13 (DIAR13) · ICD-10 K52.9
- DIARRHEA 2, WITH MICROVILLUS ATROPHY, WITH OR WITHOUT CHOLESTASIS (DIAR2) · DAVIDSON DISEASE; MICROVILLUS INCLUSION DISEASE 1; MVID1 · ICD-10 P78.3
- DIBASIC AMINO ACIDURIA I · HYPERDIBASIC AMINOACIDURIA I · ICD-10 E72.0 · ICD-11 5C60.Y
- DICARBOXYLIC AMINOACIDURIA (DCBXA) · GLUTAMATE-ASPARTATE TRANSPORT DEFECT; SLC1A1 · ICD-10 E72.0 · ICD-11 5C60.Y
- DIGENIC METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE · EPI-cblC · ICD-10 E72.1
- DIGEORGE SYNDROME (DGS) · CHROMOSOME 22q11.2 DELETION SYNDROME · ICD-10 D82.1 · ICD-11 5C53.20
- DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY (DLDD) · DLD DEFICIENCY; E3 DEFICIENCY; MSUD TYPE III · ICD-10 E74.4 · ICD-11 5C50.3
- DIHYDROPYRIMIDINASE DEFICIENCY (DHP) · DPH DEFICIENCY; DIHYDROPYRIMIDINURIA · ICD-10 E79.8 · ICD-11 5C53.02
- DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY (DPD) · THYMINE-URACILURIA, HEREDITARY;5-FLUOROURACIL TOXICITY · ICD-10 E79.8 · ICD-11 5C6Y
- DILATED CARDIOMYOPATHY (DCM) · ICD-10 I42.0 · ICD-11 5C55.2
- DIMETHYLGLYCINURIA (DMGDHD) · DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY, DMGDH DEFICIENCY · ICD-10 E72.5 · ICD-11 8A61.0Y
- DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY · ADRENAL HYPERPLASIA, CONGENITAL, DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY · ICD-10 E25.0 · ICD-11 5C53.24
- DISTAL RENAL TUBULAR ACIDOSIS (RTA) WITH HYPERAMMONEMIA [DD] · ICD-10 N25.8 · ICD-11 5C58.03
- DONOHUE SYNDROME · LEPRECHAUNISM · ICD-10 E34.8 · ICD-11 5C53.2Y
- DOPA-RESPONSIVE DYSTONIA · DYSTONIA, DOPA-RESPONSIVE, WITH OR WITHOUT HYPERPHENYLALANINEMIA, AUTOSOMAL RECESSIVE, INCLUDED · ICD-10 G24.1 · ICD-11 5C50.Y
- DOPAMINE BETA-HYDROXYLASE DEFICIENCY (DBH) · DOPAMINE BETA-HYDROXYLASE, PLASMA; DBH · ICD-10 G90.8 · ICD-11 5C50.E0
- DRAVET SYNDROME (DRVT) · EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6 (EIEE6) · ICD-10 G40.4 · ICD-11 5C51.3
- DUBIN-JOHNSON SYNDROME (DJS) · ICD-10 E80.6 · ICD-11 LD20.01
- DUCHENNE MUSCULAR DYSTROPHY (DMD) · MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC PROGRESSIVE, DUCHENNE AND BECKER TYPES; MUSCULAR DYSTROPHY, CHILDHOOD PSEUDOHYPER · ICD-10 G71.00 · ICD-11 LD24.04
- DYSTONIA, DOPA-RESPONSIVE (DRD) · SEGAWA SYNDROME; DYSTONIA, PROGRESSIVE, WITH DIURNAL VARIATIONS; GCH1 · ICD-10 G24.1 · ICD-11 4A01.23
- DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY (SPR) · SEPIAPTERIN REDUCTASE DEFICIENCY · ICD-10 G24.1 · ICD-11 5C53.20
- DYSTONIA, EARLY-ONSET, AND/OR SPASTIC PARAPLEGIA (DYTSPG) · ICD-10 G40.4 · ICD-11 8A62.Y
- EARLY-ONSET EPILEPTIC ENCEPHALOPATHIES [DD] · EOEE · ICD-10 G40.4 · ICD-11 LD2Z
- EEFSEC DEFICIENCY · ICD-10 G31.9
- EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1 (EDSARTH1) · EHLERS-DANLOS SYNDROME, TYPE VIIA, AUTOSOMAL DOMINANT; EDS7A · ICD-10 Q79.6 · ICD-11 LD28.1Y
- EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1 (EDSCL1) · ICD-10 Q79.6 · ICD-11 LD28.10
- EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2 (EDSCL2) · EHLERS DANLOS SYNDROME, MILD CLASSIC TYPE, FORMERLY · ICD-10 Q79.6 · ICD-11 LD28.10
- EHLERS-DANLOS SYNDROME, HYPERMOBILITY TYPE (EDSHMB) · EHLERS-DANLOS SYNDROME, TYPE III; EDS3 · ICD-10 Q79.6 · ICD-11 GB90.4Y
- EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE 1 (EDSSPD1) · GALACTOSYLTRANSFERASE I DEFICIENCY · ICD-10 Q79.6 · ICD-11 ---
- EHMT2-RELATED NEURODEVELOPMENTAL DISORDER (NEW) · ICD-10 E88.8
- EIF1AX-RELATED NEURODEVELOPMENTAL DISORDER (NEW) · ICD-10 E88.8
- ELAVL2-RELATED NEURODEVELOPMENTAL DISORDER (NEW) · ICD-10 E88.8
- ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1 (EMPF1) · ICD-10 G31.8 · ICD-11 8C73.Z
- ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS · ICD-10 Q02 · ICD-11 PL12
- ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES (NELABA) · LIPT2 · ICD-10 E88.8 · ICD-11 PL0Z
- ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM · TBCD · ICD-10 G93.4 · ICD-11 LD2H.Y
- ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1 (PEBEL1) · PEBEL1; NAXE · ICD-10 E88.8 · ICD-11 8A62.Y
- ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2 (PEBEL2 ) · PEBEL2; NAXD · ICD-10 E88.8 · ICD-11 LD90.Y
- ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS (PEERB) · TRAPPC2L · ICD-10 E88.9 · ICD-11 BD1Y
- EPILEPSY, BENIGN NEONATAL [DD] · CONVULSIONS, BENIGN FAMILIAL NEONATAL · ICD-10 P90, G40.3 · ICD-11 8A61.0Y
- EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT · PLPBP; PROSC · ICD-10 G40.8 · ICD-11 5C64.4Z
- EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT MENTAL RETARDATION (FESD) · LANDAU-KLEFFNER SYNDROME · ICD-10 E77.8 · ICD-11 5C50.E0
- EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10 (EIG10) · GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 5, SUSCEPTIBILITY TO, INCLUDED; GEFS5, INCLUDED · ICD-10 G40.3 · ICD-11 5C53.24
- EPILEPSY, NOCTURNAL FRONTAL LOBE, 1 (ENFL1) · ADNFLE · ICD-10 G40.0 · ICD-11 8A61.4Y
- EPILEPSY, NOCTURNAL FRONTAL LOBE, 2 (ENFL2) · ICD-10 G40.0 · ICD-11 8A61.4Y
- EPILEPSY, PROGRESSIVE MYOCLONIC, 6 (EPM6) · ICD-10 G40.3 · ICD-11 8A61.41
- EPILEPSY, PROGRESSIVE MYOCLONIC, 8 (EPM8) · CERAMIDE SYNTHASE 1 DEFICIENCY · ICD-10 G40.3 · ICD-11 5C54.2
- EPISODIC ATAXIA, TYPE 1 (EA1) · EPISODIC ATAXIA WITH MYOKYMIA; EAM; KCNA1 DEFICIENCY · ICD-10 G11.8 · ICD-11 5C60.Y
- EPISODIC ATAXIA, TYPE 2 (EA2) · ATAXIA, EPISODIC, WITH NYSTAGMUS; CACNA1A · ICD-10 G11.8 · ICD-11 5C53.21
- EPISODIC ATAXIA, TYPE 3 (EA3) · ATAXIA, EPISODIC, WITH VERTIGO AND TINNITUS · ICD-10 G11.8 · ICD-11 BC43.0Z
- EPISODIC ATAXIA, TYPE 4 (EA4) · PERIODIC VESTIBULOCEREBELLAR ATAXIA; PATX · ICD-10 G11.8 · ICD-11 5C64.10
- EPISODIC ATAXIA, TYPE 5 (EA5) · ICD-10 G11.8 · ICD-11 8A62.Y
- EPISODIC ATAXIA, TYPE 6 (EA6) · ICD-10 G11.8 · ICD-11 5C50.3
- ERYTHROCYTE LACTATE TRANSPORTER DEFECT · LACTATE TRANSPORTER DEFECT, MYOPATHY DUE TO; SLC16A1; MCT1 · ICD-10 G72.8 · ICD-11 5C53.2Y
- ERYTHROCYTOSIS, FAMILIAL, 8 (ECYT8) · BISPHOSPHOGLYCERATE MUTASE DEFICIENCY; DPGM DEFICIENCY · ICD-10 D55.2 · ICD-11 LD20.Y
- ERYTHROPOIETIC PROTOPORHYRIA (EPP2) · CLPX · ICD-10 E80.0 · ICD-11 LD24.GY
- ETHANOLAMINOSIS · ICD-10 E88.8 · ICD-11 5D2Z
- ETHYLMALONIC ENCEPHALOPATHY, EE (EPEMA) · METABOLIC ENCEPHALOPATHY (EPEMA); EPEMA SYNDROME; ETHE1 · ICD-10 G31.81 · ICD-11 5C53.20
- EXERCISE INTOLERANCE, RIBOFLAVIN-RESPONSIVE (RREI) · ICD-10 G71.3 · ICD-11 5C80.00
- EXOSTOSES, MULTIPLE, TYPE I (EXT1) · EXOSTOSIN-1 DEFICIENCY; EXT1-CDG · ICD-10 Q78.6 · ICD-11 LA05.60
- EXOSTOSES, MULTIPLE, TYPE II (EXT2) · EXOSTOSIN-2 DEFICIENCY; EXT2-CDG · ICD-10 Q78.6 · ICD-11 6A00
- EXTRAORAL HALITOSIS DUE TO METHANETHIOL OXIDASE DEFICIENCY (EHMTO) · METHANETHIOL OXIDASE (MTO) DEFICIENCY; SELENBP1 · ICD-10 E88.8 · ICD-11 5C53.2Y
- FABRY DISEASE · ANDERSON-FABRY DISEASE · ICD-10 E75.2 · ICD-11 5C58.00
- FAMILIAL HYPERINSULINEMIA AND HYPERPROINSULINEAMIA WITH MILD DIABETES · ICD-10 E16.9 · ICD-11 5C58.10
- FAMILIAL LIPOPROTEIN LIPASE DEFICIENCY (LPL-FCS) · HYPERLIPOPROTEINEMIA, TYPE I; HYPERCHYLOMICRONEMIA; LPL · ICD-10 E78.3 · ICD-11 5C58.12
- FAMILIAL MULTIPLE COAGULATION FACTOR DEFICIENCY (VKCFD1) · VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1 · ICD-10 D68.28 · ICD-11 5A45
- FAMILIAL RENAL GLYCOSURIA (FRG) · GLYS; SLC5A2 · ICD-10 E74.8 · ICD-11 5C61.5
- FANCONI RENOTUBULAR SYNDROME 1 (FRTS1) · RENAL FANCONI SYNDROME; RFS; LUDER-SHELDON SYNDROME; GATM · ICD-10 E72.0 · ICD-11 GB90.42
- FANCONI RENOTUBULAR SYNDROME 2 (FRTS2) · ICD-10 E72.0 · ICD-11 8A62.Y
- FANCONI RENOTUBULAR SYNDROME 3 (FRTS3) · EHHADH · ICD-10 E72.0 · ICD-11 9C8Y
- FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG (FRTS4) · FRTS4 WITH MODY · ICD-10 E11.2 · ICD-11 5C53.23
- FANCONI-BICKEL SYNDROME (FBS) · HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME; FBS; GLUT2 · ICD-10 E74.0 · ICD-11 3A92
- FARBER DISEASE · ASAH1; FARBER LIPOGRANULOMATOSIS; LIPOGRANULOMATOSIS; CERAMIDASE DEFICIENCY · ICD-10 E75.2 · ICD-11 5A71.00
- FAZIO-LONDE SYNDROME · BULBAR PALSY, PROGRESSIVE, OF CHILDHOOD · ICD-10 G12.2 · ICD-11 5C53.21
- FEEDING: (TOTAL) PARENTERAL NUTRITION, PN, TPN [DD] · ICD-11 MB50.1
- FEEDING: AMINO ACID FORMULA [DD] · ICD-11 5C53.20
- FEEDING: LITCHI TOXICITY [DD] · ICD-11 GB90.42
- FEEDING: MCT-FORMULAS [DD] · ICD-11 8A61.0Y
- FEEDING: MELAMINE-FORMULA [DD] · ICD-11 LD90.Y
- FEEDING: NUTRITIONAL DEFICIENCIES RESULTING FROM MILK ALTERNATIVES [DD] · ICD-11 5C50.3
- FEEDING: SHORT BOWEL SYNDROME [DD] · ICD-10 K91.2 · ICD-11 8A61.2Y
- FEEDING: THIAMINE DEFICIENY [DD] · ICD-10 E51.9, E64.8 · ICD-11 5C53.23
- FEEDING: VEGANIAN [DD] · ICD-11 5A71.01
- FETAL ALCOHOL SPECTRUM DISORDER (FASD) [DD] · ICD-10 Q86.0; P04.3
- FISH-EYE DISEASE (FED) · LCAT · ICD-10 E78.6 · ICD-11 LD28.2
- FOLATE TRANSPORT DEFICIENCY · NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY; FOLR1 · ICD-10 G31.8 · ICD-11 LA05.0
- FRIEDREICH ATAXIA (FRDA) · FXN · ICD-10 G11.1 · ICD-11 5C52.02
- FRUCTOSE INTOLERANCE, HEREDITARY (HFI) · FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY; ALDOB · ICD-10 E74.1 · ICD-11 5C51.50
- FRUCTOSE-1,6-BIPHOSPHATASE DEFICIENCY (FBP1D) · FRUCTOSE-1,6-BIPHOSPHATASE DEFICIENCY; FRUCTOSE-1,6-DIPHOSPHATASE DEFICIENCY; FBP1 · ICD-10 E74.1 · ICD-11 5C51.5Y
- FRUCTOSURIA · HEPATIC FRUCTOKINASE DEFICIENCY · ICD-10 E74.1 · ICD-11 5C51.5Y
- FUCOSIDOSIS · ALPHA-L-FUCOSIDASE DEFICIENCY · ICD-10 E77.1 · ICD-11 5C56.21
- FUMARASE DEFICIENCY · FUMARATE HYDRATASE; - CYTOSOLIC; -MITOCHONDRIAL; ACIDURIA, FUMARIC; FH · ICD-10 E88.8 · ICD-11 5C53.1
- G(M1)-GANGLIOSIDOSIS, TYPE I. PSEUDO-HURLER-DISEASE · GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I · ICD-10 E75.1 · ICD-11 5C56.00
- G(M1)-GANGLIOSIDOSIS, TYPE II. LIPIDOSIS, LATE INFANTILE SYSTEMIC · GLIOSIDOSIS, GENERALIZED GM1, TYPE II, OR JUVENILE TYPE · ICD-10 E75.1 · ICD-11 5C56.00
- G(M1)-GANGLIOSIDOSIS, TYPE III. CHRONIC/ADULT TYPE · GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III, OR ADULT TYPE · ICD-10 E75.1 · ICD-11 5C56.00
- G(M2)-GANGLIOSIDOSIS: GM2 ACTIVATOR DEFICIENCY · TAY-SACHS DISEASE, AB VARIANT; G(M2)-GANGLIOSIDOSIS WITH HEXOAMINIDASE A DEFICIENCY · ICD-10 E75.0 · ICD-11 5C56.00
- G(M2)-GANGLIOSIDOSIS: VARIANT 0, SANDHOFF DISEASE · SANDHOFF DISEASE; G(M2)-GANGLIOSIDOSIS WITH HEXOSAMINIDASE A AND B DEFICIENCY; HEXB · ICD-10 E75.0 · ICD-11 5C56.00
- G(M2)-GANGLIOSIDOSIS: VARIANT B, TAY-SACHS DISEASE · G(M2)-GANGLIOSIDOSIS WITH HEXOSAMINIDASE A DEFICIENCY · ICD-10 E75.0 · ICD-11 5C52.01
- GABA TRANSAMINASE DEFICIENCY · GAMMA-AMINOBUTYRATE TRANSAMINASE; GAMMA-AMINO BUTYRIC ACID (GABA) TRANSAMINASE DEFICIENCY · ICD-10 E72.8 · ICD-11 5C59.1
- GALACTOSEMIA (GALT-D) · GALT · ICD-10 E74.2 · ICD-11 5C51.40
- GALACTOSEMIA II (GALK-D) · GALAKTOKINASE DEFICIENCY; GALACTOKINASE DEFICIENCY · ICD-10 E74.2 · ICD-11 5C51.4Y
- GALACTOSEMIA III (GALE-D) · GALE DEFICIENCY; GALACTOSE EPIMERASE DEFICIENCY · ICD-10 E74.2 · ICD-11 5C51.4Y
- GALACTOSEMIA IV (GALAC4) · GALM · ICD-10 E88.8 · ICD-11 5A92
- GALACTOSIALIDOSIS · GOLDBERG SYNDROME; NEURAMINIDASE DEFICIENCY; GALACTOSIALIDOSIS; CTSA · ICD-10 E77.1 · ICD-11 5C56.21
- GALLOWAY-MOWAT SYNDROME 1 (GAMOS1) · MICROCEPHALY, HIATAL HERNIA, AND NEPHROTIC SYNDROME; WDR73 · ICD-10 Q04.3 · ICD-11 LD2H.Y
- GALLOWAY-MOWAT SYNDROME 2, X-LINKED (GAMOS2) · LAGE3 · ICD-10 Q04.3 · ICD-11 5C53.2Y
- GALLOWAY-MOWAT SYNDROME 3 (GAMOS3) · OSGEP · ICD-10 Q04.3 · ICD-11 5C53.2Y
- GALLOWAY-MOWAT SYNDROME 4 (GAMOS4) · TP53RK · ICD-10 Q04.3 · ICD-11 5C53.2Y
- GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO · GCLC · ICD-10 D55.1 · ICD-11 5C53.24
- GAUCHER DISEASE TYPE I (GD1) · GBA1 · ICD-10 E75.2 · ICD-11 5C56.0Y
- GAUCHER DISEASE TYPE II (GD2) · GAUCHER DISEASE, ACUTE NEURONOPATHIC TYPE; GBA · ICD-10 E75.2 · ICD-11 5A00.01
- GAUCHER DISEASE TYPE III (GD3) · GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE; GBA · ICD-10 E75.2 · ICD-11 LD24.04
- GAUCHER DISEASE TYPE IIIC (GD3C) · GBA1 · ICD-10 E75.2 · ICD-11 GB90.43
- GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY · PSAP · ICD-10 E75.2 · ICD-11 LD24.50
- GAUCHER DISEASE, PERINATAL LETHAL · GBA1 · ICD-10 E75.2 · ICD-11 8A03.Z
- GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1 (GEFSP1) · ICD-10 G40.3 · ICD-11 8A62.Y
- GILBERT SYNDROME · HYPERBILIRUBINEMIA I; UGT1A1 · ICD-10 E80.4 · ICD-11 LD21.Y
- GITELMAN SYNDROME (GTLMNS) · HYPOMAGNESEMIA-HYPOKALEMIA, PRIMARY RENOTUBULAR, WITH HYPOCALCIURIA; SLC12A3 · ICD-10 N15.8 · ICD-11 GB90.44
- GLUCAGON DEFICIENCY · HYPOGLYKEMIA DUE TO GLUCAGON DEFICIENCY · ICD-10 E16.9 · ICD-11 1A1Z
- GLUCOCORTICOID DEFICIENCY 1 (GCCD1) · FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1 · ICD-10 E27.1 · ICD-11 6A00.Z
- GLUCOCORTICOID DEFICIENCY 2 (GCCD2) · FAMILIAL GLUCOCORTICOID DEFICIENCY 2; FGD2 · ICD-10 E27.1 · ICD-11 LD20.4
- GLUCOCORTICOID DEFICIENCY 3 (GCCD3) · FAMILIAL GLUCOCORTICOID DEFICIENCY 3; FGD3; STAR · ICD-10 E27.1 · ICD-11 LD2H.Y
- GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY (GCCD4) · ICD-10 E27.1 · ICD-11 LD90.Y
- GLUCOCORTICOID DEFICIENCY 5 (GCCD5) · MITOCHONDRIAL THIOREDOXIN REDUCTASE 2 DEFICIENCY · ICD-10 E27.1 · ICD-11 ---
- GLUCOCORTICOID RESISTANCE (GCCR) · GLUCOCORTICOID RECEPTOR DEFICIENCY; NR3C1; GCCR · ICD-10 E25.8 · ICD-11 5C64.2Y
- GLUCOGLYCINURIA · ICD-10 E88.8 · ICD-11 5C56.1
- GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY (G6PD) · ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY · ICD-10 D55.0 · ICD-11 3A10.00
- GLUCOSE-GALACTOSE MALABSORPTION · SLC5A1 · ICD-10 E74.3 · ICD-11 5C61.0
- GLUT-1 DEFICIENCY SYNDROME (GLUT1DS1) · DEVIVO SYNDROME; GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIER · ICD-10 G93.4 · ICD-11 KB89.1
- GLUTAMATE FORMIMINOTRANSFERASE DEFICIENCY; FORMIMINOGLUTAMIC ACIDURIA (FIGLU) · FORMIMINOTRANSFERASE DEFICIENCY · ICD-10 E70.8 · ICD-11 5A61.5
- GLUTAMINASE DEFICIENCY WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND PROGRESSIVE ATAXIA · GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG; GLS · ICD-10 E88.8 · ICD-11 8A62.Y
- GLUTAMYL RIBOSE-5-PHOSPHATE STORAGE DISEASE · ADP-RIBOSE PROTEIN HYDROLASE DEFICIENCY · ICD-10 E88.8 · ICD-11 5C53.2Y
- GLUTARIC ACIDEMIA I (GA1) · GLUTARIC ACIDURIA I; GCDH · ICD-10 E72.3 · ICD-11 5C50.E1
- GLUTARIC ACIDURIA I (LOW EXCRETER) · ACIDEMIA, GLUTARIC ACIDEMIA I; GCDH · ICD-10 E72.3 · ICD-11 5A13.6
- GLUTARIC ACIDURIA II (MADD, ETF) · MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD; ETFA, ETFB, ETFDH · ICD-10 E71.3 · ICD-11 5C52.01
- GLUTARIC ACIDURIA TYPE III · GLUTARYL-CoA OXIDASE DEFICIENCY; C7ORF10 · ICD-10 E72.3 · ICD-11 5C64.41
- GLUTATHIONE SYNTHETASE DEFICIENCY (GSSD) · PYROGLUTAMIC ACIDURIA; 5-OXOPROLINURIA; ACIDEMIA, PYROGLUTAMIC, GSS · ICD-10 D55.1 · ICD-11 3A10.0Y
- GLUTATHIONURIA (GGT1) · GAMMA-GLUTAMYL-TRANSPEPTIDASE DEFICIENCY · ICD-10 E72.8 · ICD-11 5C58.12
- GLYCEROL INTOLERANCE SYNDROM (GIS) · GLYCEROL INTOLERANCE SYNDROM · ICD-10 E74.8 · ICD-11 5C51.1
- GLYCEROL KINASE DEFICIENCY · GKD; HYPERGLYCEROLEMIA, GLYCEROLURIA; GLYCEROL KINASE DEFICIENCY · ICD-10 E74.8 · ICD-11 5C51.1
- GLYCINE ENCEPHALOPATHY 2 (GCE2) · ICD-10 E72.5
- GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE (GLYT1) · SLC6A9 · ICD-10 E72.5 · ICD-11 8B44.00
- GLYCINE N-METHYLTRANSFERASE DEFICIENCY (GNMT) · GNMT DEFICIENCY · ICD-10 E72.1 · ICD-11 5C56.1
- GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL · PHOSPHORYLASE KINASE DEFICIENCY OF HEART · ICD-10 E74.0+G73.6 · ICD-11 5C64.2Y
- GLYCOGEN STORAGE DISEASE TYPE 0a (GSD0a) · HYPOGLYCEMIA WITH DEFICIENCY OF GLYCOGEN-SYNTHETASE IN LIVER; GYS2 · ICD-10 E74.0 · ICD-11 5C51.3
- GLYCOGEN STORAGE DISEASE TYPE 0b (GSD0b) · GYS1 · ICD-10 E74.0 · ICD-11 3A73
- GLYCOGEN STORAGE DISEASE TYPE IA (GSD1a) · VON GIERKE DISEASE; G6PC · ICD-10 E74.0 · ICD-11 5C51.3
- GLYCOGEN STORAGE DISEASE TYPE IB (GSD1b) · GLYCOGEN STORAGE DISEASE I non A; GSD1 non a; G6PT1 · ICD-10 E74.0 · ICD-11 5C51.3
- GLYCOGEN STORAGE DISEASE TYPE IC (GSD1c) · GLYCOGENOSIS, TYPE IC; SLC37A4 · ICD-10 E74.0 · ICD-11 5C51.3
- GLYCOGEN STORAGE DISEASE TYPE II. ADULT ONSET (GSD2) · GLYCOGEN STORAGE DISEASE II; GAA · ICD-10 E74.0 · ICD-11 5C51.3
- GLYCOGEN STORAGE DISEASE TYPE II. INFANTILE ONSET. POMPE DISEASE (GSD2) · GLYCOGEN STORAGE DISEASE II; GAA · ICD-10 E74.0 · ICD-11 5C51.3
- GLYCOGEN STORAGE DISEASE TYPE II. JUVENILE ONSET (GSD2) · GLYCOGENOSIS, TYPE IIB; GAA · ICD-10 E74.0 · ICD-11 5C51.3
- GLYCOGEN STORAGE DISEASE TYPE IIB. DANON DISEASE · LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY; PSEUDOGLYCOGENOSIS II · ICD-10 E74.0 · ICD-11 5C51.3
- GLYCOGEN STORAGE DISEASE TYPE III. FORBES DISEASE, CORI DISEASE (GSD3) · FORBES DISEASE, CORI DISEASE, DEBRANCHER GLYCOGENOSIS; AGL · ICD-10 E74.0 · ICD-11 5C51.3
- GLYCOGEN STORAGE DISEASE TYPE IV. ANDERSEN DISEASE (GSD4) · ANDERSON DISEASE; AMYLOPECTINOSIS; GBE1 · ICD-10 E74.0 · ICD-11 5C51.3
- GLYCOGEN STORAGE DISEASE TYPE IXA1 (GSD9A1) · PHKA2 · ICD-10 E74.0 · ICD-11 5C51.3
- GLYCOGEN STORAGE DISEASE TYPE IXB (GSD9B) · PHOSPHORYLASE KINASE DEFICIENCY OF LIVER AND MUSCLE; PHKB · ICD-10 E74.0 · ICD-11 5C51.3
- GLYCOGEN STORAGE DISEASE TYPE IXC (GSD9C) · PHKG2 · ICD-10 E74.0 · ICD-11 5C51.3
- GLYCOGEN STORAGE DISEASE TYPE IXd (GSD9D) · PHKA1 · ICD-10 E74.0 · ICD-11 9B10.2Y
- GLYCOGEN STORAGE DISEASE TYPE VI. HERS DISEASE (GSD6) · GLYCOGEN STORAGE DISEASE VI; PYGL · ICD-10 E74.0 · ICD-11 5C51.3
- GLYCOGEN STORAGE DISEASE TYPE VII. TARUI DISEASE · GSD7; GLYCOGEN STORAGE DISEASE VII; · ICD-10 E74.0 · ICD-11 5C51.3
- GLYCOGEN STORAGE DISEASE TYPE VIII (GSD8) -> TYPE IX · GLYCOGEN STORAGE DISEASE VIII; PHKA2 -> GSD9 · ICD-10 E74.0 · ICD-11 5C51.3
- GLYCOGEN STORAGE DISEASE TYPE X (GSD10) · PGAM2 · ICD-10 E74.0 · ICD-11 LD28.1Y
- GLYCOGEN STORAGE DISEASE TYPE XI (GSD11) · LACTATE DEHYDROGENASE A DEFICIENCY; LDHA · ICD-10 E74.4 · ICD-11 5C53.02
- GLYCOGEN STORAGE DISEASE TYPE XII (GSD12) · ALDOA · ICD-10 E74.0 · ICD-11 5D2Z
- GLYCOGEN STORAGE DISEASE TYPE XIII (GSD13) · ENOLASE 3 DEFICIENCY; ENO3 · ICD-10 E74.0 · ICD-11 5C64.0
- GLYCOGEN STORAGE DISEASE TYPE XV (GSD15) · GYG1 · ICD-10 E74.0 · ICD-11 LD2H.Y
- GLYCOGEN STORAGE DISEASE, TYPE V. McARDLE DISEASE (GSD5) · GLYCOGEN STORAGE DISEASE V; PYGM · ICD-10 E74.0 · ICD-11 5C51.3
- GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 1 (GPIBD1) · PIGM-CDG, GPID; PIGM · ICD-10 E88.8 · ICD-11 5C53.2Y
- GOUT SUSCEPTIBILITY 1 · URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1; ABCG2 · ICD-10 M10.99 · ICD-11 FA25.2Z
- GRACILE SYNDROME · FELLMAN SYNDROME; BCS1L · ICD-10 E88.8 · ICD-11 5C53.22
- GREENBERG SKELATAL DYSPLASIA (GRBGD) · STEROL C14 REDUCTASE DEFICIENCY; LBR · ICD-10 Q77.3 · ICD-11 5C53.2Y
- GRISCELLI SYNDROME, TYPE 1 (GS1) · MYO5A · ICD-10 E70.3 · ICD-11 5B81.Y
- GRISCELLI SYNDROME, TYPE 2 (GS2) · RAB27A · ICD-10 E70.3 · ICD-11 LD2B
- GRISCELLI SYNDROME, TYPE 3 (GS3) · MLPH, MYO5A · ICD-10 E70.3 · ICD-11 LD2B
- GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY (GRIDHH) · ICD-10 K76.8 · ICD-11 5A44
- HAJDU-CHENEY SYNDROME (HJCYS) · ICD-10 M89.5 · ICD-11 FB86.2
- HAREL-YOON SYNDROME (HAYOS) · ATAD3A · ICD-10 G60.8 · ICD-11 5C50.E0
- HARTNUP DISEASE (HND) · HARTNUP DISORDER; BEHAVIORAL DISTURBANCES, REVERSIBLE; SLC6A19 · ICD-10 E72.0 · ICD-11 5C60.Y
- HAWKINSINURIA · 4-@HYDROXYPHENYLPYRUVATE HYDROXYLASE DEFICIENCY · ICD-10 E70.2 · ICD-11 5C50.1Y
- HEARING LOSS [DD] · HL · ICD-10 H91.8 · ICD-11 BA04.Y
- HEMOCHROMATOSIS, NEONATAL · GIANT CELL HEPATITIS, NEONATAL · ICD-10 E83.1 · ICD-11 5C54.0
- HEMOCHROMATOSIS, TYPE 1 · HFE1 · ICD-10 E83.1 · ICD-11 5A61.0
- HEMOCHROMATOSIS, TYPE 2A · HFE2 · ICD-10 E83.1 · ICD-11 8A02.12
- HEMOCHROMATOSIS, TYPE 2B · HAMP · ICD-10 E83.1 · ICD-11 5C53.30
- HEMOCHROMATOSIS, TYPE 3 · HFE3 · ICD-10 E83.1 · ICD-11 8C73.Y
- HEMOCHROMATOSIS, TYPE 4 · HEMOCHROMATOSIS DUE TO DEFECT IN FERROPORTIN; SLC40A1 · ICD-10 E83.1 · ICD-11 5C53.20
- HEMOCHROMATOSIS, TYPE 5 · FTH1 · ICD-10 E83.1 · ICD-11 8C73.Y
- HEMOLYTIC ANEMIA DUE TO GLUTATHIONE REDUCTASE DEFICIENCY · GSR · ICD-10 D55.1 · ICD-11 5C53.2Y
- HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY (GPI) · PHI · ICD-10 D55.2 · ICD-11 5C58.01
- HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY (HK1) · HK1 · ICD-10 D55.2 · ICD-11 5A81.1
- HEMOLYTIC UREMIC SYNDROME, ATYPICAL, 8, WITH RHIZOMELIC SHORT STATURE (AHUS8) · COSMC-CDG · ICD-10 D59.3
- HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1 (HLH1) · FHL1; PRF1, UNC13D, STX11 · ICD-10 D76.1 · ICD-11 5C53.25
- HEPATIC LIPASE DEFICIENCY · LIPC · ICD-10 E78.4 · ICD-11 5C56.2Z
- HEREDITARY FOLATE MALABSORPTION (HFM) · FOLIC ACID, TRANSPORT DEFECT INVOLVING; FOLATE MALABSORPTION · ICD-10 D52.8 · ICD-11 5C63.1
- HISTIDINEMIA · HAL · ICD-10 E70.8 · ICD-11 5C50.20
- HISTIDINURIA · HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT; HISTIDINURIA · ICD-10 E70.8 · ICD-11 5C50.2Y
- HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME · H SYNDROME; SLC29A3 · ICD-10 D76.3 · ICD-11 5C53.23
- HOMOCARNOSINOSIS · ICD-10 E72.8 · ICD-11 5C56.2Z
- HOMOCYSTINURIA DUE TO DEFECT OF N(5,10)-METHYLENE THF DEFICIENCY (MTHFR) · MTHFR DEFICIENCY · ICD-10 E72.1 · ICD-11 5C63.1
- HOMOCYSTINURIA, CYSTATHIONINE BETA-SYNTHASE DEFICIENCY (CBS) · CBS DEFICIENCY · ICD-10 E72.1 · ICD-11 5C50.B
- HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA DUE TO DEFECT IN COBALAMIN METABOLISM, cblG COMPLEMENTATION TYPE · METHYLCOBALAMIN DEFICIENCY, cblG TYPE; METHIONINE SYNTHASE DEFICIENCY · ICD-10 E72.1 · ICD-11 5C56.2Z
- HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblE COMPLEMENTATION TYPE (HMAE) · HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA DUE TO DEFECT IN COBALAMIN METABOLISM, cblE COMPLEMENTATION TYPE, MTRR · ICD-10 E72.1 · ICD-11 5C50.B
- HYDROPS FETALIS, NON IMMUNE · HYDROPS FETALIS, IDIOPATHIC · ICD-10 P56.9, P83.2 · ICD-11 5C59.00
- HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA (HLASA) · LARS2 · ICD-10 E88.8 · ICD-11 5C56.4
- HYDROXYKYNURENINURIA · KYNURENINASE DEFICIENCY · ICD-10 E70.8 · ICD-11 5C53.2Y
- HYDROXYLYSINURIA · ICD-10 E72.3 · ICD-11 5C50.4
- HYDROXYPROLINEMIA · 4-HYDROXY-L-PROLINE OXIDASE DEFICIENCY; HYDROXYPROLINEMIA I AND II; PRODH2 · ICD-10 E72.5 · ICD-11 5C50.8
- HYPER BETA-ALANINEMIA · HYPERALANINEMIA · ICD-10 E79.8 · ICD-11 5C55.1
- HYPER-IgD SYNDROME (HIDS), MEVALONIC ACIDURIA · PERIODIC FEVER, DUTCH TYPE; HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME; HIDS · ICD-10 E85.0 · ICD-11 5C50.6
- HYPERALDOSTERONISM, FAMILIAL, TYPE I (HALD1) · CYP11B1; CYP11B2 · ICD-10 E26.0 · ICD-11 3A72.01
- HYPERALDOSTERONISM, FAMILIAL, TYPE II (HALD2) · CLCN2 · ICD-10 E26.0 · ICD-11 5C50.DY
- HYPERALDOSTERONISM, FAMILIAL, TYPE III (HALD3) · KCNJ5 · ICD-10 E26.0 · ICD-11 5C54.2
- HYPERALDOSTERONISM, FAMILIAL, TYPE IV (HALD4) · ICD-10 E26.0 · ICD-11 6A00.Z
- HYPERALPHALIPOPROTEINEMIA 1 (HALP1) · CETP · ICD-10 E78.4 · ICD-11 5C56.2Z
- HYPERAMMONEMIA, TRANSIENT, OF THE NEWBORN (THAN) [DD] · --- · ICD-10 P74.8 · ICD-11 6A0Y
- HYPERBILIRUBINEMIA, ROTOR TYPE (HBLRR) · ROTOR SYNDROME; SLCO1B1; SLCO1B3 · ICD-10 E80.6 · ICD-11 LD20.01
- HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL DOMINANT (HCVAD) · BCMO1 · ICD-10 E50.8 · ICD-11 8A62.Y
- HYPERCHOLANEMIA, FAMILIAL (FHCA) · TJP2; EPHX1 · ICD-10 E88.8 · ICD-11 FB32.20
- HYPERCHOLESTEROLEMIA, FAMILIAL, 1 (FHCL1) · LDLR · ICD-10 E78.0 · ICD-11 5C80.00
- HYPERCHOLESTEROLEMIA, FAMILIAL, 2 (FHCL2) · APOB · ICD-10 E78.1 · ICD-11 5C57.1
- HYPERCHOLESTEROLEMIA, FAMILIAL, 3 (FHCL3) · PCSK9 · ICD-10 E78.0 · ICD-11 5C53.23
- HYPERCHOLESTEROLEMIA, FAMILIAL, 4 (FHCL4) · ARH · ICD-10 E78.0 · ICD-11 5C53.2Y
- HYPERCYSTINURIA · HYPERCYSTINNURIA, ISOLATED · ICD-10 E72.0 · ICD-11 5C60.2
- HYPEREKPLEXIA · STARTLE DISEASE; KOK-DISEASE; GLRA1 · ICD-10 G25.88 · ICD-11 MD90.1
- HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES (HGCLAS) · PYRUVATE DEHYDROGENASE LIPOIC ACID SYNTHETASE DEFICIENCY; PDHLD · ICD-10 E88.8 · ICD-11 5C53.2Y
- HYPERGLYCINEMIA, NON-KETOTIC (NKH) · NKH; GLYCINE ENCEPHALOPATHY; GLYCINE CLEAVAGE SYSTEM DEFICIENCY; GLDC · ICD-10 E72.5 · ICD-11 5C50.70
- HYPERGLYCINURIA · AMINOGLYCINURIA TYPE II; SLC36A2 · ICD-10 E72.0 · ICD-11 5A13.6
- HYPERINSULINEMIC HYPOGLYCEMIA DUE TO UNCOUPLING PROTEIN 2 (UCP2) · ICD-10 E16.1 · ICD-11 5B81.Y
- HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1 (HHF1) · PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI; NESIDIOBLASTOSIS OF PANCREAS; ABCC8 · ICD-10 E16.1 · ICD-11 5A71.01
- HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2 (HHF2) · KCNJ11; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI; NESIDIOBLASTOSIS · ICD-10 E16.1 · ICD-11 5A13.6
- HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3 (HHF3) · ICD-10 E16.1 · ICD-11 3A72.00
- HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4 (HHF4) · HADH · ICD-10 E16.1 · ICD-11 3A72.0Y
- HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5 (HHF5) · INSR · ICD-10 E16.1 · ICD-11 5C53.23
- HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6 (HHF6) · HYPERINSULINISM-HYPERAMMONEMIA SYNDROME; GDH · ICD-10 E16.1 · ICD-11 LD90.Y
- HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7 (HHF7) · EXERCISE-INDUCED-HYPERINSULINSM [EIHI]; MCT1-HYPERINSULINISM; SLC16A · ICD-10 E16.1 · ICD-11 LB20
- HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 8 (HHF8) · ICD-10 E16.1 · ICD-11 8B44.00
- HYPERINSULINEMIC HYPOGLYCEMIA, TRANSIENT OR PERMANENT [DD] · ICD-10 E16.1 · ICD-11 8B44.0Z
- HYPERKYNURENINURIA · XANTHURENIC ACIDURIA · ICD-10 E70.8 · ICD-11 5C54.2
- HYPERLEUCINE-ISOLEUCINEMIA (BCAA) · ICD-10 E71.1 · ICD-11 8A03.14
- HYPERLIPOPROTEINEMIA, TYPE III (HPL3) · DEFICIENCY OR DEFECT OF APOLIPOPROTEIN E; · ICD-10 E78.2 · ICD-11 5C53.20
- HYPERLIPOPROTEINEMIA, TYPE IV (HPL4) · ICD-10 E78.2 · ICD-11 8A03.10
- HYPERLYSINEMIA I, FAMILIAL · AASS · ICD-10 E72.3 · ICD-11 5C50.4
- HYPERLYSINEMIA II · SACCHAROPINURIA; ALPHA-AMINOADIPIC SEMIALDEHYDE SYNTHASE DEFICIENCY · ICD-10 E72.3 · ICD-11 5C63.Y
- HYPERLYSINURIA · LYSINE MALABSORPTION SYNDROME · ICD-10 E72.3 · ICD-11 5C60.Y
- HYPERMANGANESEMIA WITH DYSTONIA 1 (HMNDYT1) · SLC30A10 · ICD-10 E88.8 · ICD-11 5C56.1
- HYPERMANGANESEMIA WITH DYSTONIA 2 (HMNDYT2) · MANGANESE TRANSPORTER DFECT; SLC39A14 · ICD-10 E83.3 · ICD-11 5C53.2Y
- HYPERMETABOLISM DUE TO UNCOUPLED MITOCHONDRIAL OXIDATIVE PHOSPHORYLATION 1 ( HUMOP1) · LUFT DISEASE · ICD-10 E88.8 · ICD-11 8A62.Y
- HYPERMETABOLISM DUE TO UNCOUPLED MITOCHONDRIAL OXIDATIVE PHOSPHORYLATION 2 (HUMOP2) · ICD-10 E88.8 · ICD-11 5C53.2Y
- HYPERORNITHINEMIA WITH GYRATE ATROPHY (HOGA, OAT) · ORNITHINEMIA WITH GYRATE ATROPHY OF CHOROID AND RETINA; GYRATE ATROPHY OF THE CHOROID AND RETINA · ICD-10 E72.4 · ICD-11 5C50.9
- HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA (HHH-SYNDROME) · ORNITHINE TRANSLOCASE DEFICIENCY (ORNT1); SLC25A15 · ICD-10 E72.4 · ICD-11 5C50.AY
- HYPEROXALURIA, PRIMARY, TYPE I (PH1) · OXALOSIS I, GLYCOLICACIDURIA; AGXT · ICD-10 E74.8 · ICD-11 5C51.20
- HYPEROXALURIA, PRIMARY, TYPE II (PH2) · OXALOSIS II; D-GLYCERATE DEHYDROGENASE DEFICIENCY; GRHPR · ICD-10 E74.8 · ICD-11 5C51.2Y
- HYPEROXALURIA, PRIMARY, TYPE III (PH3) · HOGA1 · ICD-10 E74.8 · ICD-11 5B81.Y
- HYPERPARATHYROIDISM 1 (HRPT1) · CDC73 · ICD-10 E21.0 · ICD-11 LD20.01
- HYPERPARATHYROIDISM, NEONATAL SEVERE (NSHPT) · CASR · ICD-10 E21.0 · ICD-11 LD20.01
- HYPERPARATHYROIDISM, TRANSIENT NEONATAL (HRPTTN) · TRPV6 · ICD-10 E21.0 · ICD-11 LD20.01
- HYPERPHENYLALANIEMIA DUE TO GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE DEFICIENCY (GTP) · GTP CYCLOHYDROLASE I DEFICIENCY; GTPCH DEFICIENCY · ICD-10 E70.1 · ICD-11 5A00.00
- HYPERPHENYLALANINEMIA DUE TO 6-PYRUVOYLTETRAHYDROPTERIN SYNTHASE DEFICIENCY (PTPS) · PHENYLKETONURIA III; BIOPTERIN SYNTHESIS DEFICIENCY; PKU III; PTPS · ICD-10 E70.1 · ICD-11 5C59.01
- HYPERPHENYLALANINEMIA DUE TO DHPR-DEFICIENCY (DHPR) · PHENYLKETONURIA II; PKU II; DIHYDROPTERIDINE REDUCTASE DEFICIENCY; ATYPICAL PKU; QDPR · ICD-10 E70.1 · ICD-11 5C59.01
- HYPERPHENYLALANINEMIA DUE TO PTERIN-4a-CARBINOLAMINE DEHYDRATASE (PCPD1) · PTERIN-4a-CARBINOLAMINE DEHYDRATASE DEFICIENCY; PRIMAPTERINURIA; PCD DEFICIENCY · ICD-10 E70.1 · ICD-11 5A45
- HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT (DNAJC12) · DNAJC12 DEFICIENCY · ICD-10 E70.1 · ICD-11 5A71.01
- HYPERPHOSPHATASIA (JPD) · JUVENILE PAGET DISEASE; TNFRSF11B · ICD-10 M88.0, M88.8., M88.9 · ICD-11 5C81.0
- HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 1 (HPMRS1) · PIGV-CDG; MABRY SYNDROME · ICD-10 Q87.8 · ICD-11 5A74.0
- HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2 (HPMRS2, PIGO-CDG)) · PIGO-CDG; GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 6; GPIBD6 · ICD-10 Q87.8 · ICD-11 8A62
- HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3 (HPMRS3) · PGAP2 · ICD-10 Q87.8 · ICD-11 8A62
- HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4 (HPMRS4) · PGAP3 · ICD-10 Q87.8 · ICD-11 8A62
- HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 5 (HPMRS5) · GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11 (GPIBD11); PIGW · ICD-10 Q87.8 · ICD-11 5A44
- HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6 (HPMRS6) · PIGY-CDG · ICD-10 Q87.8 · ICD-11 5A74.0
- HYPERPIPECOLATEMIA · ICD-10 Q82.8 · ICD-11 5C50.4
- HYPERPROLINEMIA, TYPE I · PROLINE OXIDASE DEFICIENCY; PRODH · ICD-10 E72.5 · ICD-11 5C50.8
- HYPERPROLINEMIA, TYPE II · P5CDH; ALDH4A1 · ICD-10 E72.5 · ICD-11 5C50.8
- HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE (HTGTI) · GLYCEROL-3-PHOSPHATE DEHYDROGENASE DEFICIENCY; GPD1 · ICD-10 K76.0 · ICD-11 5C56.0Y
- HYPERTROPHIC CARDIOMYOPATHY AND RENAL TUBULAR DYSFUNCTION · ICD-10 E88.8 · ICD-11 5C53.2Y
- HYPERTRYPTOPHANEMIA (HYPTRP) · TDO2 · ICD-10 E70.8 · ICD-11 8C20.0
- HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME; HUPRAS · HUPRA SYNDROME · ICD-10 E88.8 · ICD-11 5C53.2Y
- HYPERVALINEMIA · VALINEMIA · ICD-10 E71.1 · ICD-11 5C50.D
- HYPERZINCAEMIA AND HYPERCALPROTECTINAEMIA · HYPERZINCEMIA, FAMILIAL DYSALBUMINEMIC · ICD-10 E83.2 · ICD-11 5C51.3
- HYPOADRENOCORTICISM, FAMILIAL · ADRENAL HYPOPLASIA, CONGENITAL; ADDISON DISEASE; DAX-1 · ICD-10 E27.1 · ICD-11 5A74.0
- HYPOBETALIPOPROTEINEMIA, FAMILIAL, 1 (FHBL1) · ACANTHOCYTOSIS WITH HYPOBETALIPOPROTEINEMIA; APOB · ICD-10 E78.6 · ICD-11 5C53.2Y
- HYPOBETALIPOPROTEINEMIA, FAMILIAL, 2 (FHBL2) · HYPOLIPIDEMIA, FAMILIAL, COMBINED; ANGPTL3 · ICD-10 E78.6 · ICD-11 8C70.4
- HYPOGLYCEMIA, FAMILIAL NEONATAL · HYPOGLYCEMIA, LEUCINE INDUCED · ICD-10 E16.1 · ICD-11 5A45
- HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY (HIHGHH) · AKT2 · ICD-10 Q87.3 · ICD-11 5C55.0Y
- HYPOMAGNESEMIA 1, INTESTINAL (HOMG1) · TRPM6 · ICD-10 E83.4 · ICD-11 5C54.0
- HYPOMAGNESEMIA 2, RENAL (HOMG2) · FXYD2 · ICD-10 E83.4 · ICD-11 5A13.6
- HYPOMAGNESEMIA 3, RENAL (HOMG3) · CLDN16 · ICD-10 E83.4 · ICD-11 5C53.0Y
- HYPOMAGNESEMIA 4, RENAL (HOMG4) · HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC; EGF · ICD-10 E83.4 · ICD-11 GB90.41
- HYPOMAGNESEMIA 5, RENAL, WITH OCULAR INVOLVEMENT (HOMG5) · CLDN19 · ICD-10 E83.4 · ICD-11 LD2A.4
- HYPOMAGNESEMIA 6, RENAL (HOMG6) · CNNM2 · ICD-10 E83.4 · ICD-11 8A03.14
- HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 1 (HOMGSMR1) · CNNM2 · ICD-10 E83.4 · ICD-11 8A44.3
- HYPOPARATHYROIDISM, FAMILIAL ISOLATED (FIH) · HYPOPARATHYROIDISM, AUTOSOMAL DOMINANT; PTH · ICD-10 E20.8 · ICD-11 5C53.Y
- HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME (HDRS) · HDR SYNDROME · ICD-10 Q87.8 · ICD-11 LD27.0Y
- HYPOPARATHYROIDISM, X-LINKED (HYPX) · PARATHYROID GLANDS, AGENESIS OF; SOX3 · ICD-10 E20.8 · ICD-11 5C53.Y
- HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME (HRDS) · SANJAD-SAKATI SYNDROME; TBCE · ICD-10 Q87.1 · ICD-11 5C53.20
- HYPOPHOSPHATASIA, ADULT ; ODONTOHYPOPHOSPHATASIA · ALPL · ICD-10 E83.38 · ICD-11 5A72.0
- HYPOPHOSPHATASIA, CHILDHOOD · ALPL · ICD-10 E83.38 · ICD-11 LD90.Y
- HYPOPHOSPHATASIA, INFANTILE · ALPL · ICD-10 E83.38 · ICD-11 5C54.2
- HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT (XLHR) · HYPOPHOSPHATEMIA, X-LINKED; XLH; PHEX · ICD-10 E83.30 · ICD-11 5C56.0Y
- HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT (HOD) · CHLORIDE CHANNEL 7 SUPERACTIVITY · ICD-10 L81.9 · ICD-11 6A00.Z
- HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1 (CHNG1) · THYROTROPIN RESISTANCE; TSHR · ICD-10 E03.1 · ICD-11 8C73.Y
- HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2 (CHNG2) · THYROID DYSGENESIS; THYROID AGENESIS; PAX8 · ICD-10 E03.1 · ICD-11 5D2Z
- HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 3 (CHNG3) · ICD-10 E03.1
- HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4 (CHNG4) · TSHB · ICD-10 E03.1 · ICD-11 5C53.23
- HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME (HADDTS) · ICD-10 G40.4 · ICD-11 8A62.Y
- HYPOTONIA-CYSTINURIA SYNDROME · CYSTINURIA WITH MITOCHONDRIAL DISEASE; Prolyl endopeptidase-like · ICD-10 E72.0 · ICD-11 5C53.2Y
- HYPOURICEMIA, RENAL, 1 (RHUC1) · DALMATIAN HYPOURICEMIA; SLC22A12 · ICD-10 N25.8 · ICD-11 5C53.2Y
- HYPOURICEMIA, RENAL, 2 (RHUC2) · SLC2A9 · ICD-10 N25.8 · ICD-11 5C53.2Y
- IMINOGLYCINURIA · IMINOGLYCINURIA, FAMILIAL; SLC36A2 · ICD-10 E72.0 · ICD-11 5C60.Y
- IMMUNODEFICIENCY 23 (IMD23) · IMMUNODEFICIENCY WITH HYPER IgE AND COGNITIVE IMPAIRMENT; PGM3-CDG · ICD-10 E77.8 · ICD-11 5C53.21
- IMMUNODEFICIENCY 47 (IMD47); ATP6AP1-CDG · CDG IIs · ICD-10 D84.8 · ICD-11 LD24.3
- IMMUNODEFICIENCY 54 (IMD54) · FAMILIAL GLUCOCORTICOID LIKE SYNDROME; MCM4 · ICD-10 D84.8 · ICD-11 8A62.0
- IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA (IMDDHH) · NFE2L2 · ICD-10 D84.8 · ICD-11 5C53.2Y
- IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES (ISDNA) · EXOSTOSIN-LIKE GLYCOSYLTRANSFERASE 3 DEFICIENCY; EXTL3 · ICD-10 Q87.8 · ICD-11 LD27.0Y
- INFANTILE CEREBELLAR-RETINAL DEGENERATION (ICRD) · ACO2 · ICD-10 E88.8 · ICD-11 5C60.2
- INFANTILE LIVER FAILURE SYNDROME 1 (ILFS1) · INFANTILE LIVER FAILURE SYNDROME 1; LARS1 · ICD-10 K72.0 · ICD-11 8A02.12
- INFANTILE LIVER FAILURE SYNDROME 2 (ILFS2) · INFANTILE LIVER FAILURE SYNDROME 2; NBAS · ICD-10 K72.0 · ICD-11 5A61.0
- INFANTILE METABOLIC DISORDER AFFECTING MITOCHONDRIAL FUNCTION · ICD-10 G71.3
- INFANTILE-ONSET MITOCHONDRIAL ENCEPHALOPATHY · COX11 · ICD-10 G71.3 · ICD-11 6A00
- INFECTIONS OF THE NEWBORN (TORCH) [DD] · ICD-11 5C51.0
- INFLAMMATORY BOWEL DISEASE (IBD) [DD] · ICD-10 K50.9 · ICD-11 5C53.2Y
- INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA (IDDCA) · ICD-10 I49.8 · ICD-11 LD2H.Y
- INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES (IDDNPF) · ICD-10 F70-F73 · ICD-11 LD2H.Y
- INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT PERIPHERAL NEUROPATHY (IDDPN) · ICD-10 F84.8 · ICD-11 8A61.12
- INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 10 (MRD10) · ICD-10 F71 , F72 , F73 , F70
- INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 35 (MRD35) · HOUGE-JANSSENS SYNDROME 1; HJS1 · ICD-10 Q87.8
- INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 36 (MRD36) · HOUGE-JANSSENS SYNDROME 2; HJS2 · ICD-10 Q87.0
- INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 61 (MRD61) · ICD-10 F84.8
- INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 72 (MRD72) · ICD-10 Q87.3 · ICD-11 8A62
- INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 1 (MRT1) · ICD-10 F70 , F73 , F72 , F71
- INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68 (MRT68) · ICD-10 F84.8 · ICD-11 8C20.1
- INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 83 (MRT83) · ICD-10 F84.8
- INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 98 (XLID98) · MENTAL RETARDATION, X-LINKED 98; MRX98 · ICD-10 Q87.8 · ICD-11 LD90
- INTELLECTUAL DISABILITY, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA (IDEDNIK) · IDEDNIK Syndrome · ICD-10 E88.8 · ICD-11 8B44.01
- INTERSTITIAL LUNG AND LIVER DISEASE (ILLD) · Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency; MARS1 · ICD-10 J84.0 · ICD-11 8A62.Y
- INTOXICATION ACETAMINOPHEN [DD] · ICD-10 T39.3 · ICD-11 5A73
- INTOXICATION: ALCOHOLS AND DERIVATES [DD] · ICD-10 T51.8 · ICD-11 5A74.0
- INTOXICATION: SULCOTRIONE [DD] · TRIKETONE; HERBICIDAL AGENT (MIKADO TM) · ICD-10 T60.3 · ICD-11 5C56.1
- INTRAUTERINE GROWTH RETARDATION (IUGR) · SMALL FOR GESTATIONAL AGE (SGA) · ICD-10 P05.0 · ICD-11 5C53.02
- INTRINSIC FACTOR DEFICIENCY (IFD) · CBLIF · ICD-10 D51.0 · ICD-11 5C5Y
- ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY · IBDD · ICD-10 E71.1 · ICD-11 8,00E+47
- ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IA (IGHD1A) · IGHD IA; PRIMORDIAL DWARFISM; GH1 · ICD-10 E23.0 · ICD-11 5C53.4
- ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB (IGHD1B) · IGHD IB; GH1 · ICD-10 E23.0 · ICD-11 5C53.Y
- ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II (IGHD2) · IGHD II; GH1 · ICD-10 E23.0 · ICD-11 5C53.30
- ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III (IGHD3) · IGHD III; BTK · ICD-10 E23.0 · ICD-11 3A72.00
- ISOVALERIC ACIDEMIA (IVA) · ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY; IVD · ICD-10 E71.1 · ICD-11 5C50.E0
- JOUBERT SYNDROME 1 (JBTS1) · JOUBERT-BOLTSHAUSER SYNDROME; CEREBELLOPARENCHYMAL DISORDER IV; INPP5E · ICD-10 Q04.3 · ICD-11 5C50.E0
- JOUBERT SYNDROME 2 (JBTS2) · TMEM216 · ICD-10 Q04.3 · ICD-11 8A62.Y
- JOUBERT SYNDROME 3 (JBTS3) · AHI1 · ICD-10 H35.5, Q04.3
- KABUKI SYNDROME 1 (KABUK1) · KMT2D · ICD-10 Q87.0 · ICD-11 5C53.20
- KABUKI SYNDROME 2 (KABUK2) · KDM6A · ICD-10 Q87.0 · ICD-11 8C20.0
- KEARNS-SAYRE SYNDROME (KSS) · OPHTHALMOPLEGIA, PIGMENTARY DEGENARATION OF RETINA AND CARDIOMYOPATHY; KEARNS-SAYRE DISEASE · ICD-10 H49.8 · ICD-11 5C58.12
- KELLEY-SEEGMILLER SYNDROME · HPRT1 DEFICIENCY, PARTIAL; HPRT · ICD-10 E79.8 · ICD-11 8B44.01
- KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT (KIDAD) · GJB2 · ICD-10 Q80.8 · ICD-11 5C53.2Y
- KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL RECESSIVE (KIDAR) · DESMONS SYNDROME; MEDNIK-LIKE SYNDROME; AP1B1 · ICD-10 Q80.8 · ICD-11 5C53.2Y
- KESHAN DISEASE · ICD-10 E59
- KETOSIS, UNSPECIFIC [DD] · ICD-11 5C56.00
- KETOTIC HYPOGLYCEMIA · ICD-10 R82.4, E16.2 · ICD-11 KB63.4
- KRABBE DISEASE · GLOBOID CELL LEUKODYSTROPHY; GALC · ICD-10 E75.2 · ICD-11 8A44.4
- KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY · SAPOSIN A DEFICIENCY · ICD-10 E75.2 · ICD-11 8C73.Y
- L-ARABINOSURIA · ICD-10 E74.0 · ICD-11 5C53.2Y
- LACTASE DEFICIENCY, CONGENITAL · LCT · ICD-10 E73.0 · ICD-11 5C61.61
- LACTATE DEHYDROGENASE B DEFICIENCY (LDHBD) · LDHB · ICD-10 E74.0 · ICD-11 5C53.2Y
- LACTIC ACIDOSIS, HYPOGLYCEMIA AND DEVELOPMENTAL DELAY (NEW DISEASE) · ICD-10 E88.8
- LACTOSE INTOLERANCE · moved to MIM 223000 · ICD-10 E73.0 · ICD-11 5C61.61
- LACTOSE INTOLERANCE, ADULT TYPE · HYPOLACTASIA, ADULT TYPE; MCM6 · ICD-10 E73.1 · ICD-11 8A61.11
- LANOSTEROL DEMETHYLASE DEFICIENCY · CYTOCHROME P450, FAMILY 51, SUBFAMILY A, POLYPEPTIDE 1; CYP51A1 · ICD-10 E88.8 · ICD-11 6A0Y
- LATHOSTEROLOSIS · ICD-10 Q87.8 · ICD-11 5C53.22
- LEBER CONGENITAL AMAUROSIS 11 (LCA11) · IMPDH1 · ICD-10 H35.5 · ICD-11 5C56.2Z
- LEBER OPTIC ATROPHY AND DYSTONIA (LDYT) · MARSDEN SYNDROME; LEBER PLUS DISEASE; LDYT · ICD-10 H47.2 · ICD-11 5C64.3
- LEBER OPTIC ATROPHY, SUSCEPTIBILITY TO (LHON) · ICD-10 H47.2 · ICD-11 5D2Z
- LEBERS HEREDITARY OPTIC NEUROPATHY (LHON) · LEBER OPTIC ATROPHY; OPTIC ATROPHY, LEBER TYPE · ICD-10 H47.2 · ICD-11 LD90.Y
- LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY · NORUM DISEASE; LCAT · ICD-10 E78.6 · ICD-11 3A92
- LEIGH`S SYNDROME, SUBACUTE NECROTIZING ENCEPHALOPATHY (SNE) · ENCEPHALOPATHY, NECROTIZING · ICD-10 G31.88 · ICD-11 5C53.24
- LEPTIN DEFICIENCY OR DYSFUNCTION (LEPD) · OBESITY, MORBID, NONSYNDROMIC 1 · ICD-10 E66.8 · ICD-11 5C53.23
- LEPTIN RECEPTOR DEFICIENCY (LEPRD) · OBESITY, MORBID, NONSYNDROMIC 2 · ICD-10 E66.8 · ICD-11 5C53.23
- LESCH-NYHAN SYNDROME (HGPRT, HPRT) · HYPOXANTHIN GUANINE PHOSPHORIBOSYLTRANSFERASE; LESCH-NYHAN SYNDROME · ICD-10 E79.1 · ICD-11 5C55.01
- LETHAL INFANTILE MITOCHONDRIAL DISEASE (LIMM) · MTTT · ICD-10 G71.3 · ICD-11 KA65.Y
- LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET (PLDECO) · ALKALINE CERAMIDASE 3 DEFICIENCY; ACER3 · ICD-10 E75.2 · ICD-11 5C58.12
- LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION (LBSL) · MITOCHONDRIAL ASPARTYL-tRNA SYNTHETASE DEFICIENCY; DARS2 · ICD-10 E88.8 · ICD-11 LD2H.Y
- LEUKOENCEPHALOPATHY, PROGRESSIVE, INFANTILE-ONSET, WITH OR WITHOUT DEAFNESS (LEPID) · ICD-10 G93.8 · ICD-11 LD2H.Y
- LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE (LKENP) · AARS2 · ICD-10 E75.2 · ICD-11 3A73
- LEUKOTRIENE C4-SYNTHESIS DEFICIENCY · LTC4S · ICD-10 E88.8 · ICD-11 5C54.0
- LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY (LSMFLAD) · FLAD1 · ICD-10 E71.3 · ICD-11 5C64.10
- LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1 (CGL1) · BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY, TYPE 1; AGPAT2 · ICD-10 E88.1 · ICD-11 PL0Z
- LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2 (CGL2) · BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY, TYPE 2; BSCL2 · ICD-10 E88.1 · ICD-11 5C50.70
- LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2 (FPLD2) · LIPODYSTROPHY, FAMILIAL PARTIAL, DUNNIGAN TYPE; · ICD-10 E88.1
- LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4 (FPLD4) · LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PLIN1 MUTATIONS; · ICD-10 E88.1
- LIPOID ADRENAL HYPERPLASIA (StAR DEFICIENCY) · STAR · ICD-10 E25.08 · ICD-11 5C50.B
- LIPOYLTRANSFERASE 1 DEFICIENCY (LIPT1D) · LIPT1 · ICD-10 E88.8 · ICD-11 5A00.0Y
- LIVER DISEASE, LIVER FAILURE, UNSPECIFIC, PRIMARY, SECONDARY [DD] · ICD-10 K72.0 · ICD-11 5C52.10
- LIVER DISEASE, SEVERE CONGENITAL (SCOLIV) · FOCAD DEFICIENCY · ICD-10 P78.8 · ICD-11 KB8Y
- LIVER FAILURE, INFANTILE, TRANSIENT (LFIT) · ACUTE INFANTILE LIVER FAILURE · ICD-10 E88.8 · ICD-11 5C53.23
- LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY (LCAD) · ACADVL · ICD-10 E71.3 · ICD-11 5C52.01
- LONG-CHAIN FATTY ACIDS, DEFECT IN TRANSPORT OF · LONG-CHAIN FATTY ACIDS, DEFECT IN TRANSPORT OF · ICD-10 E71.3 · ICD-11 4A44.5
- LONG-CHAIN-3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY (LCHAD) · LCHAD DEFICIENCY; HADHA · ICD-10 E71.3 · ICD-11 5C56.0Y
- LYSINURIC PROTEIN INTOLERANCE (LPI) · HYPERDIBASIC AMINOACIDURIA II; DIBASIC AMINOACIDURIA II; HYPERDIBASIC AMINOACIDURIA II; LPI · ICD-10 E72.0 · ICD-11 5C60.Y
- LYSOSOMAL ACID LIPASE DEFICIENCY (LAL-D) · WOLMAN DISEASE; LAL-D; LIPA; CESD · ICD-10 E75.5 · ICD-11 5C56.0Y
- MAHVASH DISEASE (MVAH ) · GLUCAGON RECEPTOR DEFECT; GCGR · ICD-10 E16.3 · ICD-11 8A02.12
- MAJEED SYNDROME (MJDS) · LPIN2 · ICD-10 M86.3 · ICD-11 GB90.43
- MALAN SYNDROME, SOTOS SYNDROME 2 (SOTOS2) · NFIX-RELATED MALAN SYNDROME; MALNS; NFIX · ICD-10 Q87.3 · ICD-11 5C53.23
- MALEYLACETOACETATE ISOMERASE · MAAI DEFICIENCY HYPERSUCCINYLACETONEMIA, MILD; MHSA · ICD-10 E88.8 · ICD-11 8A62.Y
- MALONYL-COA DECARBOXYLASE DEFICIENCY · MALONIC ACIDURIA · ICD-10 E72.8 · ICD-11 5C50.E1
- MAMEL (METHYLMALONIC ACIDURIA MITOCHONDRIAL ENCEPHELOPATHY LEIGH-LIKE) A NEW MITOCHONDRIAL ENCEPHALOPATHY · ICD-10 G93.8 · ICD-11 5C56.2Z
- MAPLE SYRUP URINE DISEASE (MSUD) · BRANCHED-CHAIN ALPHA-KETO ACID DEHYDROGENASE DEFICIENCY (MSUD);BCKDHA, BCKDHB, DBT · ICD-10 E71.0 · ICD-11 5C50.D0
- MAPLE SYRUP URINE DISEASE, MILD VARIANT (MSUDMV) · ICD-10 E71.0 · ICD-11 5C53.23
- MAPLE SYRUP URINE DISEASE, TYPE IB (MSUD1B) · ICD-10 E71.0 · ICD-11 5C50.D0
- MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1 (MODY1) · HNF4A · ICD-10 E11.9_ · ICD-11 5A13.6
- MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10 (MODY10) · INS · ICD-10 E11.9_ · ICD-11 5C53.23
- MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11 (MODY11) · BLK · ICD-10 E11.9_ · ICD-11 5C53.23
- MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 12 (MODY12) · ICD-10 E11.9_
- MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13 (MODY13) · KCNJ11 · ICD-10 E11.90 · ICD-11 8A62
- MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 14 (MODY14) · APPL1 · ICD-10 E11.9_ · ICD-11 6A0Y
- MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2 (MODY2) · GCK · ICD-10 E11.9_ · ICD-11 5C53.2Y
- MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3 (MODY3) · HNF1A · ICD-10 E11.9_ · ICD-11 5A50.0Y
- MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 4 (MODY4) · PDX1 · ICD-10 E11.9_ · ICD-11 5A50.0Y
- MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 5 (MODY5, RCAD) · HNF1B · ICD-10 E11.2, N29.8 · ICD-11 5A72.0
- MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 6 (MODY6) · NEUROD1 · ICD-10 E11.9_ · ICD-11 5C53.23
- MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7 (MODY7) · KLF11 · ICD-10 E11.9_ · ICD-11 5C53.23
- MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, (MODY 8) WITH EXOCRINE DYSFUNCTION · CEL · ICD-10 E11.9_ · ICD-11 5C53.2Y
- MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 9 (MODY9) · PAX4 · ICD-10 E11.9_ · ICD-11 5C53.23
- MAURIAC SYNDROME · PHKG2 · ICD-10 E10.70 · ICD-11 5C53.2Y
- MEDIUM CHAIN 3-KETOACYL-CoA THIOLASE DEFICIENCY · ICD-10 E71.3 · ICD-11 5C56.02
- MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY (MCAD) · ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF · ICD-10 E71.3 · ICD-11 5C52.01
- MEDOPATHY WITH INTELLECTUAL DISABILITY, MOTOR DELAY, AND CRANIOFACIAL, CARDIAC, AND LIMB MALFORMATIONS (MED16) · GUILLOUET-GORDON SYNDROME; GGNS · ICD-10 Q78.8
- MEGALOBLASTIC ANEMIA 1 (IMERSLUND-GRASBECK SYNDROME, IGS) · VITAMIN B(12) MALABSORPTION; MGA1; · ICD-10 D51.1 · ICD-11 3A01.Y
- MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY (DHFRD) · DHFR DEFICIENCY · ICD-10 D52.8 · ICD-11 8C73.Y
- MENKES SYNDROME (MNK) · MENKES DISEASE; KINKY HAIR DISEASE; ATP7A · ICD-10 E83.0 · ICD-11 5C64.0Y
- MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS; MRFACD (MED13L) · MED13L · ICD-10 Q87.8 · ICD-11 5C51.3
- MENTAL RETARDATION, AUTOSOMAL DOMINANT 56 (MRD56) · CLATHRIN (CTLC) VARIATION; CLTC · ICD-10 F71, F72, F73, F70 · ICD-11 5C55.Z
- MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES (MRD6) · GRIN2B · ICD-10 F70-F73 · ICD-11 LD2H.Y
- MENTAL RETARDATION, AUTOSOMAL RECESSIVE 12 (CDG) · ST3GAL3-CDG; ST3GAL3 · ICD-10 F70 , F73 , F72 , F71 · ICD-11 5C53.23
- MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14 (MRT14) · ICD-10 F70 , F73 , F72 , F71 · ICD-11 LB2Y
- MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15 (MAN1B1-CDG) · MAN1B1-CDG; MAN1B1 · ICD-10 E77.8 · ICD-11 5C52.01
- MENTAL RETARDATION, AUTOSOMAL RECESSIVE 7 (CDG) · TUSC3-CDG; TUSC3 · ICD-10 F70 , F73 , F72 , F71 · ICD-11 5C53.23
- MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA (MEDNIK) · ERYTHROKERATODERMIA VARIABILIS, KAMOURASKA TYPE; AP1S1 · ICD-10 E83.0 · ICD-11 5C55.0Y
- MENTAL RETARDATION, X-LINKED 91 (MRX91) · ZDHHC15 · ICD-10 Q87.8 · ICD-11 5C53.2Y
- MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE (MRXSSR) · SMS · ICD-10 Q87.8 · ICD-11 5C53.2Y
- METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION (MECREN) · SLC25A42 · ICD-10 E87.2; G31.9 · ICD-11 5C53.24
- METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION (MECRCN) · TANGO2 · ICD-10 G31.88 · ICD-11 5C64.3
- METACHROMATIC LEUKODISTROPHY (MLD) · METACHROMATIC LEUKODYSTROPHY, JUVENILE, LATE INFANTILE · ICD-10 E75.2 · ICD-11 5C56.02
- METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY · SAPOSIN B DEFICIENCY · ICD-10 E75.2 · ICD-11 LD20.01
- METAPHYSEAL ENCHONDROMATOSIS WITH D-2-HYDROXYGLUTARIC ACIDURIA · ICD-10 Q78.8 · ICD-11 5C53.21
- METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA (METAG) · CYB5A · ICD-10 D74.0 · ICD-11 KA20.Z
- METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE · METHEMOGLOBINEMIA, TYPE I; METHEMOGLOBINEMIA, TYPE II; CYB5R3 · ICD-10 D74.0 · ICD-11 5A74.Y
- METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY (MAT, MAT1A) · MAT I/III DEFICIENCY; HYPERMETHIONINEMIA, ISOLATED PERSISTENT · ICD-10 E72.1 · ICD-11 5C50.B
- METHIONINE ADENOSYLTRANSFERASE II, ALPHA (MAT2A) · ICD-10 E72.1 · ICD-11 5C53.25
- METHIONINE MALABSORPTION · SMITH-STRANG DISEASE; OASTHOUSE URINE DISEASE · ICD-10 E72.1 · ICD-11 5C81.0
- METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY (MMSDH) · MMSDH DEFICIENCY; ALDH6A1 · ICD-10 E71.1 · ICD-11 5C60.Z
- METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE · MENTAL RETARDATION, X-LINKED 3; MRX3; HCFC1 · ICD-10 E71.1 · ICD-11 LD2H.Y
- METHYLMALONIC ACIDURIA (MMA) · METHYLMALONACIDURIA DUE TO METHYLMALONIC COA MUTASE; ACIDEMIA, METHYLMALONIC · ICD-10 E71.1 · ICD-11 5C50.E0
- METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA DUE TO ZNF143 DEFICIENCY · ICD-10 E71.1 · ICD-11 5C53.2Y
- METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE · VITAMIN B12 METABOLIC DEFECT WITH METHYLMALONICACIDEMIA AND HOMOCYSTINURIA · ICD-10 D58.8 · ICD-11 5C50.E0
- METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE · HOMOCYSTINURIA, cblD TYPE, VARIANT 1, VARIANT 2, INCLUDED; MMADHC · ICD-10 E72.1 · ICD-11 5C54.0
- METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE · ABCD4 · ICD-10 E71.1 · ICD-11 5A74.Y
- METHYLMALONIC ACIDURIA, ATYPICAL · ICD-10 E71.1 · ICD-11 5C54.0
- METHYLMALONIC ACIDURIA, cblA TYPE · METHYLMALONICACIDURIA, VITAMIN B12 RESPONSIVE, DUE TO DEFECT IN SYNTHESIS OFADENOSYLCOBALAMIN cblA; ADENOSYLCOBALAMIN DE · ICD-10 E71.1 · ICD-11 5C58.1Y
- METHYLMALONIC ACIDURIA, cblB TYPE · METHYLMALONIC ACIDURIA, VITAMIN B12-RESPONSIVE, DUE TO DEFECT IN SYNTHESIS OF ADENOSYLCOBALAMIN, cblB TYPE · ICD-10 E71.1 · ICD-11 CB04.2
- METHYLMALONIC ACIDURIA, ISOLATED, BENIGN (BACTERIAL OVERGROWTH?) · ICD-10 E71.1 · ICD-11 5C58.03
- METHYLMALONIC ACIDURIA, TRANSIENT, DUE TO TRANSCOBALAMIN RECEPTOR DEFECT (TCRD) · METHYLMALONIC ACIDEMIA, TCblR TYPE; TC RECEPTOR DEFECT; CD320 · ICD-10 E71.1 · ICD-11 PL0Z
- METHYLMALONYL-CoA EPIMERASE DEFICIENCY (MCEE) · METHYLMALONYL-CoA RACEMASE DEFICIENCY; METHYLMALONIC ACIDURIA III, FORMERLY · ICD-10 E71.1 · ICD-11 5C63.Y
- MEVALONIC ACIDURIA (MKD) · ACIDEMIA, MEVALONIC; MVK · ICD-10 E88.8 · ICD-11 5C52.10
- MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 1 (MEDS1) · ICD-10 Q02
- MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY (MSCCA) · ICD-10 G98 · ICD-11 LD20.Y
- MICROPHTHALMIA, SYNDROMIC 9 (MCOPS9) · MATTHEW-WOOD SYNDROME; SPEAR SYNDROME; STRA6 · ICD-10 Q11.2 · ICD-11 GB82
- MITCHELL-RILEY SYNDROME (MTCHRS) · DIABETES, NEONATAL, WITH PANCREATIC HYPOPLASIA, INTESTINAL ATRESIA, AND GALLBLADDER APLASIA OR HYPOPLASIA ; RFX6 · ICD-10 Q45.8 · ICD-11 5C58.03
- MITOCHONDRIAL ACETYL-CoA CARBOXYLASE 2 DEFICIENCY · ACC2 · ICD-10 E88.8 · ICD-11 LD24.K0
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1 (MC1DN1) · NADH-COENZYME Q REDUCTASE DEFICIENCY; NDUFS4 · ICD-10 G71.3 · ICD-11 PL12
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10 (MC1DN10) · NDUFAF2 · ICD-10 G71.3 · ICD-11 LD9Y
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11 (MC1DN11) · NDUFAF1 · ICD-10 G71.3 · ICD-11 LD9Y
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12 (MC1DN12) · NDUFA1 · ICD-10 G71.3 · ICD-11 GB41
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13 (MC1DN13) · NDUFA2 · ICD-10 G31.8 · ICD-11 GB41
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14 (MC1DN14) · NDUFA11 · ICD-10 G71.3 · ICD-11 5C53.2Y
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15 (MC1DN15) · C6ORF66; NDUFAF4 · ICD-10 G71.3 · ICD-11 BD52
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16 (MC1DN16) · NDUFAF5 · ICD-10 G71.3 · ICD-11 8C20.2
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17 (MC1DN17) · NDUFAF6 · ICD-10 G31.8 · ICD-11 5A51.0
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18 (MC1DN18) · NDUFAF3 · ICD-10 G71.3 · ICD-11 8A62.Y
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19 (MC1DN19) · FOXRED1 · ICD-10 G71.3 · ICD-11 5A51.0
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2 (MC1DN2) · NDUFS8 · ICD-10 G71.3 · ICD-11 PL0Z
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20 (MC1DN20) · ACAD9 DEFICIENCY; ACYL CoA DEHYDROGENASE 9 DEFICIENCY; ACAD9 · ICD-10 E71.3 · ICD-11 5C54.2
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21 (MC1DN21) · NUBPL · ICD-10 G71.3 · ICD-11 5A51.0
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22 (MC1DN22) · NDUFA10 · ICD-10 G31.8 · ICD-11 LD28.2
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23 (MC1DN23) · NDUFA12 · ICD-10 G31.8 · ICD-11 5C53.2Y
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24 (MC1DN24) · NDUFB9 · ICD-10 G71.3 · ICD-11 9C40.8
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25 (MC1DN25) · NDUFB3 · ICD-10 G71.3 · ICD-11 BC43.00
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26 (MC1DN26) · NDUFA9 · ICD-10 G31.8 · ICD-11 LD28.2
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27 (MC1DN27) · MTFMT · ICD-10 G31.8 · ICD-11 LD2H.Y
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28 (MC1DN28) · NDUFA13 · ICD-10 G31.8 · ICD-11 5C53.2Y
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29 (MC1DN29) · TMEM126B · ICD-10 G71.3 · ICD-11 5C55.0Y
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3 (MC1DN3) · NDUFS7 · ICD-10 G71.3 · ICD-11 5C53.2Y
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30 (MC1DN30) · NDUFB11 · ICD-10 G71.3 · ICD-11 6A0Y
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31 (MC1DN31) · TIMMDC1 · ICD-10 G71.3 · ICD-11 5C50.E0
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32 (MC1DN32) · NDUFB8 · ICD-10 G31.8 · ICD-11 GB41
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33 (MC1DN33) · NDUFA6 · ICD-10 G71.3 · ICD-11 5C53.Y
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 34 (MC1DN34) · NDUFAF8 · ICD-10 G71.3 · ICD-11 5C5Y
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 35 (MC1DN35) · ICD-10 G71.3 · ICD-11 5A00.01
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 36 (MC1DN36) · NDUFC2 · ICD-10 G71.3 · ICD-11 8A62.Y
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 37 (MC1DN37) · NDUFA8 · ICD-10 G71.3 · ICD-11 8A62.Y
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 39 (MC1DN39) · NDUFB7 · ICD-10 G71.3 · ICD-11 8A62.1
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4 (MC1DN4) · NDUFV1 · ICD-10 G71.3 · ICD-11 LD20.01
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5 (MC1DN5) · NDUFS1 · ICD-10 G71.3 · ICD-11 8A61.11
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6 (MC1DN6) · NDUFS2 · ICD-10 G31.8 · ICD-11 8B44.00
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7 (MC1DN7) · NDUFV2 · ICD-10 G71.3 · ICD-11 8A62.Z
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8 (MC1DN8) · NDUFS3 · ICD-10 G31.8 · ICD-11 5C53.21
- MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9 (MC1DN9) · NDUFS6 · ICD-10 G71.3 · ICD-11 LD24.20
- MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 1 (MC2DN1) · SUCCINATE CoQ REDUCTASE DEFICIENCY; SDHA; SDHD; SDHAF1 · ICD-10 G71.3 · ICD-11 5C50.E0
- MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 2 (MC2DN2) · SDHAF1 · ICD-10 G71.3 · ICD-11 8A62.Y
- MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 3 (MC2DN3) · SDHD · ICD-10 G71.3 · ICD-11 8A61.2Y
- MITOCHONDRIAL COMPLEX II DEFICIENCY, NUCLEAR TYPE 4 (MC2DN4) · ICD-10 G71.3 · ICD-11 5C53.2Y
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1 (MC3DN1) · BCS1 · ICD-10 G71.3 · ICD-11 LD2C
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 10 (MC3DN10) · ICD-10 G71.3 · ICD-11 8A62.Y
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 11 (MC3DN11) · ICD-10 G71.3 · ICD-11 5C55.0Z
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2 (MC3DN2) · ICD-10 G71.3 · ICD-11 8A62.Y
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3 (MC3DN3) · ICD-10 G71.3 · ICD-11 MB53.0
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4 (MC3DN4) · UQCRQ · ICD-10 G71.3 · ICD-11 5C53.2Y
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5 (MC3DN5) · ICD-10 G71.3 · ICD-11 5C53.2Y
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6 (MC3DN6) · CYC1 · ICD-10 G71.3 · ICD-11 LD27.2
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7 (MC3DN7) · UQCC2 · ICD-10 G71.3 · ICD-11 5C53.2Y
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8 (MC3DN8) · ICD-10 G71.3 · ICD-11 8A62.Y
- MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9 (MC3DN9) · UQCC3 · ICD-10 G71.3 · ICD-11 5C53.24
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 1 (MC4DN1) · CYTOCHROME c OXIDASE DEFICIENCY; SURF1 · ICD-10 E88.8 · ICD-11 5C53.2Y
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 10 (MC4DN10) · C12ORF62 · ICD-10 E88.8 · ICD-11 6A0Z
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 11 (MC4DN11) · ICD-10 E88.8 · ICD-11 SM37
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 12 (MC4DN12) · PET100 · ICD-10 E88.8 · ICD-11 DA90.Y
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 13 (MC4DN13) · COA6 · ICD-10 G71.3 · ICD-11 LD24.Z
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 14 (MC4DN14) · COA3 · ICD-10 E88.8 · ICD-11 8A03.1Z
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 15 (MC4DN15) · ICD-10 E88.8 · ICD-11 8C76
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 16 (MC4DN16) · ICD-10 E88.8 · ICD-11 LD2F.00
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 17 (MC4DN17) · ICD-10 E88.8 · ICD-11 5C55.2
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 18 (MC4DN18) · ICD-10 E88.8 · ICD-11 5C55.2
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 19 (MC4DN19) · PET117 CYTOCHROME c OXIDASE CHAPERONE; PET117 · ICD-10 E88.8 · ICD-11 5C53.20
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 2 (MC4DN2) · FATAL INFANTILE CYTOCHROME C OXIDASE DEFICIENCY; SCO2 · ICD-10 G71.3 · ICD-11 LD2Z
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 20 (MC4DN20) · CYTOCHROME C OXIDASE SUBUNIT 5A DEFICIENCY; COX5A · ICD-10 E88.8 · ICD-11 LD20.0Y
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 21 (MC4DN21) · ICD-10 G31.8 · ICD-11 5C55.2
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 22 (MC4DN22) · ICD-10 E88.8 · ICD-11 5C55.2
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 23 (MC4DN23) · ICD-10 E88.8 · ICD-11 8A61.1Y
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 24 (MC4DN24) · ICD-10 E88.8 · ICD-11 5C55.2
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 25 (MC4DN25) · ICD-10 E88.8 · ICD-11 5C55.2
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 3 (MC4DN3) · COX10 · ICD-10 E88.8 · ICD-11 8A03.Z
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 4 (MC4DN4) · SCO1 · ICD-10 E88.8 · ICD-11 BC43.00
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 5 (MC4DN5) · LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC; LRPPRC · ICD-10 G31.88 · ICD-11 LD90.Y
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 6 (MC4DN6) · CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2: COX15 · ICD-10 G71.3 · ICD-11 8C73.Z
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 7 (MC4DN7) · COX6B1 · ICD-10 E88.8 · ICD-11 6A00.Z
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 8 (MC4DN8) · TACO1 · ICD-10 E88.8 · ICD-11 6A00.Z
- MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 9 (MC4DN9) · CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 3; COA5 · ICD-10 G71.3 · ICD-11 9C83.11
- MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY (MC5DN1) · ATP SYNTHASE DEFICIENCY · ICD-10 E88.8 · ICD-11 5B81.Y
- MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2 (MC5DN2) · ENCEPHALOCARDIOMYOPATHY, MITOCHONDRIAL, NEONATAL, DUE TO ATP SYNTHASE DEFICIENCY; TMEM70 · ICD-10 G71.3 · ICD-11 5C5Y
- MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3 (MC5DN3) · ATP5E · ICD-10 E88.8 · ICD-11 LD27.2
- MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4 (MC5DN4) · ATP5A1 · ICD-10 E88.8 · ICD-11 GB41
- MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4A (MC5DN4A) · ICD-10 E88.8 · ICD-11 5C53.25
- MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5 (MC5DN5) · MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, ATP5F1D TYPE · ICD-10 E88.8 · ICD-11 5C53.2Y
- MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 6 (MC5DN6) · ICD-10 E88.8 · ICD-11 5C53.25
- MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 7 (MC5DN7) · ICD-10 E88.8 · ICD-11 5C53.25
- MITOCHONDRIAL DNA DEPLETION SYNDROME 1, MNGIE (MTDPS1) · MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY SYNDROME; TYMP · ICD-10 G71.3 · ICD-11 5A45
- MITOCHONDRIAL DNA DEPLETION SYNDROME 11 (MTDPS11) · MGME1 · ICD-10 G71.3 · ICD-11 9B70
- MITOCHONDRIAL DNA DEPLETION SYNDROME 12A, CARDIOMYOPATHIC TYPE, AUTOSOMAL DOMINANT (MTDPS12A) · SLC25A4 · ICD-10 Q78.8 · ICD-11 3A10.Y
- MITOCHONDRIAL DNA DEPLETION SYNDROME 12B, CARDIOMYOPATHIC TYPE, AUTOSOMAL RECESSIVE (MTDPS12B) · SLC25A4 · ICD-10 Q87.8 · ICD-11 4A01.10
- MITOCHONDRIAL DNA DEPLETION SYNDROME 13, ENCEPHALOMYOPATHIC TYPE (MTDPS13) · FBXL4 DEFICIENCY · ICD-10 E88.8 · ICD-11 GB90.4Y
- MITOCHONDRIAL DNA DEPLETION SYNDROME 14, CARDIOENCEPHALOMYOPATHIC TYPE (MTDPS14) · OPA1 · ICD-10 Q78.8 · ICD-11 GB90.4Y
- MITOCHONDRIAL DNA DEPLETION SYNDROME 15, HEPATOCEREBRAL TYPE (MTDPS15) · TFAM · ICD-10 E88.8 · ICD-11 8A60.Z
- MITOCHONDRIAL DNA DEPLETION SYNDROME 16, HEPATIC TYPE (MTDPS16) · ICD-10 E88.8 · ICD-11 5C53.2Y
- MITOCHONDRIAL DNA DEPLETION SYNDROME 17 (MTDPS17) · ICD-10 E88.8 · ICD-11 5C53.25
- MITOCHONDRIAL DNA DEPLETION SYNDROME 18 (MTDPS18) · SLC25A21 · ICD-10 E88.8 · ICD-11 LD90.Y
- MITOCHONDRIAL DNA DEPLETION SYNDROME 19 (MTDPS19) · ICD-10 E88.8
- MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MTDPS2) · MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE); TK2 · ICD-10 G71.3 · ICD-11 5A45
- MITOCHONDRIAL DNA DEPLETION SYNDROME 20 (MTDPS20) · MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY SYNDROME, LIG3-RELATED · ICD-10 G71.3
- MITOCHONDRIAL DNA DEPLETION SYNDROME 21 (MTDPS21) · ICD-10 E88.8
- MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (MTDPS3) · DEOXYGUANOSINE KINASE DEFICIENCY · ICD-10 E88.8 · ICD-11 5C73.Z
- MITOCHONDRIAL DNA DEPLETION SYNDROME 4A, ALPERS TYPE (MTDPS4A) · ALPERS-HUTTENLOCHER SYNDROME; POLG · ICD-10 G31.88 · ICD-11 5C59.01
- MITOCHONDRIAL DNA DEPLETION SYNDROME 4B, MNGIE TYPE (MTDPS4B) · MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY SYNDROME, POLG-RELATED · ICD-10 G71.3 · ICD-11 5C63.1
- MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (MTDPS5) · ENCEPHALOMYOPATHIC FORM, WITH OR WITHOUT METHYLMALONIC ACIDURIA; SUCLA2 Deficiency · ICD-10 G71.3 · ICD-11 5C57.0
- MITOCHONDRIAL DNA DEPLETION SYNDROME 6, HEPATOCEREBRAL TYPE (MTDPS6) · NAVAJO NEUROHEPATOPATHY; NNH; MPV17 · ICD-10 E88.8 · ICD-11 2A0Z
- MITOCHONDRIAL DNA DEPLETION SYNDROME 7; HEPATOCEREBRAL TYPE (MTDPS7) · SPINOCEREBELLAR ATAXIA, INFANTILE-ONSET; IOSCA; C10ORF2; TWNK · ICD-10 G11.1 · ICD-11 5A61.0
- MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY) (MTDPS8A) · MITOCHONDRIAL DNA DEPLETION SYNDROME 8B (MNGIE TYPE), INCLUDED; MTDPS8B, INCLUDED;RRM2 · ICD-10 G31.8 · ICD-11 5C56.20
- MITOCHONDRIAL DNA DEPLETION SYNDROME 9, ENCEPHALOMYOPATHIC TYPE WITH METHYLMALONIC ACIDURIA (MTDPS9) · CONGENITAL LACTIC ACIDOSIS; SUCGL1 · ICD-10 E71.1 · ICD-11 5C53.20
- MITOCHONDRIAL DNA DEPLETION SYNDROME, HEPATOCEREBRAL · MICOS10 · ICD-10 E88.8
- MITOCHONDRIAL DNA DEPLETION SYNDROME, NEW TYPE (GUK1) · GUANYLATE KINASE 1 DEFICIENCY; GUK1 · ICD-10 E88.8 · ICD-11 LD24.3
- MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME SPECTRUM · MATERNALLY-INHERITED LEIGH DISEASE (MILS) · ICD-10 G31.8 · ICD-11 8C73.Y
- MITOCHONDRIAL MYOPATHY WITH DIABETES · MITOCHONDRIAL MYOPATHY, LIPID TYPE; MTTE · ICD-10 G71.3 · ICD-11 3A02.Y
- MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS (MMLA) · MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME · ICD-10 G71.3 · ICD-11 8C73.Y
- MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY (MEOAL) · FDX2 · ICD-10 G71.3 · ICD-11 5C53.24
- MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY · SLC25A3 · ICD-10 G71.3 · ICD-11 5C64.10
- MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY (MPYCD) · BRP44L · ICD-10 E74.4 · ICD-11 5C50.B
- MITOCHONDRIAL RIBOSOMAL PROTEIN S36 (MRPS36) · KGD4 · ICD-10 E88.8 · ICD-11 8A62.Y
- MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY (SCEH) · ECHS1 · ICD-10 G31.8 · ICD-11 5C56.1
- MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY (MTPD) · HYDROXYACYL-CoA DEHYDROGENASE/3-KETOACYL-CoA THIOLASE/ENOYL-CoA HYDRATASE, ALPHA SUBUNIT; HADHA · ICD-10 G71.3 · ICD-11 5C51.3
- MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY (MTPD, HADHB) · HYDROXYACYL-CoA DEHYDROGENASE/3-KETOACYL-CoA THIOLASE/ENOYL-CoA HYDRATASE, BETA SUBUNIT · ICD-10 G71.3 · ICD-11 8C73.Y
- MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY 2 (MTPD2) · MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY 2 · ICD-10 G71.3
- MITOCHONDRIAL tRNA(Phe) DEFICIENCY (MT-TF) · MTTF · ICD-10 G71.3 · ICD-11 8C73.Z
- MITOCHONDRIAL-ENCEPHALOPATHY-LACTIC ACIDOSIS-STROKE (MELAS) · MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKELIKE EPISODES · ICD-10 G31.81 · ICD-11 8C73.Y
- MOHR-TRANEBJAERG SYNDROME (MTS) · DYSTONIA-DEAFNESS SYNDROME; DDS; JENSEN SYNDROME; TIMM8A · ICD-10 G31.81 · ICD-11 DA96.04
- MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A (MOCODA) · SULFITE OXIDASE, XANTHINE DEHYDROGENASE, AND ALDEHYDE OXIDASE, COMBINED DEFICIENCY OF · ICD-10 E72.1 · ICD-11 5C50.B
- MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B (MOCODB) · MOLYBDENUM COFACTOR DEFICIENCY B · ICD-10 E72.1 · ICD-11 LD90.Y
- MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C (MOCODC) · MOLYBDENUM COFACTOR DEFICIENCY C · ICD-10 E72.1 · ICD-11 8A60.Z
- MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY · MCT1; SLC16A1; GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME (GLUT1-DS) · ICD-10 E88.8 · ICD-11 5A44
- MORFAN SYNDROME · ICD-10 E88.9 · ICD-11 5A61.0
- MUCOLIPIDOSIS II · I CELL DISEASE · ICD-10 E77.0 · ICD-11 5C56.20
- MUCOLIPIDOSIS III ALPHA/BETA · PSEUDO-HURLER POLYDYSTROPHIA · ICD-10 E77.0 · ICD-11 5C56.20
- MUCOLIPIDOSIS III GAMMA · MUCOLIPIDOSIS III, COMPLEMENTATION GROUP C · ICD-10 E77.0 · ICD-11 BA04.Y
- MUCOLIPIDOSIS IV · SIALOLIPIDOSIS · ICD-10 E75.1 · ICD-11 6A00.Z
- MUCOPOLYSACCHARIDOSIS I-H; HURLER SYNDROME (MPS1-H) · MPS1-H, IDUA · ICD-10 E76.0 · ICD-11 5C56.30
- MUCOPOLYSACCHARIDOSIS I-S; SCHEIE SYNDROME · MPS1-S; IDUA · ICD-10 E76.0 · ICD-11 5C56.30
- MUCOPOLYSACCHARIDOSIS II; HUNTER SYNDROME · MPS2; IDS · ICD-10 E76.1 · ICD-11 5C56.31
- MUCOPOLYSACCHARIDOSIS III; SAN FILIPPO A SYNDROME · MPS3A; SGSH · ICD-10 E76.2 · ICD-11 5C56.3Y
- MUCOPOLYSACCHARIDOSIS III; SAN FILIPPO B SYNDROME · MPS3B; NAGLU · ICD-10 E76.2 · ICD-11 5C56.3Y
- MUCOPOLYSACCHARIDOSIS III; SAN FILIPPO C SYNDROME · MPS3C; HGSNAT · ICD-10 E76.2 · ICD-11 5C56.3Y
- MUCOPOLYSACCHARIDOSIS III; SAN FILIPPO D SYNDROME · MPS3D; GNS · ICD-10 E76.2 · ICD-11 5C56.3Y
- MUCOPOLYSACCHARIDOSIS IV; MORQUIO A SYNDROME · MPS4A; GALNS · ICD-10 E76.2 · ICD-11 5C56.32
- MUCOPOLYSACCHARIDOSIS IV; MORQUIO B SYNDROME · MPS4B; GLB1 · ICD-10 E76.2 · ICD-11 5C56.32
- MUCOPOLYSACCHARIDOSIS IX; HYALURONIDASE DEFICIENCY · MPS9; HYAL1 · ICD-10 E76.2 · ICD-11 8E4Y
- MUCOPOLYSACCHARIDOSIS TYPE IH/S; HURLER-SCHEIE SYNDROME · MPS1-HS; IDUA · ICD-10 E76.0 · ICD-11 5C53.2Y
- MUCOPOLYSACCHARIDOSIS VI; MAROTEAUX-LAMY SYNDROME · MPS6; ARSB · ICD-10 E76.2 · ICD-11 5C56.33
- MUCOPOLYSACCHARIDOSIS VII; SLY SYNDROME · MPS7; GUSB · ICD-10 E76.2 · ICD-11 5C56.3Y
- MUCOPOLYSACCHARIDOSIS X; ARYLSULFATASE K DEFICIENCY · MPS10; ARSK DEFICIENCY · ICD-10 E76.2 · ICD-11 6A00.Z
- MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME (MPSPS) · VPS33A · ICD-10 E76.2 · ICD-11 5C51.3
- MULTIPLE CARBOXYLASE DEFICIENCY, NEONATAL OR EARLY ONSET FORM (HLCS) · HOLOCARBOXYLASE SYNTHETASE DEFICIENCY · ICD-10 E53.8 · ICD-11 5C50.E0
- MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1 (MCAHS1) · GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 3; GPIBD3; PIGN · ICD-10 Q87.8 · ICD-11 5C57.0
- MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2 (MCAHS2) · EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 20; EIEE20; PIGA-CDG; PIGA · ICD-10 Q87.8 · ICD-11 5C57.0
- MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3 (MCAHS3) · PIGT-CDG; PIGT · ICD-10 Q87.8 · ICD-11 LD21.0
- MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 4 (MCAHS4) · EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 77; DEE77; EIEE77 · ICD-10 G40.3 · ICD-11 8A62.0
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1 (MMDS1) · NFU1 · ICD-10 E88.8 · ICD-11 9B70
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 10 (MMDS10) · ICD-10 E88.8 · ICD-11 8A62.Y
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA (MMDS2) · BOLA3 · ICD-10 E88.8 · ICD-11 5C80.00
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3 (MMDS3) · IBA57 · ICD-10 E88.8 · ICD-11 5C81.1
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4 (MMDS4) · ISCA2 · ICD-10 E88.8 · ICD-11 5C80.2
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5 (MMDS5) · ISCA1 · ICD-10 E88.8 · ICD-11 5C80.3
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6 (MMDS6) · PMPCB · ICD-10 E88.8 · ICD-11 5C80.3
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 7 (MMDS7) · ICD-10 E88.8 · ICD-11 8A62.Y
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 8 (MMDS8) · MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL; FDX2 · ICD-10 E88.8 · ICD-11 8A62.Y
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 9A (MMDS9A) · AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA; FDXR · ICD-10 E88.8 · ICD-11 8A62.Y
- MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 9B (MMDS9B) · FDXR · ICD-10 E88.8 · ICD-11 8A61.1Y
- MULTIPLE SULFATASE DEFICIENCY (MSD) · SULFATIDOSIS, JUVENILE, AUSTIN TYPE; SULFATASE DEFICIENCY, MULTIPLE; SUMF1 · ICD-10 E75.2 · ICD-11 5C50.4
- MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY (MDCCAID) · INPP5K · ICD-10 G71.08 · ICD-11 LD90.Y
- MUSCULAR DYSTROPHY, CONGENITAL, WITH OR WITHOUT SEIZURES (MYOS) · ICD-10 G71.8
- MUSCULAR DYSTROPHY, LIMB-GIRDLE (LGMDR28) · MYOPATHY, LIMB-GIRDLE, ADULT-ONSET; MYPLG · ICD-10 G71.08 · ICD-11 8A61.12
- MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (MDDGA14) · MUSCLE-EYE-BRAIN DISEASE; GMPPB-CDG · ICD-10 G71.0 · ICD-11 8C70.6
- MYASTHENIC SYNDROME, CONGENITAL, 15 (CMS15) · ALG14-CDG · ICD-10 G70.2
- MYOADENYLATE DEAMINASE DEFICIENCY (AMPDA) · MYOADENYLATE DEAMINASE DEFICIENCY, MYOPATHY DUE TO; MYOPATHY-METABOLIC, MYOADENYLATE DEAMINASE DEFICIENCY · ICD-10 G71.3 · ICD-11 5C55.0Y
- MYOCLONIC EPILEPSY AND RAGGED RED FIBER DISEASE (MERRF) · MERRF SYNDROME; FUKUHARA SYNDROME · ICD-10 G71.3 · ICD-11 LD2C
- MYOCLONIC EPILEPSY, FAMILIAL INFANTILE (FIME) · ICD-10 Q04.8
- MYOGLOBINURIA, ACUTE RECURRENT, AUTOSOMAL RECESSIVE (LPIN1) · LPIN1 · ICD-10 R82.1 · ICD-11 GB90.43
- MYOPATHY DUE TO MALATE-ASPARTATE SHUTTLE DEFECT · ICD-10 E88.8 · ICD-11 8C73.Y
- MYOPATHY OR CARDIOMYOPATHY DUE TO DESMIN DEFECT · DESMIN-RELATED MYOPATHY · ICD-10 G71.8 · ICD-11 8C76
- MYOPATHY WITH EXTRAPYRAMIDAL SIGNS (MPXPS) · ICD-10 G71.3
- MYOPATHY WITH LACTIC ACIDOSIS, HEREDITARY (HML, ISCU) · ISCU MYOPATHY; MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE · ICD-10 G71.3 · ICD-11 PL0Z
- MYOPATHY WITH RIMMED UBIQUITIN-POSITIVE AUTOPHAGIC VACUOLATION, AUTOSOMAL DOMINANT (MRUPAV) · VACUOLAR NEUROMYOPATHY · ICD-10 G71.8
- MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1 (MLASA1) · MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA; PUS1 · ICD-10 G71.3 · ICD-11 4A01.1Y
- MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2 (MLASA2) · YARS2 · ICD-10 G71.3 · ICD-11 5C56.0Y
- MYOPATHY, MITOCHONDRIAL, AND ATAXIA (MMYAT) · MSTO1 · ICD-10 G71.3 · ICD-11 5C53.2Y
- N-ACETYLASPARTYLGLUTAMATE ACCUMULATION · ICD-10 E88.8 · ICD-11 5C56.1
- N-ACETYLGLUTAMATE SYNTHETASE DEFICIENCY (NAGSD) · HYPERAMMONEMIA III; N-ACETYLGLUTAMATE SYNTHETASE DEFICIENCY · ICD-10 E72.2 · ICD-11 5C56.00
- NARP SYNDROME · NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA; MTATP6 · ICD-10 E88.8 · ICD-11 5C50.E0
- NEONATAL CHOLESTASIS (NC) [DD] · ICD-10 K71.0 · ICD-11 8A62
- NEONATAL DIABETES MELLITUS, ENTEROPATHY, THROMBOCYTOPENIA AND ENDOCRINOPATHY (IPEX) · FOXP3 · ICD-10 E31.0 · ICD-11 DB91.1
- NEPHROTIC SYNDROME, TYPE 14 (NPHS14) · SPHINGOSINE PHOSPHATE LYASE INSUFFICIENCY SYNDROME; SGPL1 · ICD-10 E88.8 · ICD-11 4A01.1Y
- NEPHROTIC SYNDROME, TYPE 7 (NPHS7) · HEMOLYTIC UREMIC SYNDROME, ATYPICAL; DGKE · ICD-10 D59.3 · ICD-11 5D2Z
- NEU-LAXOVA SYNDROME 1; NLS1 (PHGDH) · ICD-10 Q87.8 · ICD-11 GB41
- NEU-LAXOVA SYNDROME 2; NLS2 (PSAT) · ICD-10 Q87.8 · ICD-11 5C53.22
- NEUROBLASTOMA, SUSCEPTIBILITY TO [DD] · NEUROBLASTOMA · ICD-10 C74.9 · ICD-11 5C56.2Z
- NEURODEGENERATION AND SEIZURES DUE TO COPPER TRANSPORT DEFECT (NSCT) · ICD-10 G23.0
- NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET (NADGP) · SQSTM1 · ICD-10 G11.9 · ICD-11 5C53.2Y
- NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1 (NBIA1) · PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION; PANK2 · ICD-10 G23.0 · ICD-11 PL0Z
- NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4 (NBIA4) · MITOCHONDRIAL PROTEIN-ASSOCIATED NEURODEGENERATION; MPAN · ICD-10 G23.0
- NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5 (NBIA5) · BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; WDR45 · ICD-10 G23.0 · ICD-11 5A00.01
- NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6 (NBIA6) · ICD-10 G23.0
- NEURODEGENERATION, CHILDHOOD-ONSET, WITH ATAXIA, TREMOR, OPTIC ATROPHY, AND COGNITIVE DECLINE (CONATOC) · ICD-10 G11.9
- NEURODEGENERATION, CHILDHOOD-ONSET, WITH MULTISYSTEM INVOLVEMENT DUE TO MITOCHONDRIAL DYSFUNCTION (CONDMIM) · SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION · ICD-10 G11.9 · ICD-11 8A62.0
- NEURODEGENERATION, INFANTILE-ONSET, BIOTIN-RESPONSIVE (NERIB) · SOLUTE CARRIER FAMILY 5 (SODIUM-DEPENDENT VITAMIN TRANSPORTER), MEMBER 6; SLC5A6 · ICD-10 G11.9 · ICD-11 5C53.2Y
- NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES (NEDLBA) · HOUGE-JANSSENS SYNDROME 3; HJS3 · ICD-10 F84.8
- NEURODEVELOPMENTAL DISORDER WITH BRAIN ABNORMALITIES, POOR GROWTH, AND DYSMORPHIC FACIES (NEDBGF) · ADAT3 · ICD-10 H50.8 · ICD-11 5C64.5
- NEURODEVELOPMENTAL DISORDER WITH CARDIOMYOPATHY, SPASTICITY, AND BRAIN ABNORMALITIES (NEDCASB) · ICD-10 E88.8 · ICD-11 LD20.01
- NEURODEVELOPMENTAL DISORDER WITH DEVELOPMENTAL DELAY AND INFANTILE SPASM · ICD-10 G40.4 · ICD-11 8A62.Y
- NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND BRAIN ATROPHY (NEDEBA) · ICD-10 F84.8
- NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND AUTISTIC FEATURES WITH OR WITHOUT HYPERKINETIC MOVEMENTS (NEDHAHM) · VAMP2 · ICD-10 F84.8 · ICD-11 LD2F.1Y
- NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ABSENT SPEECH, AND HYPOTONIA (NEDMISH) · ICD-10 E88.8 · ICD-11 6A0Y
- NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES (NEDMAS) · Seryl-tRNA synthetase 1 deficiency, SARS1 · ICD-10 F70, F71, F72, F73 · ICD-11 8A62.Y
- NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION (NEDMEHM) · 5,10-METHENYLTETRAHYDROFOLATE SYNTHETASE DEFICIENCY (MTHFS) · ICD-10 E88.8 · ICD-11 5C50.Y
- NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, IMPAIRED LANGUAGE, AND GAIT ABNORMALITIES (NEDMILG) · ICD-10 F84.8
- NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, IMPAIRED LANGUAGE, EPILEPSY, AND GAIT ABNORMALITIES (NEDMILEG) · ICD-10 F84.8
- NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY (NDMSCA) · VARS1 · ICD-10 F84.8 · ICD-11 5C53.22
- NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT (NDHMSD) · ICD-10 F70-F73 · ICD-11 LD90.Y
- NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE (NDHMSR) · ICD-10 F70 , F73 , F72 , F71
- NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT, ABSENT LANGUAGE, CEREBRAL HYPOMYELINATION, AND BRAIN ATROPHY; · TAF8 · ICD-10 F84.8 · ICD-11 8A62.Y
- NEURODEVELOPMENTAL DISORDER WITH SPASTICITY, HYPOPLASIA OF THE CORPUS CALLOSUM, AND RECURRENT INFECTIONS (NEDSCI) · ICD-10 E88.8
- NEURODEVELOPMENTAL DISORDER WITH STRUCTURAL BRAIN ABNORMALITIES AND CRANIOFACIAL ABNORMALITIES (NEDBAC) · ICD-10 E88.8 · ICD-11 6A0Y
- NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES · NEMMLAS; WARS2 · ICD-10 F70-F73 · ICD-11 5C55.2
- NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET (IMNEPD1) · PTRH2 · ICD-10 Q87.8 · ICD-11 8C73.Y
- NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 11 (HMND11) · DHMN11 · ICD-10 G64
- NEUROOCULAR SYNDROME 1 (NOC1) · ICD-10 Q87.8
- NEUROOCULAR SYNDROME 2, PAROXYSMAL TYPE (NOC2) · DAGLA DEFICIENCY · ICD-10 G96.8
- NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE (HMSNR) · CHARCOT-MARIE-TOOTH DISEASE, TYPE 4G; CMT4G; HK1 · ICD-10 G60.0 · ICD-11 5A45
- NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY (NLSDM) · NEUTRAL LIPID STORAGE DISEASE WITHOUT ICHTHYOSIS; PNPLA2 · ICD-10 E75.5 · ICD-11 5C60.Z
- NEUTROPENIA, SEVERE CONGENITAL, 9, AUTOSOMAL DOMINANT (SCN9) · ICD-10 D70
- NEWBORNS, PREMATURE INFANTS, TRANSIENT IMMATURITY OF TRANSPORT SYSTEMS OR ENZYMES [DD] · ICD-10 P74.9 · ICD-11 5C58.00
- NICOTINAMIDE ADENINE DINUCLEOTIDE DEFICIENCY · VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 3; VCRL3 · ICD-10 Q87.8 · ICD-11 6A02
- NIEMANN-PICK DISEASE TYPE A · ICD-10 E75.2 · ICD-11 5C56.0Y
- NIEMANN-PICK DISEASE TYPE B · ICD-10 E75.2 · ICD-11 5C55.0Y
- NIEMANN-PICK DISEASE TYPE C1 (NPC1) · ICD-10 E75.2 · ICD-11 KB23.0Z
- NIEMANN-PICK DISEASE, TYPE C2 (NPC2) · ICD-10 E75.2 · ICD-11 LD24.04
- NO METABOLIC DISEASE / ENDOCRINE DISORDER [DD] · ICD-11 3A10.0Y
- NONALCOHOLIC FATTY LIVER DISEASE [DD] · NAFLD · ICD-10 K76.0 · ICD-11 5C56.1
- NOVEL NEURODEVELOPMENTAL SYNDROME (RABGAP1) · ICD-10 F84.8 · ICD-11 LD90.Y
- NPTN-RELATED NEURODEVELOPMENTAL DISORDER (NEW) · ICD-10 E88.8
- NUCLEOTIDE DEPLETION SYNDROME · ICD-10 G71.3 · ICD-11 5C50.E1
- NUTRITION:COFFFEE CONSUMPTION [DD] · ICD-11 8A03.1Y
- O-FUCOSE-SPECIFIC BETA-1,3-N-GLUCOSYLTRANSFERASE DEFICIENCY · PETERS-PLUS SYNDROME; PTRPLS; B3GALTL-CDG · ICD-10 Q13.8 · ICD-11 5C50.G
- OBESITY [DD] · LEANNESS, INCLUDED · ICD-10 E66.8 · ICD-11 LD90.Y
- OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY · OBESITY AND ENDOCRINOPATHY DUE TO IMPAIRED PROCESSING OF PROHORMONES; PCSK1 · ICD-10 E66.8 · ICD-11 5C53.23
- OCCIPITAL HORN SYNDROME · EHLERS DANLOS SYNDROME TYPE IX; CUTIS LAXA, X-LINKED; ATP7A · ICD-10 E83.0 · ICD-11 5C55.1
- OCULOCEREBRORENAL SYNDROME OF LOWE · LOWE OCULOCEREBRORENAL SYNDROME; OCRL · ICD-10 E72.0 · ICD-11 5C53.2Y
- ODONTOCHONDRODYSPLASIA 1 (ODCD1) · GOLDBLATT SYNDROME · ICD-10 Q78.8 · ICD-11 LD24.2Y
- OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY (OPA1) · DOMINANT OPTIC ATROPHY PLUS SYNDROME; DOA+; OPA1 · ICD-10 H47.2 · ICD-11 5C53.2Y
- ORNITHINE TRANSCARBAMYLASE DEFICIENCY (OTC) · ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY; OTC DEFICIENCY · ICD-10 E72.4 · ICD-11 5C50.AY
- OROTIC ACIDURIA, HEREDITARY (HOA) · OROTIC ACIDURIA I; UMPS · ICD-10 E79.8 · ICD-11 3A03.0
- OSTEOGENESIS IMPERFECTA, TYPE I (OI1) · OSTEOGENESIS IMPERFECTA WITH BLUE SCLERAE; COL1A1 · ICD-10 Q78.0 · ICD-11 5C53.2Y
- OSTEOGENESIS IMPERFECTA, TYPE II (OI2) · COL1A2 · ICD-10 Q78.0
- PAGANINI-MIOZZO SYNDROME (MRXSPM) · MENTAL RETARDATION, X-LINKED, SYNDROMIC, PAGANINI-MIOZZO TYPE · ICD-10 F84.8 · ICD-11 LD2F.1Y
- PARKINSONISM-DYSTONIA, INFANTILE, 1 (PKDYS1) · DOPAMINE TRANSPORTER DEFICIENCY SYNDROME (DTDS); SLC6A3 · ICD-10 G24.8 · ICD-11 5C50.AY
- PARKINSONISM-DYSTONIA, INFANTILE, 2 (PKDYS2) · SOLUTE CARRIER FAMILY 18 (VESICULAR MONOAMINE), MEMBER 2; SLC18A2 · ICD-10 G25.8 · ICD-11 3A10.Y
- PATENT DUCTUS VENOSUS [DD] · INTRAHEPATIC PORTOSYSTEMIC VENOUS SHUNT; PDV · ICD-10 Q26.8 · ICD-11 5C53.20
- PCBP1-RELATED NEURODEVELOPMENTAL DISORDER (NEW) · ICD-10 E88.8
- PEARSON SYNDROM (PS) · PEARSON MARROW-PANCREAS SYNDROME · ICD-10 D64.0 · ICD-11 KA60
- PELIZAEUS MERZBACHER DISEASE · PROTEOLIPID PROTEIN, MYELIN; PELIZAEUS-MERZBACHER SYNDROME · ICD-10 E75.2 · ICD-11 5A73
- PELLAGRA-LIKE SYNDROME · ICD-10 E64.9 · ICD-11 8A62.0
- PENDRED SYNDROME (PDS) · THYROID HORMONOGENESIS, GENETIC DEFECT IN, IIB THYROID HORMONE ORGANIFICATION DEFECT IIB DEAFNESS WITH GOITER GOITER-; S · ICD-10 E07.1 · ICD-11 5C50.E1
- PENTOSURIA; ESSENTIAL BENIGN PENTOSURIA (PNTSU) · DCXR · ICD-10 E74.8 · ICD-11 5C51.0
- PEROXISOMAL DISORDERS, NEW TYPE, LIVER · ICD-10 E71.3 · ICD-11 LD2H.Y
- PEROXISOME BIOGENESIS DISORDER 1A (PBD1A) · ZELLWEGER SYNDROME; PEX1 · ICD-10 Q87.8 · ICD-11 5C57.0
- PEROXISOME BIOGENESIS DISORDER 1B (PBD1B, NALD) · ADRENOLEUKODYSTROPHY/INFANTILE REFSUM DISEASE); PEX1 · ICD-10 E71.3 · ICD-11 LD44.N0
- PEROXISOME BIOGENESIS DISORDER 2A (PBD2A) · ICD-10 E71.3 · ICD-11 8A62.Y
- PEROXISOME BIOGENESIS DISORDER 2B (PBD2B) · ADRENOLEUKODYSTROPHY, NEONATAL; PEX5 · ICD-10 E71.3 · ICD-11 5C55.0Y
- PEROXISOME BIOGENESIS DISORDER 3A (PBD3A) · PEX12 · ICD-10 Q87.8 · ICD-11 BA04.Y
- PEROXISOME BIOGENESIS DISORDER 3B (PBD3B) · INFANTILE REFSUMS DISEASE; PEX12 · ICD-10 G60.1 · ICD-11 5C57.1
- PEROXISOME BIOGENESIS DISORDER 4A (PBD4A) · ZELLWEGER; PEX6 · ICD-10 Q87.8 · ICD-11 8A62.Y
- PEROXISOME BIOGENESIS DISORDER 4B (PBD4B) · PEX6 · ICD-10 E71.3 · ICD-11 5C53.2Y
- PERRAULT SYNDROME 1 (PRLTS1) · OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS; HSD17B4 · ICD-10 Q87.8 · ICD-11 5C53.20
- PERRAULT SYNDROME 2 (PRLTS2) · HARS2 · ICD-10 Q87.8 · ICD-11 3A73
- PERRAULT SYNDROME 3 (PRLTS3) · FORMERLY DEAFNESS, AUTOSOMAL RECESSIVE 81 · ICD-10 Q87.8 · ICD-11 5C53.20
- PERRAULT SYNDROME 4 (PRLTS4) · LARS2 · ICD-10 Q87.8 · ICD-11 9C82.4
- PHENYLKETONURIA (PKU) · HYPERPHENYLALANINEMIA, MILD, INCLUDED; HPA, INCLUDED; PAH · ICD-10 E70.0, E70.1 · ICD-11 5C50.00
- PHENYLKETONURIA, FETAL EFFECTS FROM MATERNAL (MPKU) · ICD-10 E70.1 · ICD-11 5C50.02
- PHOSPHATIDYLINOSITOL 4-KINASE TYPE 2 ALPHA DEFICIENCY (PI4K2A) · PHOSPHATIDYLINOSITOL 4-KINASE, TYPE II · ICD-10 G40.4 · ICD-11 5C53.2Y
- PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY 1, CYTOSOLIC (PEPCK1) · PEPCK-C; PEPCK1 DEFICIENCY, CYTOSOLIC · ICD-10 E74.4 · ICD-11 5C51.3
- PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, MITOCHONDRIAL (PEPCK2) · PEPCK-M; PEPCK2 DEFICIENCY · ICD-10 E74.4 · ICD-11 5B52
- PHOSPHOGLYCERATE KINASE 1 DEFICIENCY · PGK1 DEFICIENCY · ICD-10 E74.0 · ICD-11 5C53.2Y
- PHOSPHOHYDROXYLYSINURIA (PHLU) · ICD-10 E72.9 · ICD-11 5C60.1
- PHOSPHOPANTOTHENOYLCYSTEINE DECARBOXYLASE DEFCiENCY (PPCDC) · ICD-10 I42.0
- PHOSPHORIBOSYL PYROPHOSPHATE SYNTHETASE I DEFECT (CMTX5) · CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5; ROSENBERG-CHUTORIAN SYNDROME; PRPS1 · ICD-10 G60.0 · ICD-11 8B44.00
- PHOSPHORIBOSYLAMINOIMIDAZOLE CARBOXYLASE DEFICIENCY (PAICSD) · PAICS DEFICIENCY; PAICS · ICD-10 E79.8 · ICD-11 ---
- PHOSPHORIBOSYLFORMYLGLYCINAMIDINE SYNTHASE DEFICIENCY (PFAS) · ICD-10 E79.8
- PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY (PRPPS) · PRPS1 SUPERACTIVITY · ICD-10 E79.8 · ICD-11 5C50.E0
- PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY · PSAT · ICD-10 E72.8 · ICD-11 5C54.0
- PHOSPHOSERINE PHOSPHATASE DEFICIENCY (PSPH) · PSPHD · ICD-10 E72.8 · ICD-11 5C56.0Y
- PITUITARY HORMONE DEFICIENCY, COMBINED, 1 (CPHD1) · POU1F1 · ICD-10 E23.0 · ICD-11 XM9KW2
- PITUITARY HORMONE DEFICIENCY, COMBINED, 2 (CPHD2) · PANHYPOPITUITARISM; HANHART DWARFISM; PROP1 · ICD-10 E23.0 · ICD-11 5A72.0
- PITUITARY HORMONE DEFICIENCY, COMBINED, 3 (CPHD3) · PITUITARY HORMONE DEFICIENCY, COMBINED, WITH RIGID CERVICAL SPINE DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM; LHX3 · ICD-10 E23.0 · ICD-11 KB60.40
- PITUITARY HORMONE DEFICIENCY, COMBINED, 4 (CPHD4) · SHORT STATURE, PITUITARY AND CEREBELLAR DEFECTS, AND SMALL SELLA TURCICA; LHX4 · ICD-10 E23.0 · ICD-11 BC65.0
- PITUITARY STALK INTERRUPTION SYNDROME (PSIS) · ECTOPIC NEUROHYPOPHYSIS · ICD-10 E23.6 · ICD-11 5C53.23
- POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY (PGBM1) · POLYGLUCOSAN BODY MYOPATHY, EARLY-ONSET, WITH OR WITHOUT IMMUNODEFICIENCY; PBMEI ; RBCK1 · ICD-10 E74.0 · ICD-11 DC10.02
- POLYGLUCOSAN BODY MYOPATHY 2 (PGBM2) · GYG1 · ICD-10 E74.0 · ICD-11 8A03.14
- POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM (APBN) · ADULT POLYGLUCOSAN BODY DISEASE (APBD); GBE1 · ICD-10 E74.0 · ICD-11 8A03.14
- POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT (PHARC) · ICD-10 G60.1 · ICD-11 8A62
- PONTOCEREBELLAR HYPOPLASIA · HEATR5B · ICD-10 Q04.3 · ICD-11 8A62.Y
- PONTOCEREBELLAR HYPOPLASIA, TYPE 10 (PCH10) · CLP1 · ICD-10 Q04.3 · ICD-11 5C53.21
- PONTOCEREBELLAR HYPOPLASIA, TYPE 11 (PCH11) · TBC1D23 · ICD-10 Q04.3 · ICD-11 5C53.21
- PONTOCEREBELLAR HYPOPLASIA, TYPE 12 (PCH12) · ICD-10 Q04.3 · ICD-11 5C53.21
- PONTOCEREBELLAR HYPOPLASIA, TYPE 13 (PCH13) · VPS51 · ICD-10 Q04.3 · ICD-11 LD24.00
- PONTOCEREBELLAR HYPOPLASIA, TYPE 14 (PCH14) · PPIL1 · ICD-10 Q04.3 · ICD-11 8A60.9
- PONTOCEREBELLAR HYPOPLASIA, TYPE 1A (PCH1A) · VRK1 · ICD-10 Q04.3 · ICD-11 5C53.20
- PONTOCEREBELLAR HYPOPLASIA, TYPE 1B (PCH1B) · EXOSC3 · ICD-10 Q04.3 · ICD-11 LD2H.Y
- PONTOCEREBELLAR HYPOPLASIA, TYPE 1C (PCH1C) · EXOSC8 · ICD-10 Q04.3 · ICD-11 LD2H.Y
- PONTOCEREBELLAR HYPOPLASIA, TYPE 1D (PCH1D) · EXOSC9 · ICD-10 Q04.3 · ICD-11 5C53.Y
- PONTOCEREBELLAR HYPOPLASIA, TYPE 1E (PCH1E) · SLC25A46 · ICD-10 Q04.3 · ICD-11 8A62.Y
- PONTOCEREBELLAR HYPOPLASIA, TYPE 2A (PCH2A) · TSEN54 · ICD-10 Q04.3 · ICD-11 5C56.2Z
- PONTOCEREBELLAR HYPOPLASIA, TYPE 2B (PCH2B) · TSEN2 · ICD-10 Q04.3 · ICD-11 5A60.0
- PONTOCEREBELLAR HYPOPLASIA, TYPE 2C (PCH2C) · TSEN34 · ICD-10 Q04.3 · ICD-11 8A62
- PONTOCEREBELLAR HYPOPLASIA, TYPE 2D (PCH2D) · SEPSECS · ICD-10 Q04.3 · ICD-11 5C80.2
- PONTOCEREBELLAR HYPOPLASIA, TYPE 2F (PCH2F) · TSEN15 · ICD-10 Q04.3 · ICD-11 8A03.14
- PONTOCEREBELLAR HYPOPLASIA, TYPE 3 (PCH3) · PCLO · ICD-10 Q04.3 · ICD-11 5C53.2Y
- PONTOCEREBELLAR HYPOPLASIA, TYPE 4 (PCH4) · TSEN54 · ICD-10 Q04.3 · ICD-11 8A62.0
- PONTOCEREBELLAR HYPOPLASIA, TYPE 5 (PCH5) -> (PCH4) · TSEN54 · ICD-10 Q04.3 · ICD-11 8A62
- PONTOCEREBELLAR HYPOPLASIA, TYPE 6 (PCH6) · RARS2 · ICD-10 Q04.3 · ICD-11 3A73
- PONTOCEREBELLAR HYPOPLASIA, TYPE 7 (PCH7) · TOE1 · ICD-10 Q04.3 · ICD-11 5C53.21
- PONTOCEREBELLAR HYPOPLASIA, TYPE 8 (PCH8) · CHMP1A · ICD-10 Q04.3 · ICD-11 5C53.21
- PONTOCEREBELLAR HYPOPLASIA, TYPE 9 (PCH9) · AMPD2 · ICD-10 Q04.3 · ICD-11 5B3Z
- PORPHYRIA CUTANEA TARDA, TYPE I (PCT) · ICD-10 E80.1 · ICD-11 5C50.E0
- PORPHYRIA CUTANEA TARDA, TYPE II (HEP) · HEPATOERYTHROPOIETIC PORPHYRIA, FAMILIAL TYPE · ICD-10 E80.1 · ICD-11 5C50.A3
- PORPHYRIA VARIEGATA (VP) · VARIEGATE PORPHYRIA; PPOX · ICD-10 E80.2 · ICD-11 5C52.01
- POSTAXIAL ACROFACIAL DYSOSTOSIS (POADS) · DIHYDROOROTATE DEHYDROGENASE DEFICIENCY (DHODH); MILLER SYNDROME · ICD-10 Q75.4 · ICD-11 5C55.2
- PRADER-WILLI SYNDROME (PWS) · PRADER-LABHART-WILLI SYNDROME · ICD-10 Q87.1 · ICD-11 LD90.3
- PREMATURE INFANTS [DD] · ICD-10 P07.3 · ICD-11 6A00.Z
- PREMATURE INFANTS, BRONCHOPULMONARY DYSPLASIA (BPD) [DD] · ICD-10 P27.1 · ICD-11 5C51.Y
- PRENATAL NICOTINE EXPOSURE DURING PREGNANCY [DD] · Maternal smoking during pregnancy · ICD-10 P04.2 · ICD-11 8A62
- PREP-RELATED NEURODEVELOPMENTAL DISORDER (NEW) · ICD-10 E88.8
- PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES (PASNA) · APA WITH SEIZURES AND NEUROLOGICAL ABNORMALITIES; CACNA1D · ICD-10 E26.0 · ICD-11 8B44.01
- PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS (PEO) · POLG · ICD-10 H49.4 · ICD-11 8A61.41
- PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 6 (PEOA6) · DNA2 · ICD-10 G71.3 · ICD-11 EC23.2Y
- PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2 (PEOB2) · RNASEH1 · ICD-10 G71.3 · ICD-11 4A01.23
- PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 6 (PEOB6) · ICD-10 G71.3
- PROLIDASE DEFICIENCY · ICD-10 E72.8 · ICD-11 5C50.B
- PROOPIOMELANOCORTIN DEFICIENCY (POMC) · OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR (OBAIRH) · ICD-10 E66.8 · ICD-11 8A62.Y
- PROPIONIC ACIDEMIA (PA, PCCA) · KETOTIC HYPERGLYCINEMIA; PA; PROPIONIC ACIDEMIA; PCCA · ICD-10 E71.1 · ICD-11 5C50.E0
- PROPIONIC ACIDEMIA (PA, PCCB) · KETOTIC HYPERGLYCINEMIA; PA; PROPIONIC ACIDEMIA; PCCB · ICD-10 E71.1 · ICD-11 5C53.2Y
- PROTOPORPHYRIA, ERYTHROPOIETIC (EPP1) · FERROCHELATASE DEFICIENCY; FECH · ICD-10 E80.0 · ICD-11 5A13.6
- PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED (XLEPP) · XLDPP; ALAS2 · ICD-10 E80.0 · ICD-11 LD24.3
- PROXIMAL RENAL TUBULAR ACIDOSIS-OCULAR ANOMALY SYNDROME (PRTAO) · SLC4A4 · ICD-10 N25.8 · ICD-11 5C64.41
- PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT (PHA1A) · MCR, NR3C2 · ICD-10 N25.8 · ICD-11 3A10.Y
- PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE (PHA1B) · SCNN1A, SCNN1B, SCNN1G · ICD-10 N25.8 · ICD-11 8A03.14
- PSEUDOHYPOALDOSTERONISM, TYPE IIA (PHA2A) · GORDON HYPERKALEMIA-HYPERTENSION SYNDROME; WNK1, WNK4, KLHL3, CUL3 · ICD-10 I15.1 · ICD-11 5C56.2Z
- PSEUDOHYPOALDOSTERONISM, TYPE IIB (PHA2B) · WNK4 · ICD-10 I15.1 · ICD-11 8A03.1Y
- PSEUDOHYPOALDOSTERONISM, TYPE IIC (PHA2C) · WNK1 · ICD-10 I15.1 · ICD-11 5B5F
- PSEUDOHYPOALDOSTERONISM, TYPE IID (PHA2D) · KLHL3 · ICD-10 I15.1 · ICD-11 5B5F
- PSEUDOHYPOALDOSTERONISM, TYPE IIE (PHA2E) · CUL3 · ICD-10 I15.1 · ICD-11 3A10.Y
- PSEUDOHYPOPARATHYROIDISM, TYPE IA (PHP1A) · ALBRIGHT HEREDITARY OSTEODYSTROPHY · ICD-10 E20.1 · ICD-11 5A50.1
- PSEUDONEONATAL ADRENOLEUKODYSTROPHY · PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY; ACOX1 · ICD-10 E71.3 · ICD-11 8C73.1
- PULMONARY HEMOSIDEROSIS · IPH; IDIOPATHIC PULMONARY HEMOSIDEROSIS · ICD-10 E83.1+, J99.8* · ICD-11 5C53.23
- PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY (PNP) · PNP · ICD-10 D81.5 · ICD-11 3B14.2
- PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY (PNPO) · PNPO; SEIZURES, PYRIDOXINE-RESISTANT, PLP-SENSITIVE · ICD-10 G40.8 · ICD-11 5C54
- PYRUVATE CARBOXYLASE DEFICIENCY (PC) · LACTIC ACIDEMIA WITHOUT HYPOXEMIA, LEIGH SYNDROME · ICD-10 E74.4 · ICD-11 5C53.03
- PYRUVATE DEHYDROGENASE DEFICIENCY (E1); PDC · PYRUVATE DEHYDROGENASE COMPLEX, E1-ALPHA; PDHA1 · ICD-10 E74.4 · ICD-11 5C53.02
- PYRUVATE DEHYDROGENASE DEFICIENCY (E2) · PDHDD; LACTIC ACIDEMIA DUE TO DEFECT OF E2 LIPOYL TRANSACETYLASE OF THE PYRUVATE DEHYDROGENASE COMPLEX · ICD-10 E74.4 · ICD-11 5C50.E0
- PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD · PDHB · ICD-10 E74.4 · ICD-11 5C53.20
- PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY · LACTIC ACIDEMIA DUE TO DEFECT IN LIPOYL-CONTAINING COMPONENT X OF THE PYRUVATE DEHYDROGENASE COMPLEX; PDHX · ICD-10 E74.4 · ICD-11 5C51.3
- PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY (PDHPD) · LACTIC ACIDEMIA WITH PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY; PDP1 · ICD-10 E74.4 · ICD-11 5C50.B
- PYRUVATE KINASE DEFICIENCY · PYRUVATE KINASE DEFICIENCY OF ERYTHROCYTE; PK DEFICIENCY; PKLR · ICD-10 D55.2 · ICD-11 3A10.Y
- RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 1 (RILDBC1) · FARSB · ICD-10 G93.8 · ICD-11 8A62.Y
- RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 2 (RILDBC2) · FARSA · ICD-10 G93.8 · ICD-11 LD20.2
- REFSUM DISEASE, CLASSIC · PHYTANIC ACID OXIDASE DEFICIENCY; PHYTANIC ACID STORAGE DISEASE · ICD-10 G60.1 · ICD-11 5C57.1
- RENAL FAILURE, ACUTE OR CHRONIC [DD] · ACUTE KIDNEY INJURY / CHRONIC RENAL FAILURE · ICD-10 N19 · ICD-11 5C51.4Y
- RENAL TUBULAR ACIDOSIS, DISTAL, 1 (DRTA1) · SLC4A1 · ICD-10 N25.8 · ICD-11 3A10.Y
- RENAL TUBULAR ACIDOSIS, DISTAL, 3, WITH OR WITHOUT SENSORINEURAL HEARING LOSS (DRTA3) · ATP6V0A4 · ICD-10 N25.8 · ICD-11 5C60.Y
- ReNU SYNDROME (RENU) · NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, BRAIN ANOMALIES, DISTINCTIVE FACIES, AND ABSENT LANGUAGE (NEDHAFA)
- RESPIRATORY CHAIN DEFICIENCIES [DD] · ICD-10 E88.8 · ICD-11 5C50.E1
- RESPIRATORY DISTRESS SYNDROME, HYALINE MEMBRANE DISEASE [DD] · ICD-10 P22.0 · ICD-11 5C52.11
- RETICULAR DYSGENESIS · SEVERE COMBINED IMMUNODEFICIENCY WITH LEUKOPENIA; DE VAAL DISEASE; AK2 · ICD-10 D81.0 · ICD-11 5C56.2Z
- RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME (RDJCSS) · RDH11 · ICD-10 Q87.8 · ICD-11 5C53.2Y
- RETINITIS PIGMENTOSA 59 (CDG) · CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ibb, INCLUDED; DHDDS-CDG · ICD-10 H35.5 · ICD-11 5C53.23
- RETINITIS PIGMENTOSA 79 (RP79) · HK1 · ICD-10 H35.5 · ICD-11 3C0Y
- RETINITIS PIGMENTOSA 99, X-LINKED · ICD-10 H35.5
- RETT SYNDROME (RTT) · AUTISM, DEMENTIA, ATAXIA, AND LOSS OF PURPOSEFUL HAND USE; MECP2 · ICD-10 F84.2 · ICD-11 4A01.21
- REYE SYNDROME (RS) · ICD-10 G93.7 · ICD-11 NE60
- REYE SYNDROME LIKE MANIFESTATIONS · FATTY METAMORPHOSIS OF VISCERA; VISCERA, FATTY METAMORPHOSIS · ICD-10 G93.7 · ICD-11 8A02.11
- RHABDOMYOLYSIS AND MYOGLOBINURIA [DD] · ICD-10 M62.89 · ICD-11 5C53.2Y
- RIBOFLAVIN TRANSPORTER 1 DEFICIENCY (RTD1) · RIBOFLAVIN TRANSPORTER DEFICIENCY, TYPE 1; SLC52A1 · ICD-10 P00.4 · ICD-11 5C52.10
- RIBOFLAVIN TRANSPORTER 2 DEFICIENCY (RTD2) · BROWN-VIALETTO-VAN LAERE SYNDROME 2 (BVVLS2); SLC52A2 · ICD-10 G12.1 · ICD-11 5C53.2Y
- RIBONUCLEOTIDE REDUCTASE, M2B (RRM2B) · MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY); RRM2B · ICD-10 G31.8 · ICD-11 5C64.10
- RIBOSE-5-PHOSPHATE ISOMERASE DEFICIENCY · RPIA · ICD-10 G93.8 · ICD-11 ---
- S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY (SAHH) · HYPERMETHIONINEMIA, FAMILIAL; AHCY · ICD-10 E72.1 · ICD-11 5C56.3Y
- SALLA DISEASE · SIALURIA, FINNISH TYPE · ICD-10 E77.8 · ICD-11 5C54.0
- SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME (SPDRS) · GM3 SYNTHASE DEFICIENCY; ST3GAL5-CDG; ST3GAL5 · ICD-10 E77.8 · ICD-11 5C55.0Y
- SARCOSINEMIA · SARCOSINE DEHYDROGENASE COMPLEX DEFICIENCY; HYPERSARCOSINEMIA; SARDH · ICD-10 E72.5 · ICD-11 5C50.71
- SC4MOL DEFICIENCY · MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS; MCCPD; MSMO1 · ICD-10 E88.8 · ICD-11 GB6Z
- SCAVANGER RECEPTOR B1 DEFICIENCY (SCARB1) · HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 6; HDLCQ6 · ICD-10 E88.8 · ICD-11 6A00.Z
- SCHNECKENBECKEN DYSPLASIA (CDG) · CHONDRODYSPLASIA, LETHAL NEONATAL, WITH SNAIL-LIKE PELVIS; SLC35D1-CDG; · ICD-10 Q77.7 · ICD-11 LD24.D
- SEDOHEPTULOKINASE DEFICIENCY (SHPKD) · SHPK · ICD-10 E88.8 · ICD-11 LD2H.Y
- SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME (SCBMS) · ICD-10 Q02
- SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE (SESAMES) · SESAME SYNDROME; EAST SYNDROME; KCNJ10 · ICD-10 G40.4 · ICD-11 5C56.30
- SENGERS SYNDROME · CATARACT AND CARDIOMYOPATHY; AGK · ICD-10 Q87.8 · ICD-11 4A85.0Z
- SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS (SANDO) · SENSORY ATAXIC NEUROPATHY WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE · ICD-10 E88.8 · ICD-11 5C53.21
- SEPSIS, NEONATAL [DD] · ICD-10 P36.9 · ICD-11 5D2Z
- SERINE DEFIENCY SYNDROME (NEW DISEASE?) · ICD-10 E72.8 · ICD-11 ---
- SEVERE COMBINED IMMUNODEFICIENCY (SCID) · ICD-10 D81.0 - D18.9 · ICD-11 5C58.02
- SEVERE COMBINED IMMUNODEFICIENCY DUE TO ADENOSINE DEAMINASE DEFICIENY (ADA-SCID) · SCID DUE TO ADA DEFICIENCY · ICD-10 D81.3 · ICD-11 5B5A
- SHORT CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY (HADH) · SHADH DEFICIENCY, SCHAD DEFICIENCY, FORMERLY · ICD-10 E71.3 · ICD-11 5C52.01
- SHORT CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY (SCAD) · ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF; ACADS · ICD-10 E71.3 · ICD-11 5C52.01
- SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS (SDDHD, TKT) · TRANSKETOLASE DEFICIENCY; TKT · ICD-10 E88.8 · ICD-11 5D0Y
- SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION (SSMED) · ICD-10 Q87.1
- SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY (SOPH) · SOPH-SYNDROME; NBAS · ICD-10 Q87.1 · ICD-11 PL0Z
- SHORT-CHAIN DEHYDROGENASE/REDUCTASE FAMILY, MEMBER 9 (DHRS9) · ICD-10 G40.2
- SIALIC ACID STORAGE DISEASE, INFANTILE TYPE · INFANTILE SIALIC ACID STORAGE DISORDER · ICD-10 E77.8 · ICD-11 5C59.01
- SIALIDOSIS TYPE I · NEURAMINIDASE DEFICIENCY; MUCOLIPIDOSIS I · ICD-10 E77.1 · ICD-11 5A13.6
- SIALIDOSIS TYPE II · NEURAMINIDASE DEFICIENCY; MUCOLIPIDOSIS I; NEU1 · ICD-10 E77.1 · ICD-11 5C56.21
- SIALURIA · SIALURIA, FRENCH TYPE · ICD-10 E77.8 · ICD-11 LD20.01
- SIDEROBLASTIC ANEMIA 1 (SIDBA1) · ALAS2 · ICD-10 D64.0 · ICD-11 8A03.1Z
- SIDEROBLASTIC ANEMIA 2, PYRIDOXINE-REFRACTORY (SIDBA2) · SLC25A38 · ICD-10 D64.0 · ICD-11 5A2Y
- SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA (ASAT) · ABCB7 · ICD-10 D64.0 · ICD-11 8A44.4
- SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1 (SGBS1) · ICD-10 Q87.3 · ICD-11 LD2C
- SINGLETON-MERTEN SYNDROME 1 (SGMRT1) · ICD-10 Q78.8 · ICD-11 LD24.KY
- SINGLETON-MERTEN SYNDROME 2 (SGMRT2) · ICD-10 Q78.8 · ICD-11 LD24.KY
- SMITH-LEMLI-OPITZ SYNDROME (SLOS) · SLOS; DHCR7 · ICD-10 Q87.1 · ICD-11 5A9Y
- SMITH-MCCORT DYSPLASIA 2 (SMC2) · ICD-10 Q77.7
- SNIJDERS BLOK-CAMPEAU SYNDROME (SNIBCPS) · ICD-10 Q87.0
- SORBITOL DEHYDROGENASE DEFICIENCY · DISTAL HEREDITARY MOTOR NEURONOPATHY (HMNR8), SORD · ICD-10 E88.8 · ICD-11 5C53.23
- SOTOS SYNDROME 1 (SOTOS1) · CEREBRAL GIGANTISM; NSD1 · ICD-10 Q87.3 · ICD-11 5A72.1
- SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE (SPAX5) · AFG3L2 · ICD-10 G11.4 · ICD-11 LD24.K0
- SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE (SACS) · SACS · ICD-10 G11.1 · ICD-11 5C52.01
- SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT (SPG10) · u.c. · ICD-10 G11.4 · ICD-11 8B44.00
- SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE (SPG11) · u.c. · ICD-10 G11.4 · ICD-11 8B44.01
- SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT (SPG12) · u.c. · ICD-10 G11.4 · ICD-11 8B44.00
- SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE (SPG14) · u.c. · ICD-10 G11.4
- SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE (SPG15) · u.c. · ICD-10 G11.4
- SPASTIC PARAPLEGIA 16, AUTOSOMAL RECESSIVE (SPG16) · u.c. · ICD-10 G11.4
- SPASTIC PARAPLEGIA 17, AUTOSOMAL RECESSIVE (SPG17) · u.c. · ICD-10 G11.4
- SPASTIC PARAPLEGIA 18A, AUTOSOMAL RECESSIVE (SPG18A) · u.c. · ICD-10 G11.4
- SPASTIC PARAPLEGIA 18B, AUTOSOMAL RECESSIVE (SPG18B) · u.c. · ICD-10 G11.4
- SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT (SPG19) · u.c. · ICD-10 G11.4
- SPASTIC PARAPLEGIA 2, X-LINKED (SPG2) · ICD-10 G11.4 · ICD-11 LD90.Y
- SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE (SPG20) · u.c. · ICD-10 G11.4
- SPASTIC PARAPLEGIA 23, AUTOSOMAL RECESSIVE (SPG23) · u.c. · ICD-10 G11.4
- SPASTIC PARAPLEGIA 24, AUTOSOMAL RECESSIVE (SPG24) · u.c. · ICD-10 G11.4
- SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE (SPG28) · ICD-10 G11.4 · ICD-11 5C63.21
- SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT (SPG3A) · STRUMPELL DISEASE · ICD-10 G11.4 · ICD-11 8B44.00
- SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT (SPG4) · ICD-10 G11.4 · ICD-11 8B44.00
- SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE (SPG43) · ICD-10 G11.4 · ICD-11 8B44.01
- SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE (SPG5A) · ICD-10 G11.4 · ICD-11 4A41.2Z
- SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT (SPG6) · ICD-10 G11.4 · ICD-11 8B44.00
- SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CEREBELLAR ATAXIA (SPG7) · u.c. · ICD-10 G11.4 · ICD-11 8B44.01
- SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT (SPG73) · ICD-10 G11.4 · ICD-11 5C56.2Z
- SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT (SPG8) · u.c. · ICD-10 G11.4 · ICD-11 8B44.00
- SPASTIC PARAPLEGIA 82, AUTOSOMAL RECESSIVE (SPG82) · ICD-10 G11.4 · ICD-11 5C53.2Y
- SPASTIC PARAPLEGIA 91, AUTOSOMAL DOMINANT, WITH OR WITHOUT CEREBELLAR ATAXIA (SPG91) · ICD-10 G11.4
- SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT (SPG9A) · CATARACTS WITH MOTOR NEURONOPATHY, SHORT STATURE, AND SKELETAL ABNORMALITIES; ALDH18A1 · ICD-10 G11.4 · ICD-11 8A03.Z
- SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE (SPG9B) · ICD-10 G11.4 · ICD-11 5A13.6
- SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION (SPEMR) · ICD-10 G11.4 · ICD-11 5C53.2Y
- SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15 (SCAR15) · SALIH ATAXIA · ICD-10 G11.1
- SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20 (SCAR20) · SNX14 · ICD-10 Q87.8 · ICD-11 5D2Z
- SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21 (SCAR21) · CALFAN SYNDROME; SCYL1 · ICD-10 G11.0 · ICD-11 5C50.Y
- SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25 (SCAR25) · ATG5 · ICD-10 G11.1 · ICD-11 5A74.0
- SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 34 (SCAR34) · CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 3 · ICD-10 G11.8
- SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3 (SCAN3) · ICD-10 G11.1 · ICD-11 5C53.2Y
- SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE (SCE-EDS) · SLC39A13 · ICD-10 Q79.6 · ICD-11 5C52.0Y
- SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE (SCDO3) · LFNG · ICD-10 Q76.8 · ICD-11 8C73.Y
- SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE (SEMDG) · NANS · ICD-10 Q77.7 · ICD-11 8A62.Y
- SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE (SMDS) · METAPHYSEAL CHONDRODYSPLASIA, CONGENITAL LETHAL; GPX4 · ICD-10 Q77.8 · ICD-11 5C53.2Y
- SPONDYLOPERIPHERAL DYSPLASIA · COL2A1 · ICD-10 Q77.7 · ICD-11 8A62.Y
- SQUALENE SYNTHASE DEFICIENCY · NEURODEVELOPMENTAL DISORDER WITH LOW CHOLESTEROL AND ABNORMAL URINE ORGANIC ACIDS · ICD-10 E71.3 · ICD-11 8A6Y
- STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME (SHDRA) · TMEM260-CDG · ICD-10 Q20.8 · ICD-11 8A62.Y
- SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY (SSADH) · 4-HYDROXYBUTYRIC ACIDURIA; SSADH DEFICIENCY; ACIDEMIA, GAMMA-HYDROXYBUTYRIC;ALDH5A1 · ICD-10 E72.8 · ICD-11 5C50.E1
- SUCCINYL CoA: 3-KETOACID CoA TRANSFERASE DEFICIENCY (SCOT) · 3-@OXOACID CoA TRANSFERASE; OXCT; KETOACIDOSIS OF INFANCY · ICD-10 E71.3 · ICD-11 5C52.02
- SUDDEN CARDIAC FAILURE, INFANTILE (SCFI) · ICD-10 P29.0 · ICD-11 LD20.01
- SULFIDE QUINONE OXIDOREDUCTASE DEFICIENCY (SQOR) · SQOR · ICD-10 E88.9 · ICD-11 5C58.0Y
- SULFITE OXIDASE DEFICIENCY, ISOLATED (ISOD) · SULFOCYSTEINURIA; SUOX · ICD-10 E72.1 · ICD-11 5C50.B
- SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1 (SMDP1) · PULMONARY ALVEOLAR PROTEINOSIS; CONGENITAL ALVEOLAR PROTEINOSIS; SFTPB · ICD-10 P28.0 · ICD-11 5C53.20
- SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2 (SMDP2) · INTERSTITIAL LUNG DISEASE DUE TO SURFACTANT PROTEIN C DEFICIENCY; SFTPC · ICD-10 P28.8 · ICD-11 5C53.0Y
- SYNTAXIN-BINDING PROTEIN 6 (STXBP6) · ICD-10 G40.4 · ICD-11 8A62.Y
- TANGIER DISEASE (TGD) · TGD · ICD-10 E78.6 · ICD-11 5C64.41
- TELANGIECTASIA, IMPAIRED INTELLECTUAL DEVELOPMENT, MICROCEPHALY, METAPHYSEAL DYSPLASIA, EYE ABNORMALITIES, SHORT STATURE · TIMES SYNDROME · ICD-10 Q87.8 · ICD-11 8A62
- TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME (TPBS) · CHONDROITIN SULFATE SYNTHASE 1 DEFICIENCY; CHSY1-CDG · ICD-10 Q87.2 · ICD-11 KA21.4
- TESSADORI-BICKNELL-VAN HAAFTEN NEURODEVELOPMENTAL SYNDROME 1 (TEBIVANED1) · ICD-10 F84.8 · ICD-11 8A62.Y
- THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2 · ENCEPHALOPATHY, THIAMINE-RESPONSIVE, BTBGD; SLC19A3 · ICD-10 G93.8 · ICD-11 3A01.0
- THIAMINE METABOLISM DYSFUNCTION SYNDROME 3 (MICROCEPHALY TYPE); THMD3 · AMISH LETHAL MICROCEPHALY; SLC25A19 · ICD-10 Q02 · ICD-11 PL0Z
- THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY TYPE); THMD4 · BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY · ICD-10 E88.8 · ICD-11 PL0Z
- THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE); THMD5 · THIAMINE PYROPHOSPHOKINASE DEFICIENCY; TPK1 · ICD-10 G96.8 · ICD-11 5C63.22
- THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME (TRMA) · ROGERS SYNDROME · ICD-10 Q21.0 · ICD-11 5C53.23
- THIOPURINE METHYLTRANSFERASE DEFICIENCY · THIOPURINES, POOR METABOLISM OF, 1; THPM1; TPMT · ICD-10 E79.8 · ICD-11 8,00E+48
- THYMIDYLATE KINASE DEFICIENCY · NEURODEGENERATION, CHILDHOOD-ONSET, WITH PROGRESSIVE MICROCEPHALY; · ICD-10 G11.9 · ICD-11 5C53.2Y
- THYROID HORMONE METABOLISM, ABNORMAL (THMA) · SECISBP2 · ICD-10 E03.1 · ICD-11 GB82
- TIMOTHY SYNDROME (TS) · CACNA1C · ICD-10 I45.8 · ICD-11 LD90
- TRANSALDOLASE DEFICIENCY · TALDO DEFICIENCY · ICD-10 E74.8 · ICD-11 5D2Z
- TRANSCOBALAMIN I DEFICIENCY · TCN1 DEFICIENCY · ICD-10 E53.8 · ICD-11 8A03.0
- TRANSCOBALAMIN II DEFICIENCY · TCN2 DEFICIENCY · ICD-10 D51.2 · ICD-11 5C58.1Y
- TRANSIENT NEONATAL DIABETES MELLITUS 1 (TNDM1) · ZFP57 · ICD-10 P70.2 · ICD-11 5B52
- TRANSIENT NEONATAL DIABETES MELLITUS 2 (TNDM2) · ABCC8 · ICD-10 P70.2 · ICD-11 LD2F.1Y
- TRIMETHYLAMINURIA (FMO3) · FISH ODOR SYNDROME; FMO3 DEFICIENCY · ICD-10 E88.8 · ICD-11 5C50.G
- TRIMETHYLAMINURIA, SECONDARY (FMAU) · ICD-10 E88.9 · ICD-11 8A62
- TRIOSEPHOSPHATE ISOMERASE DEFICIENCY (TPID) · ICD-10 D55.2 · ICD-11 5C53.4
- TRYPTOPHANURIA WITH DWARFISM · HYPERTRYPTOPHANEMIA · ICD-10 E70.8 · ICD-11 5C50.F2
- TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1 (HFTC) · MORBUS TEUTSCHLAENDER; GALTNT3-CDG · ICD-10 M11.2 · ICD-11 KA06.1
- TYROSINE HYDROXYLASE DEFICIENCY · SEGAWA SYNDROME, AUTOSOMAL RECESSIVE; L-DOPA RESPONSIVE DYSTONIA; TH · ICD-10 G24.1 · ICD-11 5C54.0
- TYROSINEMIA I · FUMARYLACETOACETATE HYDROLASE DEFICIENCY; HEPATORENAL TYROSINEMIA; TYROSINOSIS, ACUTA AND CHRONIC; FUMARYLACETOACETASE · ICD-10 E70.2 · ICD-11 5C50.11
- TYROSINEMIA II · RICHNER-HANHART SYNDROME. OCULOCUTANEOUS TYROSINEMIA, TYROSINE TRANSAMINASE DEFICIENCY · ICD-10 E70.2 · ICD-11 5C50.12
- TYROSINEMIA III · 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY · ICD-10 E70.2 · ICD-11 5C64.20
- TYROSINEMIA, TRANSIENT, OF THE NEWBORN · TYROSINE METABOLISM, DELAYED MATURATION IN · ICD-10 P74.5 · ICD-11 5C55.1
- UREIDOPROPIONASE DEFICIENCY · BETA-AMINOISOBUTYRIC ACID, URINARY EXCRETION OF · ICD-10 E79.8 · ICD-11 5C50.E0
- UREMIA [DD] · ICD-10 N19 · ICD-11 5C52.00
- URIDINE 5-PRIME MONOPHOSPHATE HYDROLASE DEFICIENCY · NT5C3A · ICD-10 D55.3 · ICD-11 5C53.22
- URIDINE-CYTIDINEURIA (URCTU) · NUCLEOSIDE TRANSPORTER-1 DEFICIENCY; SLC28A1 · ICD-10 E88.8 · ICD-11 5C50.E0
- UROCANASE DEFICIENCY (UROCD) · UROC1 · ICD-10 E70.8 · ICD-11 5C64.41
- VERY-LONG-CHAIN ACYL CoA DEHYDROGENASE DEFICIENCY (VLCAD) · VLCAD DEFICIENCY; ACADVLD · ICD-10 E71.3 · ICD-11 5C53.4
- VICI SYNDROME (VICIS) · IMMUNODEFICIENCY WITH CLEFT LIP/PALATE, CATARACT, HYPOPIGMENTATION, AND ABSENT CORPUS CALLOSUM; EPG5 · ICD-10 Q87.8 · ICD-11 LD90.Y
- VITAMIN B12 DEFICIENCY [DD] · ICD-10 E53.8 · ICD-11 5C52.00
- VITAMIN B12 DEFICIENCY IN PREGNANCY [DD] · ICD-10 E53.8 · ICD-11 8C73.Z
- VITAMIN D DEFICIENCY IN PREGNANCY [DD] · ICD-10 E55.9 · ICD-11 5C53.23
- VITAMIN D-DEPENDENT RICKETS, TYPE 2A (VDDR2A) · VITAMIN D-DEPENDENT RICKETS, TYPE 2A, WITH OR WITHOUT ALOPECIA; VDR · ICD-10 E83.3 · ICD-11 5C53.2Y
- VITAMIN E DEFICIENCY (AVED) · FAMILIAL ISOLATED DEFICIENCY OF VITAMIN E; TTPA · ICD-10 G11.1 · ICD-11 KB60.20
- WILSON DISEASE (WD) · HEPATOLENTICULAR DEGENERATION; ATP7B · ICD-10 E83.0 · ICD-11 5C64.00
- WOLCOTT-RALLISON SYNDROME · WRS; EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS; EIF2AK3 · ICD-10 E13 · ICD-11 LD28.2
- WOLFRAM SYNDROME 1 (WFS1) · DIABETES MELLITUS AND INSIPIDUS WITH OPTIC ATROPHY AND DEAFNESS · ICD-10 E13.8 · ICD-11 5C50.8
- WOLFRAM SYNDROME 2 (WFS2) · ICD-10 E13.8 · ICD-11 5A72.0
- WOLFRAM-LIKE SYNDROME (WFSL) · HEARING LOSS, PROGRESSIVE, WITH OPTIC ATROPHY AND/OR IMPAIRED GLUCOSE REGULATION · ICD-10 E34.8 · ICD-11 8C73.Y
- WOODHOUSE-SAKATI SYNDROME · HYPOGONADISM, ALOPECIA, DIABETES MELLITUS, MENTAL RETARDATION, DEAFNESS, AND EXTRAPYRAMIDAL SYNDROME; DCAF17 · ICD-10 Q87.8 · ICD-11 ---
- X-LINKED ACROGIGANTISM (XLAG) · CHROMOSOME Xq26.3 DUPLICATION SYNDROME · ICD-10 E22.0 · ICD-11 LA05.0
- X-LINKED ALPORT SYNDROME-DIFFUSE LEIOMYOMATOSIS · ICD-10 Q87.8
- X-LINKED ICHTHYOSIS · STEROID SULFATASE DEFICIENCY; STS · ICD-10 Q80.1 · ICD-11 5C53.24
- XANTHINURIA TYPE I · XANTHINURIA; XANTHINE OXIDASE DEFICIENCY; XDH · ICD-10 E79.8 · ICD-11 5C55.00
- XANTHINURIA TYPE II · XANTHINE DEHYDROGENASE AND ALDEHYDE OXIDASE; MOCOS · ICD-10 E79.8 · ICD-11 5C50.0Y
- XIA-GIBBS SYNDROME (XIGIS) · MENTAL RETARDATION, AUTOSOMAL DOMINANT 25, FORMERLY; MRD25, · ICD-10 Q87.8 · ICD-11 8A62.Y
- YME1L1 DEFICIENCY · OPTIC ATROPHY 11; OPA11; YME1L1 · ICD-10 H47.2 · ICD-11 6A0Y
- ZIEGLER-HUANG SYNDROME (ZHS) · ZINC TRANSPORTER 7; ZNT7 · ICD-10 Q87.8 · ICD-11 8A62.Y
- ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD; FEEDING: BREAST MILK [DD] · ZINC DEFICIENCY, NEONATAL, DUE TO LOW BREAST MILK ZINC; SLC30A2 · ICD-10 E60 · ICD-11 5C56.0Y

